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Prediker 11:5 (1983) “Net so min as wat jy kan verstaan 
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swanger vrou, net so min kan jy die werk van God 
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ABSTRACT OF THE THESIS  
 
CHAPTER 1  
In this chapter the aim is to outline the different chapters under section A. 
 
Against this background, we will conduct a literature review of relevant studies 
performed, and evaluate their comments regarding identifying embryo markers 
which can be utilized to improve overall ART outcome. We will evaluate the 
embryo marker sHLA-G in detail, using a prospective randomized study as well 
as a retrospective multi-centre study. The role of the morphology and genetic 
profile of an oocyte, zygote and embryo and subsequent blastocyst formation will 
be evaluated with the help of WGA/CGH. The work will then be summarized and 
conclusions will be made as well as possible suggestions for future directions will 
be indicated. In section B the methodology of the studies explaining the role of 
the candidate is illustrated. 
 
CHAPTER 2 
In this chapter the impact of the oocyte/zygote and the embryo on 
implantation/pregnancy rate was discussed. The morphologic characteristics of 
the oocyte, the cumulus–oocyte-complex (COC), the zona pellucida, the 
perivitelline space, cytoplasm and meiotic spindle and the polar body and its 
appearance were discussed in detail.  The morphologic characteristics of  
embryo fragmentation and its effect on embryo development, ploidy and 
blastocyst formation were also studied. Embryo markers to predict pregnancy 
outcome were researched based on the international literature. The pronuclear 
morphology and early cleavage were highlighted as non-invasive embryo 
markers to predict outcome. 
 
A non-invasive biochemical marker, soluble Human Leucocyte-Antigen-G  
(sHLA-G), that is expressed by developing embryos was researched. The value 
of blastocyst transfer and the improved ongoing pregnancy rate compared to 
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cleavage stage embryos were highlighted based on a recent meta-analysis. A 
detailed discussion on sHLA-G as well as Array-CGH and the future of these 
tests followed. 
 
CHAPTER 3 
In this chapter the aim was to compare pregnancy and implantation rates when 
embryos are selected based on a single Day 3 (D 3) morphology score vs. a 
GES score plus sHLA-G expression. This was a prospective randomized study 
(n = 214) undergoing fresh ICSI cycles. Embryos were selected for transfer based 
on either Day 3 morphology score (Group A) or GES-scoring plus sHLA-G 
expression (Group B). The following results were reported: Clinical [35/107 (33%) 
vs. 52/107 (49%)] and ongoing pregnancy [20/107 (19%) vs. 52/107 (49%)] rates 
were significantly different between Group A and Group B (p < 0.05). Implantation 
rates were not significantly different between Group A [52/353 (15%)] and Group 
B [73/417 (18%)] (p < 0.05). The number of pregnancies lost during the first 
trimester was nearly 12 times higher in Group A [25/52 (48%)]. It was concluded 
that the miscarriage rate was significantly lower in Group B than Group A and the 
pregnancy results were superior when embryos were selected based on GES 
plus sHLA-G expression. 
 
CHAPTER 4 
Several studies have reported an association between the presence of soluble 
human leukocyte antigen-G (sHLA-G) in human embryo culture supernatants 
(ES) with implantation and pregnancy outcome in vitro. However, the actual 
presence role during implantation and effect on implantation and pregnancy 
outcome are still controversial. A retrospective multi-centre study was performed 
on 2040 ICSI patients in six different centers.  All embryos were individually 
cultured and a chemiluminescence enzyme-linked immunosorbent assay (ELISA) 
was used to detect the presence of sHLA-G in culture medium surrounding 
embryos.  In all centers, a positive sHLA-G result was associated with an 
increase in odds of multiple clinical implantations (OR: 1.48, 95% CI: 1.07 to 
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2.05, p-value: 0.0170), and an increased odds of multiple on-going pregnancies 
(OR: 1.66, 95% CI: 1.10, 2.51, p-value: 0.0170). Data from this multi-centre study 
emphasize that sHLA-G expression is a valuable non-invasive embryo marker to 
assist in improving pregnancy outcome with the theoretical potential to reduce 
multiple pregnancies.  A combination of sHLA-G expression and extended 
embryo culture to the blastocyst stage might provide future tools by which to 
select single embryos for transfer and reduce the risk of multiple gestational, 
without compromising their pregnancy rates. 
 
CHAPTER 5 
In this chapter the ploidy status of first and second polar bodies and Day 3 
blastomere, embryo morphology and biochemical (sHLA-G) characteristics were 
correlated with blastocyst development and subsequent pregnancy outcome. All 
oocytes/zygotes and embryos were individually cultured to the blastocyst stage. 
PB-I, PB-II and blastomeres underwent whole genome amplification (WGA) and 
comparative genome hybridization (CGH) and complete karyotyping.  Each 
embryo‟s culture medium supernatant was collected and analyzed for sHLA-G 
expression on Day 2. The following results were reported:  Fifty seven mature 
(MII) donor oocytes were obtained, 33/57 (57.9%) were aneuploid, 21/57 (36.8%) 
were euploid and 3/57 (5%) were “inconclusive”. No correlation was found 
between CGH status of PB-I, PB-II and the GES-score. Furthermore, no 
correlation was established between PB-I CGH results and blastocyst 
morphology grade. There was a significant correlation between PB-I CGH and 
blastomere CGH results. Euploid and aneuploid PB-I developed into 58% and 
67% blastocysts, respectively. Kappa statistics (>0.7) revealed a positive 
correlation between the ploidy of PB-I, PB-II and the blastomeres. It was 
concluded that following ICSI and sequential genetic karyotyping of the 
oocyte/zygote and subsequent blastomeres, the majority of oocytes fertilized and 
subsequent zygotes developed into blastocysts, despite their ploidy status.  We 
therefore conclude that blastocyst development is not associated with ploidy. 
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CHAPTER 6 
Identifying a developmentally competent embryo to transfer that has the highest 
probability to develop into a live baby has been an issue of debate and continues 
research. The aim of this chapter is to discuss the morphological, biochemical 
and genetic features of an embryo that has been shown to be predictive of 
implantation and pregnancy outcome in ART using most current evidence. 
A literature search was performed looking at the correlation between pronuclear 
morphology, early cleavage, cleavage stage embryos, blastocyst development, 
the presence of sHLA-G, CGH, embryo development and implantation/pregnancy 
rates in ART. Based on the available literature, a combination of observations 
could assist the scientist with embryo selection. The pronuclear stage 
morphology, the early embryo division, cleavage embryo stage and quality of the 
day 3 embryos provides limited guidance.  However, choosing a blastocyst with a 
positive sHLA-G result on Day 5 is the optimal combination to make the final 
selection before embryo transfer or freezing. This non-invasive approach should 
improve pregnancy outcome and reduce multiple pregnancy rates. As far as the 
use of the more invasive technology such as aCGH is concerned, more research 
on pregnancy outcome is needed. 
 
CHAPTER 7 
A combination of observations for embryo selection, starting with oocyte grading, 
pronuclear stage morphology, early zygote cleaving and cleavage-stage embryo 
morphology/quality on Day-3, however, ultimately using extended embryo culture 
and choosing a blastocyst on Day 5 with positive sHLA-G values available, will 
assist the scientist in making the final decision before selecting an embryo for 
transfer or cryopreservation. The use of aCGH (for chromosomal analysis) is 
invasive and is still considered experimental. 
 
Finally we conclude that despite all the above mentioned parameters to select an 
embryo for transfer that will develop into a live baby, more extensive research 
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and international corroboration is needed in order to improve and standardize 
embryo selection criteria. 
 
OPSOMMING VAN DIE TESIS 
 
HOOFSTUK 1 
Die doel in hierdie hoofstuk is om die verskillende hoofstukke onder Afdeling A 
uiteen te sit.  Daar word beplan om „n literatuur oorsig te doen van toepaslike 
studies rakend embriomerkers wat swangerskap-uitkoms in in vitro bevrugting 
kan verbeter. Verder sal die embriomerker sHLA-G deeglike bestudeer word met 
behulp van „n prospektiewe gerandomiseerde studie, asook „n retrospektiewe 
multisentrum studie.  Die rol van embrio morfologie en die genetiese profiel van 
die ovum, sigoot asook die embrio en die daaropvolgende blastosist vorming sal 
geëvalueer word met behulp van WGA/CGH. Alle bevindings sal daarna 
opgesom word, gevolg deur „n sinvolle gevolgtrekking en laastens sal voorstelle 
gemaak word vir toekomstige navorsing op die gebied. 
 
In Afdeling B sal die metodiek van die studies verduidelik word, asook „n 
beskrywing gegee word van die kandidaat se rol gedurende die navorsings 
projekte in hierdie tesis. 
 
HOOFSTUK 2 
In hierdie hoofstuk word die impak van die oösiet en die embrio op die 
inplanting/swangerskap-koers bespreek.  Die morfologiese eienskappe van die 
oösiet, die kumulus-oösiet kompleks, die sona pellucida, die perivitelline spasie, 
sitoplasma en meiotiese spoel, die poolliggaam en die se voorkoms word 
breedvoerig bespreek. 
 
Die morfologiese eienskappe van die embrio, fragmentasie en die invloed 
daarvan op die embrio, ploïdie, en blastosistvorming word bespreek. 
Embriomerkers om swangerskapsuitkoms te voorspel, gebaseer op 
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internasionale literatuur, is ook nagevors. Die pronukleêre morfologie en vroeë 
deling word as nie-indringende embriomerkers uitgelig om swangerskapsuitkoms 
te voorspel. 
 
„n Biochemiese, nie-indringende merker wat deur ontwikkelende embrios 
uitgedruk word, oplosbare menslike leukosiet antigeen-G (sHLA-G), word 
bespreek. Die waarde van blastosist oordrag en die verbeterde koers van 
voortgaande swangerskappe in vergelyking met verdelende embrios, is ook 
uitgelig, gebaseer op „n onlangse metanalise. „n Breedvoerige bespreking van 
sHLA-G asook “Array-CGH” en die toekoms van hierdie toetse word behandel. 
 
HOOFSTUK 3 
Die doel van hierdie hoofstuk is om swangerskap en inplantingskoerse te 
vergelyk wanneer embrios geselekteer word op „n enkel Dag 3 (D 3) morfologie 
beoordeling, teenoor „n kumulatiewe GES-telling plus sHLA-G uitdrukking. 
Hierdie was „n prospektiewe ewekansige studie (n=214) waar pasiënte ICSI-
siklusse ondergaan het. Embrios is geselekteer vir terugplasing gebaseer op óf 
Dag 3 morfologie telling (Groep A), óf „n kumulatiewe GES-telling plus sHLA-G 
uitdrukking (Groep B). 
 
Die volgende resultate is gerapporteer: kliniese swangerskappe [35/107 (33%) vs 
52/107 (49%)] en voortgaande swangerskappe [20/107 (19%) vs. 52/107 (49%)] 
se sukses koerse is beduidend verskillend tussen Groep A en Groep B (p<0.05).  
Inplantingskoerse is nie beduidend verskillend tussen Groep A [52/353 (15%)] en 
Groep B [73/417 (18%)] (p<0.05) nie. 
 
Die aantal swangerskappe wat tot niet gegaan het tydens die eerste trimester 
was bykans 12 keer hoër in Groep A [25/52 (48%)].   Die slotsom was dat die 
miskraamsyfer beduidend laer in Groep B as in Groep A is en die swangerskap 
syfer betekenisvol beter was wanneer die selektering van embrios op GES plus 
sHLA-G gebaseer is. 
Stellenbosch University  http://scholar.sun.ac.za
xvi 
 
HOOFSTUK 4 
Verskeie studies het „n assosiasie getoon tussen die teenwoordigheid van 
oplosbare menslike leukosiet antigeen-G (sHLA-G) in menslike embrio kultuur en 
swangerskaps uitkoms in vitro. „n Retrospektiewe studie is op 2040 ICSI pasiënte 
by 6 verskillende sentra gedoen om die effek van s-HLAG verder te bestudeer. 
Alle embrios is individueel gekweek om die teenwoordigheid van sHLA-G in „n 
kultuurmedium rondom die embrios te identifiseer. In alle sentra is „n positiewe 
sHLA-G uitslag met „n toename in die waarskynlikheid van veelvuldige 
inplantings geassosieer (OR: 1.48, 95% CI: 1.07 tot 2.05, p-waarde: 0.0170), 
asook „n toename in waarskynlikheid van meervoudige swangerskappe wat 
voortduur (OR: 1.66, 95% CI: 1.10, 2.51, p-waarde: 0.0170). 
 
Data uit die multisentriese studie beklemtoon dat sHLA-G uitdrukking „n 
waardevolle nie-indringende embriomerker is om by te dra tot die verbetering van 
swangerskapsuitkoms, asook die teoretiese potensiaal om meervoudige 
swangerskappe te verminder. 
 
„n Kombinasie van sHLA-G uitdrukking en verlengde embrio kultuur tot die 
blastosist stadium mag moontlik „n toekomstige hulpmiddel wees waardeur 
enkele embrios vir terugplasing geselekteer kan word. Daardeur kan die risiko 
van meervoudige swangerskappe beperk word sonder om die 
swangerskapkoerse in gevaar te stel. 
 
HOOFSTUK  5 
In dié hoofstuk word die ploïdie status van die eerste en tweede poolliggaampies 
en Dag 3 blastomere, embrio morfologie en biochemiese (sHLA-G) eienskappe 
gekorrelleer met blastosist ontwikkelling en uiteindelike swangerskapsuitkoms. 
Alle oösiete/sigote en embrios is individueel tot die blastosist stadium gevolg. 
PB-I, PB-II en blastomere het “volledige kariotipering ondergaan deur gebruik te 
maak van die toets “comparative genome hybridization (CGH)”. Elke embrio se 
kultuurmedium supernatant is versamel en ontleed vir sHLA-G uitdrukking op 
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Dag 2. Die volgende uitslae is gerapporteer: Sewe-en-vyftig mature (MII) donor 
oösiete is verkry; 33/57 (57.9%) is aneuploïd, 21/57 (36.8%) is euploïd en 3/57 
(5%) is onbeslis. Geen verwantskap is gevind tussen CGH status van PB-I, PB-II 
en die GES-telling. Geen verwantskap is gevind tussen CGH status van sHLA-G. 
Verder was daar geen verwantskap gevind tussen PB-I CGH uitslae en blastosist 
morfologie graad nie.  Daar was „n beduidende korrelasie tussen PB-I CGH en 
blastomeer CGH uitslae.  
 
Euploïde en aneuploïde PB-I het onderskeidelik in 58% en 67% blastosiste 
ontwikkel. Daar is „n positiewe verwantskap tussen die ploïdie van PB-I, PB-II en 
die blastomere aangetoon [Kappa (>0.7)]. Dit is afgelei dat na ICSI en 
sekwensiële genetiese kariotipering van die oösiet/sigoot en daaropvolgende 
blastomere, die meerderheid oösiete bevrug is en die daaropvolgende sigote 
ontwikkel het tot blastosiste, ongeag hul ploïdie status. Ons afleiding is dus dat 
blastosist ontwikkelling nie aan ploïdie verwant is nie. 
 
HOOFSTUK  6 
In hierdie hoofstuk bespreek ons waarnemings wat betref seleksie kriteria om die 
beste embrios te kies vir terugplasing wat uiteindelik tot „n suksesvolle 
swangeskap sal lei. Morfologiese, biochemiese en genetiese faktore is 
ondersoek.  „n Onderskeiding is gemaak tussen nie-indringende (mikroskopiese 
en biochemiese) en indringende (embrio biopsie, aCGH) tegnieke. 
 
'n Kombinasie van nie-indringende observasies, wat insluit pronukliere mofologie, 
vroee sigoot verdeling en vroeë embrio morfologie/kwalitieit op Dag-3 het 
beperkte inligting verskaf wat betref swangerskapkans. Verlengde embrio 
kweking tot die blastosist stadium (Dag-5) plus „n positiewe sHLA-G resultaat 
gee egter veel meer voordelige inligting aan die embrioloog met die embrio 
seleksie proses, voor embrio terugplasing of bevriesing.  Laasgenoemde inligting 
sal die swangerskap syfer bevoordeel en die meervoudige swangerskap kans 
verlaag. Wat die indringende tegniek (aCGH) betref, word veel meer data 
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benodig rakend die potensiele voor- en nadele wat betref swangerskap uitkoms, 
voordat „n sinvolle gevolgtrekking gemaak kan word. 
 
HOOFSTUK  7 
„n Volledige literatuur oorsig dui daarop dat alle beskikbare riglyne om embrios te 
kies vir terugplasing,  ingespan moet word. In die studie is daar gekyk na „n 
kombinasie van hierdie voorstelle. Daar is begin met die morfologie van die 
pronukliere stadium, gevolg deur vroeë sigoot-verdeling, asook beoordeling van 
embrios se morfologie/kwaliteit op Dag-3 van ontwikkeling.  Daar word 
voorgestel dat die keuse van „n blastosist op Dag 5, gekombineerd met „n 
positiewe oplosbare menslike leukosiet antigeen G (shla-G) die embrioloog van 
hulp kan wees om die beste embrio te kies vir terugplasing of bevriesing.  Hierdie 
nie-indringende riglyn behoort swangerskap-uitkoms te verbeter asook 
meervoudige swangerskappe te verminder. Indringende tegnieke soos ACGH 
benodig verdere in diepte navorsing en data verkryging om die waarde van 
hierdie toets te kan beoordeel. 
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Chapter 1 
 
The evaluation of different embryo markers and their subsequent effect on embryo 
development, implantation and pregnancy outcome in an in-vitro fertilization program. 
 
ABSTRACT 
 
In this chapter the aim is to outline the different chapters under section A. 
 
Against this background, we will conduct a literature review of relevant studies performed, 
and evaluate their comments regarding identifying embryo markers which can be utilized 
to improve overall ART outcome. We will evaluate the embryo marker sHLA-G in detail, 
using a prospective randomized study as well as a retrospective multi-centre study. The 
role of the morphology and genetic profile of an oocyte, zygote and embryo and 
subsequent blastocyst formation will be evaluated with the help of WGA/CGH. The work 
will then be summarized and conclusions will be made as well as possible suggestions for 
future directions will be indicated. In section B the methodology of the studies explaining 
the role of the candidate is illustrated. 
 
INTRODUCTION: 
 
There are unique challenges to having successful healthy pregnancies at the age > 37 in 
life.  In general, one out of every 6 women in the reproductive age experiences problems 
with infertility (CDC Statistics in 2001).  In this group, only 25% of women under the age of 
40 conceive after proper treatment and deliver a healthy baby (CDC Statistics in 2001).  
Although there have been substantial improvements in ART over the last two decades the 
reported success rate with IVF has not improved significantly. In this group, only 25% of 
women under the age of 40 conceive after proper treatment and deliver a healthy baby 
(CDC Statistics in 2001).  Although there have been substantial improvements in ART over 
the last two decades the reported success rate with IVF has not improved significantly.  
 
Controlled ovarian hyperstimulation (COH) was introduced. 
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Transfer of multiple embryos to the uterus (instead of one) was introduced to increase the 
likelihood of pregnancy, hoping that at least one embryo would implant and result into a 
baby. However, unfortunately this approach also lead to high order multiple (triplets or 
greater) pregnancies, which is followed by the risk of premature-related peri-natal and 
neonatal complications. 
 
Originally the indication to perform IVF was irreparable fallopian tubular disease.  
Subsequently, unexplained infertility, infertility caused by endometriosis, and recurrent 
failure with intrauterine insemination (IUI) were added to the list of indications for IVF. 
 
In 1990, researchers at the Jones Institute in Virginia (USA), were first to describe 
successful male and female pro-nuclear development following intracytoplasmic sperm 
injection (ICSI).  In 1992, researchers at the Free University of Brussels refined 
micromanipulation techniques, protocols and procedures and reported successful oocyte 
fertilization, embryo transfer and established pregnancies, following ICSI.  There have 
been numerous modifications of ICSI procedures as well as multiple indications for its 
performance. (Nagy et al., 1993; Van Steirteghem et al., 1993; Van Steirteghem et al., 
1994; Palermo et al., 1992) .Although ICSI was initially reserved for cases associated with 
severe male infertility (Palermo et al., 1995), the technique was subsequently applied on 
patients with immunologic disorders, AMA (advanced maternal age), ASA (anti-sperm anti-
bodies as well as unexplained infertility (Devroey et al., 1994). 
 
In the past, most approaches aimed at identifying the ―best‖ embryos for transfer have 
focused on: (i) morphological assessment of embryos prior to transfer, (ii) pre-implantation 
genetic testing of biopsied polar bodies (derived from mature oocytes) and blastomeres 
(derived from 3-day old embryos) and (iii) prolonged embryo culture for 5-6 days post 
fertilization; and then transferring only embryos that, by having reached the blastocyst 
stage of development, have improved implantation potential.  Morphological evaluations 
apparently furnish clues that enhance proficiency at choosing the best pre-embryos for 
transfer; however, these systems are severely limited in their ability to provide reliable 
evidence for subsequent normal development. 
 
Recently, different criteria for selecting embryos for transfer have been introduced and 
influenced on the success rates of IVF clinics throughout the world (Alikani et al., 1999; 
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Sakkas et al., 1999; Van Royen et al., 1999; Scott et al., 2000).  How to select ―the best 
embryo‖ for transfer has become a very important topic of interest.  The initial selection of 
embryos for transfer was based on morphology on the day of embryo transfer (Ng et.al., 
1999).   However, a higher IVF success rate has been reported using various different 
selection criteria, which have been used during the course of embryo development to day 
three. (Alikani et al., 1999; Sakkas et al., 1999; Van Royen et al., 1999).  Implantation of 
an embryo with a high embryonic grade significantly increases the chances that it will 
successfully develop into a healthy fetus and subsequent normal baby.  The graduated 
embryo scoring (GES) system has recently been introduced, in which an embryo is 
separately cultured in its own drop, allowing for sequential microscopic assessment of 
developmental criteria (Fisch et al., 2001) (See Chapter 3 Table 1).  A score is then 
assigned to each embryo on Day 3, 72 hours post-oocyte retrieval.  It was possible to 
demonstrate that embryos that score ≥70 out of a possible 100 allotted points have the 
greatest potential to implant after being transferred to the uterus and/or survive to the 
blastocyst stage if maintained in extended embryo culture for 2-3 additional days. 
 
Currently, most IVF programs select the best quality embryos for transfer on Day 3 and the 
remaining embryos are kept in culture until Day 6 after insemination; therefore, such 
embryos are allowed to progress to the blastocyst stage in vitro before freezing (Racowsky 
et al., 2000).   In most IVF settings, embryos that have been defined as being of lesser 
morphologic quality are frequently cultured to Day 5/6 to evaluate their developmental 
potential to the blastocyst stage.   
 
Which scoring or evaluation system to use on Day 3 to achieve the acceptable pregnancy 
rate comparable to embryos that are transferred at the blastocyst stage is a subject for 
controversy (Coskun et al., 2000 and Kovacic et al., 2002).   The transfer of selected 
embryos on day 3 should yield a pregnancy rate equivalent to that which could be 
achieved had the transfer been done on Day 5/6 (Scholtes et al., 1996 and Blake et al., 
2002).  
 
Several researchers have set individual criteria to use in the process of selecting which 
embryos to transfer.  Scott et al., (2000) suggested that embryos should be cultured in 
micro drops and pro-nuclei be evaluated on Day 1 of culture, in order to optimize 
assessment of an embryo’s implantation potential.  
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 Alikani et al. (1999) looked at embryo fragmentation and its influence on pregnancy rates 
and concluded that fragmented embryos resulted in lower pregnancy rates.  Sakkas et a.,. 
(1999) evaluated early cleavage of embryos and concluded that early cleavage could be 
important criteria for selecting day 3 embryos for the transfer.  Strict morphologic 
grading/evaluation were established for embryos on Day 3, by Van Royen et al., (1999) 
and for blastocyst by Gardner et al., (2000).  Both groups stated that these findings are 
central to the attainment of optimal implantation and pregnancy rates on Day 3 and 5, 
respectively.   
 
The detection of soluble Human Leukocyte Antigen-G (sHLA-G) in the culture medium of 
early cleaving embryos at 44-46 hr after insemination provided evidence that embryos 
could be selected by their maternal genomic function since there was a correlation 
between sHLAG expression by an embryo and the positive predictability of pregnancy 
(Sher et al., 2004).   
 
Karyotypic studies of aborted fetuses have been used to draw the inference that the 
proportion of concepti with chromosome abnormalities is very high. Whole genome 
amplification (WGA) and comparative genomic hybridization (CGH) has previously been 
used to identify the presence of genomic imbalance in embryonic cells during pre-
implantation genetic screening (PGS).  CGH has been used to the study of numerical and 
structural abnormalities of single blastomeres from disaggregated 3-day-old human 
embryos. (Voullaire et al. 2000).   PGS has been used to identify the gender and embryos 
with genetic abnormalities.  Although PGS provided some evidences for unexplained early 
abortions (Rubio et al., 2003), and cured for various chromosomal translocation cases 
(Scriven et al., 2001), it fundamentally failed what it was supposed to provide, improved 
pregnancy rates.  In best case scenario, the pregnancy rate after PGD was 30%, and 
currently it could offer information for only 7 autosomal chromosomes (13,15, 16, 18, 21, 
and 22) and 2 sex chromosomes (X and Y) (Ziebe et. al., 2003) .  High-order multiple 
pregnancies (Jones et al., 2001) and monozygotic twin pregnancies (Tarlatizis et al., 2002; 
Sheiner et al., 2001) are additional issues that are associated with the transfer of multiple 
embryos.  There is an urgent need to develop a reliable system to identify embryos in 
culture with high potential to develop into a viable pregnancy.  Embryologists/physicians 
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will be able to selectively limit transfer to one or two embryos, by using a very specific set 
of criteria, in order to virtually eliminate the risk of high order multiple gestations.   
 
Currently several tools are available to evaluate embryos for transfer, as indicated above, 
but we are still faced with unknown factors, such as oocyte and embryo dimorphism. 
  
It is known that in patients < 39 years of age 40-60 % and in patient’s › 39 years of age up 
to 80% of their embryos is genetically abnormal (Kahraman et al., 2000) despite all the 
tools that are used to separate the ―best‖ embryo.  The current grading is soley based on 
morphology and biochemistry (s-HLA-G); however, even a top quality embryo on Day 3 or 
blastocyst can be genetically abnormal.   
 
Wind et al., (2001) illustrated that there are specific differences in the intra structural 
organelles of normal and abnormal oocytes when transmission electron microscopy (TEM) 
is used for such evaluation.    
 
If we are heading in the direction of identifying a normal embryo for transfer, this study 
might provide some insight to achieve this goal.  Starting observations at the follicular 
level, then grading the COC and oocyte by performing light microscopy, then first and 
second polar body (PB) biopsy/ whole genome amplification (WGA), comparative genome 
hybridization (CGH) analysis, soluble human leukocyte antigen-G (sHLA-G) expression, 
Day 3 morphology, blastomere biopsy/ whole genome amplification (WGA), comparative 
genome hybridization (CGH), using a Graduated score (GES) and subsequent blastocyst 
formation. 
 
The overall objective of this thesis is to study different embryo markers and their 
subsequent effect on embryo development, implantation and pregnancy outcome in an in-
vitro fertilization program. 
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Section A 
 
Chapter 2 
Against this background, we conduct a literature review of relevant studies performed, 
along with their comments regarding identifying embryo markers which can be utilized to 
improve overall ART outcome. 
 
Chapter 3  
A prospective randomized controlled study was performed to compare pregnancy and 
implantation rates when embryos are selected based on a single Day 3 (D 3) morphology 
score vs. a GES score plus sHLA-G expression.  
 
Chapter 4  
A retrospective multi-centre study was performed on 2040 ICSI patients in six different 
centers, to determine if the presence of sHLA-G have an effect on implantation and 
pregnancy outcome in vitro. 
 
Chapter 5  
To correlate first and second polar bodies and Day 3 blastomere ploidy, embryo 
morphology and biochemical (sHLA-G) characteristics with blastocyst development and 
pregnancy outcome in vitro. 
 
Chapter 6  
The aim of this chapter is to discuss the morphological, biochemical and genetic features 
of an embryo that has been shown to be predictive of implantation and pregnancy 
outcome in ART using most current evidence. 
 
Chapter 7 
Summary and conclusion 
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Section B 
 
Methodology of the studies and explaining the role of the candidate.  
 
CHAPTER 3 
 
MATERIALS AND METHODS 
 
Patients 
 
Stimulation (Performed by MD) 
 
Patients were pre-treated with oral contraceptives received Lupron (TAP Pharmaceuticals, 
Lake Forest, IL) in a long protocol after pre-treatment with oral contraceptive (OC) birth 
control pills for 1–3 weeks and were treated by a human derived gonadotropin (Bravelle; 
Ferring Pharmaceuticals Inc, Suffern, NY) to activate ovarian follicular stimulation. 
Ovulation was triggered when at least two follicles were 18 mm and half the remaining 
were ≥15 mm. Oocytes were harvested transvaginally using ultrasound guidance 35 h post 
hCG. All patients underwent controlled ovarian hyper-stimulation (COH) by the same 
physician. 
 
Embryo culture (Performed by Dirk Kotze) 
 
All metaphase II (MII) embryos were injected by ICSI 3–4 hours post retrieval. All zygotes 
were cultured individually in 50 µl droplets of P-1 medium, supplemented with 10% 
Synthetic Serum Substitute (SSS) (Irvine Scientific, Santa Ana, CA). After 44–46 h 
embryos were moved to Complete Blastocyst Medium (Irvine Scientific, Santa Ana, CA). 
At this point, ±35 µl from the remaining P-1 culture media drops were collected in 200 µl 
micro-centrifuge tubes and immediately frozen. All samples were shipped to a central 
location and tested for sHLA-G, using an enzyme-linked immunosorbent sandwich (ELISA) 
assay. All embryos were transferred on day 3. 
 
Embryos scoring (Performed by Dirk Kotze) 
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The GES-score (Dirk Kotze applied GES-score to all embryos) 
 
To apply the GES-score, all mature oocytes underwent ICSI with a single sperm and were 
individually cultured. In order to apply the GES-score, oocytes were evaluated at 16–18 h 
post ICSI when the presence of pronuclear as well as nucleoli alignment along the 
pronuclear axis was evident; a score of 20 was allotted where nucleoli alignment was 
prevalent. The second observation took place at 25–27 h, at which time early cleavage 
was noted. A score of 30 was allotted when cleavage was observed. Furthermore, at this 
time a score was given based on the presence/absence of fragmentation. When 
fragmentation was absent a score of 30 was given, <20% fragmentation received a score 
of 25 and >20% received a score of zero (0). The third and final score was given 64–67 h 
after ICSI and involved the number of blastomeres and embryo grade. Example: six cell 
grade one—6(I),7(I), 8(I), 8(II), 9(I) scored 20 points, seven cell, grade II (7(II)), 9(II), 10(I), 
11(I) and compacting(I) scored ten points. The maximum GES-score totaled 100 points  
(See Chapter 3 Table 1 and Chapter 3 Figure 3: GES-score illustration) 
 
The Day 3 score (performed by Dirk Kotze) 
 
The Day 3 score that was applied in this study was a modification Veeck’s criteria for Day 
3 embryos combined with our laboratory’s criteria (unpublished data DK). Embryos were 
scored based on their blastomere number, size and symmetry as well as the percentage of 
fragmentation that was present. Example: a grade one embryo: 8–11 cell with even sized 
blastomeres (+8 points) and without fragmentation (+2 points) scored a max of ten points, 
a grade two embryo: 8–11 cell with even sized blastomeres (+8 points) and with <10% 
fragmentation (0 points) scored a max of eight points, a grade three embryo 8–11 cell (+8 
points) with uneven blastomere (−1 points) and >10% fragmentation (−3 points) scored a 
max of four points. 
The same embryologist (Dirk Kotze) preformed all embryology and embryo scoring in this 
study. 
 
Soluble HLA-G assay (Shipped to SIRM Las Vegas for analysis - Dirk Kotze 
competant to perform sHLA-G assay) 
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A monoclonal antibody (mAb; MEM-G9 MCA 2044; Serotec, Raleigh, NC) against sHLA-G 
was used to coat a 96-well Nunc-Immunoplate (Fisher Scientific, Chino CA) using a 
concentration of 2 µg/ml in 0.1 mol/l carbonate buffer at pH 9.5 for 1 h at 37°C. The plate 
was then refrigerated overnight at 4°C. On the following day, the plate was thoroughly 
washed using 100 µl of phosphate-buffered saline (PBS) and 0.05% Tween-20. The wash 
was repeated twice using 100 µl PBS and 5% bovine serum albumin (BSA) for 15 min 
each. A 50 µl aliquot of PBS and 5% BSA was added to each well before adding the 
sample of 50 µl of embryo supernatant. Amniotic fluid (AF) was used as a positive control. 
AF (50 µL) and 50 µl of pure Complete Blastocyst culture media (Irvine Scientific) in which 
no embryos had been cultured (the negative control) Samples were incubated for a period 
of 1 h at 37°C. After incubation, the plates were washed three times with PBS, followed by 
incubation with a specific biotin conjugated mAB (w6/32 MCA81B; Serotec) at a 1:1000 
dilution in PBS and 1% BSA for 45 min at 37°C and then washed five times with PBS. 
Streptavidin alkaline phosphatase conjugated (BD Bioscience Pharmigen, San Diego, CA) 
at a concentration of 1:1000 in carbonate buffer was incubated for 30 min at 37°C and 
washed five times with PBS, after which phosphatase substrate was added at a 
concentration of 1 mg/ml in 10% diethanolamine at pH 9.8 for 30 min. The colorimetric 
reaction was then stopped by the addition of 50 µl of 3 mol/l NaOH. The sHLA-G 
concentration was determined by absorbance at 405 nm on the EL800 Universal 
Microplate Reader (Bio-Tek Instruments Inc., Winooski, VT). 
 
Embryo selection and transfer (Dirk Kotze performed embryo selection and assisted 
the physician with transfer for all patients in this study) 
 
Individual embryos were defined as having positive sHLA-G expression if their surrounding 
media expressed sHLA-G with an optical density inside the range of 0.184–0.196. Those 
outside the above mentioned range were designated as sHLA-G negative. In Group A, one 
hundred and seven (107) patients received embryos for transfer and all of these embryos 
were selected by using a Day 3 score only. In Group B, one hundred and seven (107) 
patients received embryos for transfer by first selecting any embryos that had a positive 
sHLA-G expression, and correlating such with the highest available GES score. 
Furthermore, in Group B the patients received embryos containing at least one sHLA-G 
positive in the cohort for transfer. In this study no more than four (4) embryos were 
recommended for transfer. However, the final decision regarding the number of embryos 
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for transfer was left to the patient after an informed consent that was based on American 
Society for Reproductive Medicine guidelines. All embryos were transferred on day 3 of 
culture, using ultra sound guidance and an echogenic catheter (Wallace, Smith Medical, 
UK). Serum β-hCG levels were measured 11 days and 13 days after the transfer (Dirk 
Kotze performed phlebotomy on patients and used an Immulite immunoassay analyzer to 
run β-hCG as well as Progesterone assays.) The patient was considered positive for 
biochemical pregnancy when the first value was >5.0 IU and the next value 2 days later 
was double the first. Clinical pregnancy rates were based on a six (6) week ultrasound with 
a gestational sac containing a fetal heartbeat. Ongoing pregnancy rates were based on a 
ten to twelve (10–12) week ultrasound with gestational sac containing one or more 
growing fetuses with appropriate heart rates. 
 
Statistical analysis 
 
Basic statistics such as the number and percentage (%) of categorical data as well as the 
mean and standard deviation (SD) of continuous data were calculated (by Dirk Kotze using 
Excel). Detailed statistical analysis was carried out using SPSS version 15 (Statistical 
Package for the Social Science). Comparison between mean values of continuous 
variables was calculated using the Students t-test for parametric and the Mann–Whitney-U 
test for non-parametric data, while the Chi-square was used for categorical data and the 
Odds ratio and 95% confidence calculated. Significance value was set at p < 0.05 
(Performed by Dr Carl Lombard). 
 
Miscarriage rates between treatment groups were calculated as a percentage of 
pregnancy loss between biochemical, clinical and ongoing rates. Fetal loss between 
treatment groups were calculated between clinical and ongoing pregnancies. 
Retrospective data were calculated as a percentage. (Calculated by Dirk Kotze using 
Excel) 
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CHAPTER 4 
 
MATERIALS AND METHODS 
 
Patients  
Consenting ART patients between July 2003 and Dec 2010 who underwent 
intracytoplasmic sperm injection (ICSI), the majority used a specific ELISA test 46 hours 
post-ICSI to determine sHLA-G expression, however, some embryos were transferred as 
―untested‖. 
The Study design (Dirk Kotze designed this multi-center study and compiled all raw data 
into organized tables for each site) 
 
Data was retrospectively gathered from six fertility clinics (Los Angeles (LA), Las Vegas 
(LV), New Jersey (NJ), New York (NY), FISCH, and Sacramento (SAC) that performed a 
sHLA-G assay/test on the majority of their consenting ART patients between July 2003 
and Dec 2010.  Since protocols at all clinics were standardized, the procedural variabilities 
were limited. We retrospectively compared IVF outcome in all patients regardless of age 
since the goal was to compare ART outcome for sHLA-G positive, sHLA-G negative and 
untested cohorts.  The majority of clinics transferred embryos on Day 3, however, data for 
embryos transferred on Day 5/6 (blastocyst) as well as single embryo transfer were also 
recorded.  
 
For each group, the data consists of the number of chemical pregnancies observed, 
number of clinical implantations observed together with whether these were single 
implantations, twins, triplets or quadruplets, and the number of on-going pregnancies 
together with whether these were single pregnancies, twins, triplets or quadruplets. In 
addition, we have the mean age and standard deviation of the women in each group, and 
the number of embryos returned per group together with the average number of embryos 
returned per individual per group. We are interested in the existence of an association 
between the outcome of the sHLA-G test and the different pregnancy outcomes (chemical 
pregnancy, clinical implantation, and on-going pregnancy).  
 
Ovarian Stimulation (Performed by MD) 
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Patients were stimulated using similar protocols at all sites.  All patients received Lupron 
(TAP, Pharmaceuticals) in a long protocol after pretreatment with oral contraceptive pills 
for one to three weeks. Ovarian follicular development was stimulated with recombinant-
FSH at doses of 225-450IU a day. Ovulation was triggered when at least 2 follicles were 
18 mm and half the remainder was ≥15mm. Oocytes were recovered transvaginally under 
ultrasound guidance 34.5 hours later. All monitoring of controlled ovarian hyper stimulation 
(COH) as well as egg retrievals (ER’s) and embryo transfers (ET’s) were performed by the 
same physician at each center.   
 
Embryo Culture (Dirk Kotze performed all aspects of embryology involved and 
applied GES-score to all embryos at Sacramento site) 
 
All metaphase II (MII) oocytes were fertilised using ICSI 4-6 hours after retrieval.  All 
embryos were cultured individually in 35µl droplets of P1 (Irvine Scientific) supplemented 
with 10% SSS (Irvine Scientific) using Nunc 60x15mm dishes, since 2007 embryos were 
cultured individually in 35µl droplets of GLOBAL (LifeGlobal) supplemented with 10% SSS 
(Irvine Scientific) using Embryo Corral (SunIVF) dishes under oil at 37°C in a 6% C02, 5% 
O2, 89% N2 environment.  All embryos were sequentially microscopically evaluated over a 
period of 72 hours following ICSI and graded by Graduated Embryo Scoring (GES) (Table 
1). Embryos were transferred into extended culture medium 44 - 46 hours post-ICSI, which 
can improved embryo development, as reported previously (Keskintepe). Initially individual 
embryos whose surrounding media expressed sHLA-G within an optic density (OD) range 
of 0.190  0.006  (the geometric mean) were defined as having positive sHLA-G 
expression while those outside this range were designated as sHLA-G negative.  
Each centers applied different criteria for ―negative‖ to ―positive‖ sHLA-G ranges, (See 
Chapter 4 Table 2).  
The original droplets of culture medium (35µl) were collected in 0.5 ml micro-centrifuge 
tubes with attached cap (VWR-Scientific) – frozen immediately at -20 °C and shipped on 
ice for sHLA-G expression testing – to a central location- were identical sHLA-G Assay 
were used (west of Mississippi to Las Vegas (LV) –east of Mississippi to New York (NY) - 
using the same specific enzyme-linked immunosorbent (ELISA) assay. Furthermore, all 
embryos were graded by applying the GES – score, GES≥70 scoring embryos combined 
with positive sHLA-G expression were selected for transfer (Kotze et al., 2010).   
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Soluble HLA-G Assay  (Sacramento is west of Mississippi we shipped to Las Vegas (LV)) 
 
sHLA-G Assay monoclonal antibody (mAb) (MEM-G9 MCA2044; Serotec, Raleigh, NC, 
USA) against sHLA-G was used to coat a 96-well Nunc-Immunoplate (Fisher Scientific, 
Chino, CA, USA) using a concentration of 2 μg/ml in 0.1 mol/l carbonate buffer pH 9.5 for 
1 h at 37 °C. The plate was then refrigerated at 4 °C overnight. On the following day, the 
plate was thoroughly washed twice using 100 μl phosphate-buffered-saline (PBS) plus 
0.05% Tween-20. The next wash was repeated twice using 100 μl of PBS+5% bovine 
serum albumin (BSA) for 15 min each. A 50 μl aliquot of PBS+5% BSA was added to each 
well prior to adding the sample of 50  μl embryo supernatant. JEG-3 cell line (which 
secretes HLA-G) supernatant was used as a positive control (Bamberger et al., 2000). 
Fifty microlitres of JEG-3 supernatant and 50 μl of pure blastocyst culture media (Irvine 
Scientific) in which no embryos had been cultured (the negative control) were incubated 
for a period of 1 h at 37 °C.  
 
Following incubation, the plates were washed three times with PBS, followed by incubation 
with a specific biotin-conjugated mAb (w6/32 MCA81B; Serotec) at a 1:1000 dilution in 
PBS+1% BSA for 45 min at 37 °C and then washed five times with PBS. Streptavidin–
alkaline phosphatase conjugate (BD Bioscience PharMigen, San Diego, CA, USA) at a 
concentration of 1:1000 in carbonate buffer was incubated for 30 min at 37 °C and washed 
five times with PBS, after which phosphatase substrate was added at a concentration of  
1 mg/ml in 10% diethanolamine pH 9.8 for 30 min. The colorimetric reaction was then 
stopped by the addition of 50 μl of 3 mol/l NaOH. The relative concentration of sHLA-G 
was estimated from absorbance measured at 405 nm on an EL800-ELISA microplate 
reader (Bio-Tek Instruments Inc., Winooski, VT, USA). A standard supernatant of sHLA-
G/.221 transfectant served as reference in standard calibration curves. 
  
Embryo transfer (Dirk Kotze performed embryo selection and assisted the phycisian 
with transfer for all Sacramento patients in this multi-center study) 
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Embryo transfers were performed on Day 3 (70-72 hours post ICSI) or blastocyts on 
Day5/6 (84-96 hours post ICSI) - depending on each center’s preference.  All centers used 
a Wallace Trail, followed by a Wallace Sure View catheter, both under direct ultrasound 
guidance. 
 
Pregnancy testing  
A pregnancy test was performed 10 days after embryo transfer (ET) and an ultrasound 
performed at 7 weeks pregnancy duration. Serum β-hCG levels were measures 11 and 13 
days after the date of the egg retrieval.  (Dirk Kotze performed phlebotomy on patients and 
used an Immulite immunoassay analyzer to perform β-hCG as well as Progesterone 
assays for Sacramento patients).  An initial value of >5.0 IU followed by a doubling of this 
number was considered positive.  Pregnancies were defined as chemical (β-hCG positive), 
clinical (6-7 week OBUS including a sac FHB)) and ongoing (10-12 week OBUS including 
a sac FHB)   
 
STATISTICAL METHODS (Data was compiled by Dirk Kotze and organized into tables in 
Excel - detailed stats was performed by Dr Carl Lombard). 
 
Chapter 5 
 
MATERIALS AND METHODS 
 
The candidate was involved in the following steps. The candidate shared PB-1, PB-2 and 
blastomere biopsies and vitrification of embryos with Dr Levent Keskintepe.  
 
Patients 
Oocyte donors for this study were five healthy, young (≤28 years of age), consenting 
patients without reproductive problems.  Sperm from proven donors (with a record of 
successfully fathering a pregnancy) were obtained from Cryogam bank (Cryogam, CO). All 
donors were appropriately screened for infectious and sexually transmitted diseases and 
for auto-immune parameters that might adversely affect embryo implantation.  
 
Embryo Culture:  (Dirk Kotze performed with Dr Levent Keskintepe) Embryology data 
collection: All oocytes collected were kept in chronological sequence and were individually 
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cultured in 100 µl modified human tubal fluid (mHTF) + 10% HSA, under oil at 37 °C. All 
oocytes were denuded immediately after retrieval and graded (modification of Xia et al., 
1997) (Table 1). PB-1 was micro-surgical removed and underwent whole genome 
amplification (WGA), followed by complete karyotyping using metaphase comparative 
genome hybridization (CGH). All mature oocytes (M II) were fertilized  by intracytoplasmic 
sperm injection (ICSI) and sequentially cultured in 50 µl droplets of Quinn’s Advantage 
Protein Plus Cleavage medium (In-vitro fertilization, Inc., Trumbull, CT) under oil at 6% 
CO2, 5% O2 and 90% N2, 37°C in a humidified environment. On Day 1 fertilization was 
assessed 16-18 hours post-ICSI, at which time alignment of the nucleoli was documented, 
and subsequently signs of cleavage at 26 hours post-ICSI. At this time PB-II was micro-
surgically removed from normally fertilized (2PN) oocytes and underwent WGA/CGH 
karyotyping. On Day 2 (at 46 hours post-ICSI the embryos were moved into 50 µl droplets 
of Multi Blastocyst medium (Global one, IVF Online) + 10% SSS (Irvine Scientific, Santa 
Ana, CA). The original droplets of culture medium surrounding each individual embryo 
were collected and tested for sHLA-G expression, using a specific enzyme linked 
immunosorbent assay (ELISA). Embryos with an optical density (O/D) range of 
0.190±0.006 were considered ―positive’ for the expression of sHLA-G.  Each individually 
cultured embryo was evaluated at 72 hours post-ICSI – applying a graduated embryo 
Score (GES) described by Fisch et al. (2001 /2003) Then, a single mono-nucleated 
blastomere was micro-surgically removed from each cleaved embryo and underwent 
WGA/CGH karyotyping. All embryos were cultured to the blastocyst stage and graded, 
using a modified version of Dokras et al.’s (1993) procedure. (See Chapter 5 Table 3)  
See Figure A –Sequence of events pictures 
 
 Blastocyst Vitrification and Warming 
 
Vitrification: was done by modifying the method previously described by Mukaida et al. 
(2003). This modified technique involved the use of an ICSI needle as follows: About 10 
minutes prior to vitrification, expanded blastocysts were placed in 50 µl drops of mHTF 
with 10% SSS, vol/vol (Irvine Scientific).  Each blastocyst had its blastocoel artificially 
collapsed through assertive needle aspiration.  The inner cell mass (ICM) was positioned 
at the 6 or 12 o’clock position using a holding pipette connected to a micromanipulator. A 
30° ICSI needle was then introduced via the cellular junction of the trophectoderm into the 
blastocoel cavity and the fluid was aspirated until the blastocyst had completely collapsed 
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and no blastocoel fluid remained, (Mukaida et al., (2001), (2003).  Blastocysts were then 
placed in 0.5 ml of mHTF (Base solution; IVF Online) supplemented with 10% (vol/vol) 
SSS for 2) minutes at 37°C.  Thereafter, blastocysts were placed in base solution + 0.96 
mol/l DMSO (D 5879, Sigma, St. Louis, MO) + 1.2 mol/l ethylene glycol (EG; P 3265, 
Sigma) for 90 seconds. Finally, blastocysts were placed in base solution + 1.9 mol/l DMSO 
+ 2.4 mol/l EG + 1 mol/l sucrose (S 7903, Sigma) + 0.1 mol/l Ficoll (F 8636, Sigma) for 30 
seconds. Then, each blastocyst was individually placed onto a cryo-loop (Hampton 
Research, CA) using 1-2 µl cryo-solution and plunged into liquid nitrogen. Blastocyst 
grading applied: (See Chapter 4 Table 3)     
 
Warming: The cryo-loop was removed from its vial and immersed into base solution + 0.34 
mol/l sucrose for 2 minutes at 37°C. The embryo was then moved to base solution + 0.17 
mol/l sucrose for 3 minutes and finally placed in base solution for 5 minutes. Intact 
embryos were cultured in 50 µl of Global One medium at 37°C in 6% CO2 for a minimum 
of 2 hours to evaluate blastocoel re-expansion (i.e. survival). 
 
Recipient Hormonal Treatment and Embryo Transfer: Following the onset of birth control 
pill-induced menstruation, oestradiol valerate IM (4-8mg) was administered every 3 days 
for a period of 8-12 days, until endometrial thickness had reached > 8 mm in sagital 
diameter and the plasma [E2] had stabilized at 1300-3000 Pmol/l. At that point, daily IM 
injections of 100 mg progesterone in oil (PIO) were initiated. On the 6th day of PIO, subject 
to patient choice and availability, two (2) thawed/warmed blastocysts were cryo-
transferred, using ultrasound guidance and an echogenic catheter (Wallace, Smith 
Medical, UK).  Serum beta human chorionic gonadotropin (β-hCG) levels were measured 
8-10 days after the transfer. The patient was considered biochemically pregnant when the 
first value was >5.0 IU and the next value 2 days later was double the first.  Clinical 
pregnancy rates were based on a 6-week ultrasound scan detecting a gestational sac 
containing a fetal heartbeat.  In the event of an ultrasound-confirmed pregnancy, an 
estrogen/progesterone supplementation regimen was continued.  Ongoing pregnancy 
rates were based on a 10–12-week ultrasound examination.  In all cases where pregnancy 
did not occur or did not survive, hormonal treatment was immediately stopped. 
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Each blastocyst was referenced back to its oocyte, zygote and embryo of origin. All clinical 
procedures were performed by the same physician and laboratory procedures were 
performed by the same embryologist.  
 
Stimulation (Performed by MD) 
 
Patients received Lupron (TAP Pharmaceuticals, Lake Forest, IL) in a long  
protocol after pre-treatment with oral contraceptive (OC) birth control pills for 1-3 weeks 
and were treated with a human-derived gonadotropin (Bravelle; Ferring Pharmaceuticals 
Inc, Suffern, NY) in order to stimulate follicular development in the ovaries. Ovulation was 
triggered when at least two follicles were 18 mm and half of the remaining were 15 mm. 
Oocytes were retrieved transvaginally using ultrasound guidance at 35 hours post hCG. 
  
(All the steps below for WGA/CGH were analyzed at SIRM’s genetics referrence lab 
on site in Las Vegas) 
 
Extraction and Amplification of Genomic DNA  
 
Genomic DNA was obtained by laser dissection and needle aspiration from three sources: 
the oocyte’s first polar body (PB-I), zygote’s second polar body (PB-II), and subsequent 
day 3 embryo’s blastomere. The cellular material was aspirated into a 200 µl thin-walled 
PCR tube (VWR catalog, 82006-602) for lyses and amplification using the Qiagen Repli-g 
kit (catalog, 59045). Ten ng of Repli-g control genomic DNA was used as a positive control 
and 0.5 µl of nuclease-free water as a negative control (Eppendorf catalog, 955155017). 
The reactions were set up following the Repli-g protocol and incubated for 8 hours at 30°C 
for amplification, followed by 10 minutes at 70°C for enzyme inactivation. Both incubation 
steps were performed using an Applied Biosystems 2720 Thermal cycler. Amplified DNA 
was placed at either 4°C for short-term storage or at -20°C for long-term storage.  
 
Genomic DNA Confirmation and Quantification  
 
For confirmation of WGA products, 5 µl reaction aliquots were mixed with 1 µl 6X Blue-
Orange Loading Dye (Promega # G1881) and electrophoresed through a 1.0% agarose 
gel containing 0.1% ethidium bromide in TBE buffer (90mM Tris-HCl, 90 mM boric acid 
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and 2 mM EDTA, pH 8.0). For quantification of the genomic DNA, 5 µl reaction aliquots 
were diluted with 95 µl of molecular biology-grade, nuclease-free water and analyzed with 
an Eppendorf BioPhotometer.  
 
Nick Translation of Genomic DNA  
 
The WGA products were fluorescently labeled using the Vysis Nick Translation Kit 
(catalog, 32-801024). One µg genomic DNA for each sample was labeled with 
SpectrumGreen™ direct-labeled dUTP by nick translation, following the Vysis protocol.  
Translation reactions were carried out using an Applied Biosystems 2720 Thermal cycler 
at 15°C for 2 hours and 70°C for 10 minutes to stop the reaction. The size of the resulting 
SpectrumGreen™ labeled probes was assessed by electrophoresis of 5 µl aliquots of 
1.0% agarose gel containing 0.1% ethidium bromide in TBE buffer (90 mM Tris-HCl, 90 
mM boric acid and 2 mM EDTA, pH 8.0). Probes of usable quality were in the range of 300 
- 3000 bp, as per the manufacturer’s recommendation. 
  
Probe Preparation and Comparative Genomic Hybridization 
 
The SpectrumGreen™ labeled probes were purified by ethanol precipitation. Briefly, 10 
µl/200 ng nick-translated reference DNA, 1 µl/100 ng SpectrumRed reference DNA (Vysis 
# 32-80423 or 32-804024), and 10 µl/ 10 µg Cot-1 DNA (Vysis # 32-800028) used to 
suppress repetitive sequences and prevent non-specific hybridization, were added to a 1.5 
ml micro-centrifuge tube.   
 
For precipitation of the hybridization mix, 2.1 µl (0.1 volume) 3M sodium acetate, followed 
by 52.5 µl (2.5 volumes) of 100% EtOH was added to the DNA, vortexed briefly and placed 
on dry ice for 15 minutes, then centrifuged at 12 000 rpm for 30 minutes at 4°C to pellet 
the DNA. The supernatant was removed and the pellet dried for 10–15 minutes under a 
vacuum at ambient temperature. The pellet was resuspended in 3 µl molecular biology 
grade water and 7 µl CGH hybridization buffer (Vysis # 30670003) and placed in the dark 
during slide preparation.  CGH-normal metaphase slides (Vysis # 30-806010) were 
prepared following the manufacturer’s protocol. Briefly, the slides were denatured in 70% 
formamide, 10% SSC pH 5.3, and 20% molecular biology grade water for 5 minutes at 
73°C for 5 minutes followed by an ethanol dehydration series of a minute each (70%, 85%, 
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and 100%).  The slides were dried by touching the bottom edge to a blotter and wiping the 
underside with a paper towel, then placed on a 45–50°C slide warmer to allow remaining 
EtOH to evaporate. The probe mix was denatured by heating for 5 minutes in a 73°C water 
bath. Ten µl of the probe mix was applied to the slides. The coverslip was placed over the 
slide and sealed with diluted rubber cement. The hybridizations were carried out with Vysis 
Hybrite chambers for a minimum of 48 hours and a maximum hybridization time of 72 
hours to clear background. Following hybridization, the cover slips were carefully removed 
along with any remaining rubber cement residue, taking care not to damage the slide 
surface. The slides were then agitated in 0.4X SSC/0.3% NP-40 wash solution at 74+1°C 
for 1-3 seconds, then let stand for 2 minutes, then agitated in 2X SSC/0.1% NP-40 at 
ambient temperature for 1-3 seconds, then let stand for 1 minute. The slides were allowed 
to dry vertically at ambient temperature in the dark. Once completely dry, 10 µl DAPI II 
counter stain (Vysis 30804931) was added to each side, followed by a cover slip, and 
immediately sealed with clear non-fluorescing fingernail polish. Keskintepe et al., (2007) 
collected and validated results from first, second PB’s and two blastomeres and reported a 
positive/negative occurrence of less that 10%. 
  
Image Capture and Analysis  
 
The following optical filters visualized the fluorochromes used in the hybridization: a filter 
set specific for DAPI, Texas Red® (Cat. No. 30-150491) and FITC (fluorescein 
isothiocyanate) (Cat. No. 30-150291) to view the counter stain, SpectrumRed or 
SpectrumGreen DNA, respectively, a triple band pass filter set designed to simultaneously 
excite and emit light specific for DAPI.  
 
Soluble HLA-G Assay (Performed at SIRM Las Vegas for analysis) 
 
A monoclonal antibody (mAb; MEM-G9 MCA 2044; Serotec, Raleigh, NC) against sHLA-G 
was used to coat a 96-well Nunc-Immunoplate (Fisher Scientific, Chino CA) using a 
concentration of 2 µg/ml in 0.1 mol/l carbonate buffer at pH 9.5 for 1 hour at 37ºC. The 
plate was then refrigerated overnight at 4ºC. On the following day, the plate was 
thoroughly washed using 100 µl of phosphate-buffered saline (PBS) and 0.05% Tween 20. 
The wash was repeated twice using 100 µl PBS and 5% bovine serum albumin (BSA) for 
15 minutes each. A 50 µl aliquot of PBS and 5% BSA was added to each well before 
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adding the sample of 50 µl of embryo supernatant. Amniotic fluid (AF) was used as a 
positive control. AF (50 µl) and 50 µl of pure blastocyst culture media (Irvine Scientific) in 
which no embryos had been cultured (the negative control) were incubated for a period of 
1 hour at 37ºC. After incubation, the plates were washed three times with PBS, followed by 
incubation with a specific biotin conjugated mAB (w6/32 MCA81B; Serotec) at a 1:1000 
dilution in PBS and 1% BSA for 45 minutes at 37ºC and then washed five times with PBS. 
Streptavidin alkaline phosphatase conjugated (BD Bioscience Pharmigen, San Diego, CA) 
at a concentration of 1:1000 in carbonate buffer was incubated for 30 minutes at 37ºC and 
washed five times with PBS, after which phosphatase substrate was added at a 
concentration of 1 mg/ml in 10% diethanolamine at pH 9.8 for 30 minutes. The colorimetric 
reaction was then stopped by the addition of 50 µl of 3 mol/l NaOH. The sHLA-G 
concentration was determined by absorbance at 405 nm on the EL800 Universal 
Microplate Reader (Bio-Tek Instruments Inc., Winooski, VT). 
 
Statistical analysis (Performed by Dr Carl Lombard) 
 
Fisher’s exact test was used to test for association between two categorical studied 
variables. The small marginal totals for some levels of the categories variables necessitate 
the use of this test. The agreement between the PB-I and PB-II and blastocyst was 
evaluated through the kappa statistic. The median levels of expression of sHLA-G for the 
categories of oocyte grade, PB-I, PB-II and blastocyst grade were calculated together with 
the interquartile range (IQR). To compare the median levels of sHLA-G between the levels 
of these variables two statistical methods were used. Since oocyte grade has a strict 
ordinal structure the estimation and testing of the Spearman correlation coefficient 
between sHLA-G and oocyte grade is an optimal test for the hypothesis of no difference in 
median sHLA-G levels across the categories of oocyte grade. For the remaining variables 
a Kruskal-Wallis test (non-parametric analysis of variance) was performed for the 
comparison of the median levels of soluble sHLA-G. 
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 Figure A: Sequence of events 
Picture presentation of procedures that occurred during thesis data gathering 
 
 
 
1) Egg Retrieval (COC) 
 
2) 
Denuding COC in 
hyalironidase to 
determine maturity (MII 
oocyte) 
 
3) PB-1 biopsy 
 
4) ICSI  
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5) 
Fert Check and PB-2 
biopsy (2PN-zygote) 
 
6) Early Cleavage (2-cell) 
 
7) Day-2 (4-cell) 
 
8) Day-3 (8-cell) 
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9) Day-3 blastomere biopsy  
 
10) Day 5 (Early Blastocyst) 
 
11) 
Day 5 (Expanded 
Blastocyst) 
 
12) 
Day 5/6 (Hatching 
Blastocyst) 
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CHAPTER 2 
 
GAMETE FACTORS AFFECTING EMBRYO QUALITY AND PREGNANCY 
OUTCOME IN ASSISTED REPRODUCTION TECHNOLOGY (ART)  
 
ABSTRACT 
 
In this chapter the impact of the oocyte/zygote and the embryo on implantation/pregnancy 
rate was discussed. The morphologic characteristics of the oocyte, the cumulus–oocyte-
complex (COC), the zona pellucida, the perivitelline space, cytoplasm and meiotic spindle 
and the polar body and its appearance were discussed in detail.  The morphologic 
characteristics of the embryo-fragmentation and its effect on embryo development, ploidy 
and subsequent blastocyst formation were also studied. Embryo markers to predict 
pregnancy outcome were researched based on the international literature. The pronuclear 
morphology and early cleavage were highlighted as non-invasive embryo markers to 
predict outcome. 
 
A non-invasive biochemical marker, soluble Human Leucocyte-Antigen-G (sHLA-G), that is 
expressed by developing embryos was researched. The value of blastocyst transfer and 
the improved ongoing pregnancy rate compared to cleavage stage embryos were 
highlighted based on a recent meta-analysis. A detailed discussion on sHLA-G as well as 
Array-CGH and the future of these tests followed. 
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INTRODUCTION 
 
In vitro fertilization (IVF) was initially performed during natural fertility cycles, and involved 
removal of a single oocyte from its natural environment. In 1978, a mature oocyte was 
recovered through the use of laparoscopy, fertilized outside the body, and the cleaved 
embryo was transferred back into the patient’s uterus.  This resulted in the first successful 
IVF-conceived pregnancy by Steptoe & Edwards 1978.  
 
Over the last three decades, major adjustments to this basic theme have been introduced 
with the goal of increasing the efficiency and the success rates.  One addition was the 
introduction of COH (Controlled Ovarian Hyper-stimulation) by Sher et al. (1987).  The 
goal of COH was to increase the number of mature oocytes available for fertilization. In 
1988 Lazendorf et al., were the first to describe successful male and female pro-nuclear 
development following intracytoplasmic sperm injection (ICSI).  In 1992 Palermo et al., 
researchers at the Free University of Brussels refined micromanipulation techniques, 
protocols and procedures and reported successful oocyte fertilization, embryo transfer 
(ET), and established pregnancies following ICSI.  Since then there have been numerous 
modifications of ICSI procedures as well as expanded indications for its applications. 
 
There has been growing interest in strategies to reduce the multiple birthrates without 
compromising the success of IVF pregnancies. Most approaches aimed at identifying the 
“best” embryos for transfer have focused on: (i) morphological assessment of embryos 
prior to transfer (Ng et al., 1999) and (ii) prolonged embryo culture for 5-6 days post-
fertilization, with the goal of then transferring only embryos that have reached the 
blastocyst stage of development. Blastocysts have improved implantation potential 
(Gardner et al., 1998; Schoolcraft, 1999), but require specialized culture systems. During 
extended embryo culture in vitro – from the cleavage stage to blastocyst stage, some 
embryos with inferior developmental potential did not progress into blastocysts. In order to 
select competent embryo(s) for transfer strict morphologic grading/evaluation criteria for 
day 3 embryos were established by Van Royen et al., (1999a) and for blastocysts by 
Gardner et al. (2000a). Both groups stated that these criteria were central to the 
attainment of optimal implantation and pregnancy rates on Days 3 and 5, respectively. 
Although morphological evaluations apparently furnish clues that enhance proficiency in 
selecting embryos for transfer, these systems are severely limited in their ability to provide 
reliable evidence for subsequent implantation and normal development.   
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Karyotypic studies of aborted fetuses have revealed that the proportion of concepti with 
chromosome abnormalities is very high. Early studies using pre-implantation genetic 
screening with fluorescent in situ hybridization (PGS FISH) have demonstrated that ≥50% 
of embryos considered for transfer with IVF are in fact aneuploid (Munne et al., 1993).  
FISH has been the most widely used method for analyzing the polar body and blastomere 
chromosomal complements. A primary limitation of this technique is the limited number of 
chromosomes able to be tested.  Wells et al. (2002) reported the first use of comparative 
genome hybridization (CGH) on polar bodies and reported an improved IVF outcome when 
transferring embryos with a completely normal genome. Since then several researchers 
have reported application of CGH techniques (Le Caignec et al., 2006; Sher et al., 2007; 
Treff et al., 2010), as genetic screening tools on human embryos. 
 
An additional technique for assessing embryo competence is to look for markers of healthy 
metabolism.  For instance, researchers reported the detection of soluble human leukocyte 
antigen (sHLA), a non-classical major histocompatibility complex (MHC), in culture 
medium surrounding clusters of developing embryos (Jurisicova et al., 1996a/b; Menicucci 
et al., 1999), provided clues for better quality embryos. sHLA may be a biochemical 
marker to assist in the identification of embryos with the highest implantation potential for 
transfer.  The presence of sHLA-G improved pregnancy (Noci et al., 2005), implantation 
potential (Fuzzi et al., 2002), embryo selection and pregnancy outcome (Rebmann et al., 
2007). Despite reports for its positive influence as far as ART outcome, there have also 
been questions regarding sHLA-G delectability and true value (Sageshima et al., 2007; 
Sargent et al., 2007; Vercammen et al., 2008). 
 
Despite the above-mentioned “improvements”, less than one in four women under the age 
of 40 achieve a live birth following IVF treatment, and approximately 5% of fresh oocytes 
collected produce a viable baby.  Furthermore, birthrates vary from single digits to over 
50% depending on the number of embryos transferred.  Over the last decade, the reported 
success rate with IVF has not significantly changed. Against this background, we conduct 
a literature review of relevant studies performed, along with their comments regarding 
identifying embryo markers which can be utilized to improve overall ART outcome (SART 
data, 2010). 
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CUMULUS-OOCYTE-COMPLEX (COC) 
 
The background information was based on non-human and human studies. Prior to 
ovulation oocytes are surrounded with tightly layered cumulus granulose cells. These cells 
are interconnected to each other and the oocyte by a complex membrane-cellular process 
and gap junctions (Albertini et al., 1994).  Cumulus cells are dependent on this process to 
provide a continuous supply of glucose and pyruvate as energy source (Gardner et al., 
1996; Preis et al., 2005). Cumulus cells have many FSH-receptors (Robker & Richards, 
1998) and are exposed to growth factors expressed by the oocyte itself (Erickson & 
Shimasaki, 2000). Gregory et al. (1998) reported a correlation between proliferation of 
cumulus cells and implantation potential. The combined presence of both growth factors 
(epidermal growth factor [EGF] and insulin-like growth factor I [IGF-I]) resulted in maximum 
rates of cumulus expansion and nuclear maturation (Lorenzo et al., 1994). 
 
The luteinizing hormone (LH) - surge causes the cumulus layers to expand and plays an 
important role in final maturation and subsequent fertilization (Somfai et al., 2004; Yang et 
al., 2005 [human]). Rattannachaiyanont et al. (1999) reported no correlation between 
COC-morphology and fertilization, cleavage and pregnancy rates.  Ebner et al., (2008) 
drew the same conclusion; furthermore, decreased maturation was reported when oocytes 
were surrounded by dense layers of corona radiate cells.  Applying their criteria to 
evaluate COC quality, Ng et al. (1999) reported an association between COC quality and 
both fertilization and pregnancy. The cumulus matrix and cumulus cells also participate in 
fertilization by influencing spermatozoa binding and penetration of the COC in humans 
(Chung et al., 2009; Hong et al., 2009). A study by Lin et al., (2003) using a 5-scale 
cumulus-corona-radiate cell evaluation found a correlation between embryo development 
potential and blastocyst quality.  In a review study about the mechanism involved during 
ovulation by Russel & Robker (2007), they concluded that cumulus cells surrounding 
oocytes in the follicle play a very important part in an oocyte’s development in vitro, 
maturation and ovulation.  Cumulus expansion is a direct result of endocrine exposure and 
growth factor released by the oocyte to the surrounding cumulus layers. These factors 
synthesized, processed and secreted by oocytes within the cumulus impacts the 
developmental potential of zygotes (Hussein et al., 2006). Finally they hypothesized that 
these factors facilitate detachment and expulsion of the COC mass from the follicle.  
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ZONA PELLUCIDA 
 
The oocytes and embryos of all mammals are surrounded by a “protective barrier” of 
glycol-proteins, known as the zona pellucida (Herrler et al., 2000; Sinowatz et al., 2001; 
Lefievre et al., 2004).  These proteins are expressed by the oocyte as well as the 
granulose cells and might play an important role in granulose cell differentiation and 
folliculogenesis.  Prasad et al., (2000) described the structure and function of mammalian 
zona proteins.  These proteins might play an important role during the fertilization process: 
attaching and binding of capacitated sperm, inducing the acrosome reaction (Ganguly et 
al., 2010); penetration of zona pellucida (ZP) (Gardner & Evans, 2006); and a mechanism 
to prevent polyspermia (Soupart & Strong, 1975).  During folliculogenesis, both the oocyte 
and the granulose cells contribute to the protein expression (Sinowatz et al., 2001).  The 
ultra-structure of the zona has also been described (Wassarman et al., 1999; Oehninger et 
al., 2003; Wassarman et al., 2004).  Using conventional scanning electron microscopy 
(SEM) to determine the structure of the ZP of in vitro mature (MII) human oocytes revealed 
a large spongy multilayered network; however, in immature (germinal vesicle (GV) and 
atretic oocytes the surface of the ZP was compact and smooth (Familiari et al., 2008).  
Continued communication between the developing oocyte and the surrounding 
environment is essential (Albertini et al., 1994) and should this communication be 
disrupted between the oocyte and its surrounding cells – ZP – essential messages will not 
reach the oocyte and could jeopardize meiotic arrest, oocyte maturation and subsequent 
embryo development (Rankin et al., 1999). 
 
Methods to assess the morphology of the zona have been described – video-
cinematography with Hoffman Modulation optics (Cohen et al., 1989), digital imaging 
system (Wright et al., 1990), PolScope real time (Shen et al., 2005) and SEM (Familiari et 
al., 2008). 
 
Characteristics 
 
The following aspects of the ZP will be discussed:  
 Zona thickness 
 Birefringence 
 Zona darkness and thickness 
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o Zona thickness: as early as 22 years ago Cohen et al. 1989 reported areas of 
“thinning” in the zona of cleaved embryos.  Wright et al. (1990) associated thinning 
with implantation and pregnancy potential.  Bertrand et al. (1995) concluded that ZP 
thickness influences sperm penetration, even when the spermatozoa are 
considered normal.  ZP thickness appears to be an additional factor that should be 
taken into account when interpreting the fertilization rate and could be an indicator 
for the use of micro-injection procedure (ICSI).  The morphological appearance of 
the ZP could function as an indicator of folliculogenesis and subsequent oocyte 
maturation.  A correlation was found between overall ZP thickness and its variation 
during pre-implantation development and pregnancy outcome, (Cohen et al., 1989; 
Palmstiema et al., 1998; and Gabrielsen et al., 2001).  The inner zona layer can be 
evaluated by either the radial orientation of glycoproteins and its angular deviation 
(Frattarelli et al., 2007) or the birefringence of the inner layer (Montag et al., 2007; 
Montag et al., 2008).  Light retardation of the ZP, in particular of the inner layer, was 
correlated with conception by Shen et al., (2005).  Furthermore, Rama Raju et al., 
(2007) also found an association between the retardance of the inner layer of the 
zona and blastocyst development.  Montag et al., (2007, 2008) - where German 
strict IVF regulations apply - used zona imaging on mature (MII) oocytes as primary 
selection criteria for ET, they concluded that ZP features are a powerful predictor of 
pregnancy outcome. 
 
Changes in zona thickness correlated with the number of blastomeres, grade, % 
fragmentation, patient age and were more evident in embryos transferred from 
cycles resulting in successful pregnancies (Garside et al., 1997). Rankin et al., 
(2000) concluded that the ZP itself plays an important role in vivo during fertilization 
and implantation.  Thickness and organization of ZPs of human eggs and embryos 
varies considerably and can be quantitatively imaged with the PolScope (Pelletier et 
al., 2004).  Zona thickness could be used to predict implantation potential (Cohen et 
al., 1989).  Bertrand et al. (1995) reported higher fertilization rates in oocytes 
surrounded by “thinner” ZPs.  On the other hand, Host et al. (2002) reported 
improved blastocyst formation and improved embryo quality when the inner zona 
layer was “thicker”.  Rama Raja et al., (2007) reported that an increased thickness 
of the inner layer of the zona correlated with increased blastocyst formation.  Shen 
et al., (2005) reported a correlation between increased zona layer thickness and 
improved embryo development and clinical pregnancy rates.  No correlation was 
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found between zona thickness and fertilization, pronuclear morphology, embryo 
development and clinical pregnancies (Esfandiari et al., 2006).  Blastocyst formation 
is associated with thinning ZP (Garside et al., 1997; Check et al., 1998; Mantoudis 
et al., 2001; Balaban et al., 2000). Zona thickness was associated with embryo 
quality, embryo development and pregnancy rates by Gabrielson et al. (2000).  
Other studies, however (Garside et al., 1997; Palmstierna et al., 1998; Gabrielson 
et al., 2001; Host et al., 2002), reported that ZP thickness was not associated with 
improved pregnancy rates.  Kultu et al. (2010) concluded that laser-assisted zona 
thinning of Day 3 embryos has no beneficial effect on clinical pregnancy and 
implantation outcomes. Furthermore, Cohen (2010) commented on the detrimental 
effect of artificially thinning of the ZP by inexperienced technicians or the “over 
exposure“  to laser energy during assisted hatching. 
 
o Zona birefringence: the birefringence of the inner zona layer could affect the 
fertilization rate and embryo development (Shen et al., 2005; Rama Raju et al., 
2007; Montag et al., 2008).  In contrast to the above-mentioned, Madaschi et al. 
2009 reported no correlation between variations in birefringence of the zona’s inner 
layer on fertilization rates and embryo quality. However, when oocytes with high 
birefringence were used, clinical pregnancy rates were improved (Shen et al., 2005; 
Rama Raju et al., 2007; Montag et al., 2008; Madaschi et al., 2009), whereas 
oocytes with a low birefringence were associated with increased miscarriage rates 
(Madaschi et al., 2009).  Loutradis et al. (1999) considered multiple morphological 
features of the zona and their subsequent effect on oocyte development and 
concluded that only dramatic damage to the zona (broken or empty) has an effect 
on ICSI outcome.  
 
The inner zona layer (using a birefringence score) was a strong predictor of 
blastocyst formation but not of embryo quality or pregnancy (Ebner et al., 2010). In 
another study De Almeida Ferreira Braga et al., (2010) suggested that ZP 
birefringence (ZPB) could be a useful tool to predict embryo development for MII 
oocytes, but did not report any association between ZPB and oocyte maturity. Using 
polscopy – the ZP characteristics can be used as a positive predictor of embryonic 
development in vitro (Rama Raju et al., 2007).  In contrast, Cheng et al. (2010) 
reported no differences in ZPB scores between normally fertilized (2PN) and 
abnormally fertilized (3PN) oocytes with conventional IVF.  Furthermore, Day 3 
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embryo quality and clinical pregnancy outcome could not be predicted by ZPB-
scoring. 
 
o Zona darkness and thickness: there was no association between zona darkness 
and fertilization, pronuclear morphology, embryo development and clinical 
pregnancies (De Sutter et al., 1996; Balaban et al., 1998; Ten et al., 2007). Rienzi 
et al., (2008) reported no correlation between both zona darkness and thickness, 
subsequent fertilization, pronuclear morphology, embryo development and clinical 
pregnancy rates.   
 
PERIVITELLINE SPACE 
 
Background  
 
The perivitelline space (PV-space) is the space between the inner layer of the ZP and the 
cell membrane of an oocyte (oolemma).  The PV-space of unfertilized human oocytes 
contains a hyaluronan-rich extracellular matrix.  Granules and filaments are present and 
appear similar to the matrix between cumulus and corona radiate cells (Dandekar et al., 
1992). The PV-space is relevant because it is where the polar body is released after 
meiosis.   
 
Post fertilization cortical granules released from the ovum are deposited in the PV-space 
to form a cortical granule envelope (containing proteins).  Polysaccharides released from 
the granules cause the space to swell, pushing the ZP farther away from the oolemma.  
This envelope could play a role in the polyspermic block (Talbot et al., 2003).  In a study 
by Ueno et al., (2008) the PV-space size in mice was significantly greater for in vivo 
matured oocytes vs in vitro matured oocytes; however, no difference in fertilization rates 
was reported between the two groups.  Furthermore, the incidence of polyspermy for in 
vivo matured oocytes was significantly lower than for those matured in vitro. These 
findings suggest that the PV-space might be related to the increased incidence of 
polyspermia in mouse oocytes. 
 
In a study by Danfour et al., (2010), evaluating the behaviour of the oolemma during ICSI 
identified preimplantation embryos with good potential to form blastocysts, and 
consequently on implant result in a pregnancy.  Hassan et al., (1998) and Ten et al.,           
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(2007) reported no correlation between debris present inside the PV-space and both in 
vivo and in vitro embryo development.  In contrast Farhi et al., (2002) reported that the 
presence of coarse granules in the PV-space was associated with lower implantation and 
pregnancy rates. The size of the PV-space and presence of cortical granules was 
associated with embryo quality, but not with implantation and pregnancy rates (Chamayou 
et al., 2006).  Ten et al., (2007) associated embryo quality with an increased PV-space.  
However, no correlation was reported between increased PV-space and subsequent 
embryo development by De Sutter et al., (1996) and Balaban et al., (1998 and 2008).  
Large PV-space correlated with low fertilization, but had no effect on further embryo 
development (Rienzi et al., 2008). 
 
POLAR BODIES  
 
Background 
 
Early oocytes are also classified as immature (GV or metaphase I (MI) stage). The 
breakdown of the GV initiated by human chorionic gonadotropin (hCG) in vitro promotes 
the resumption of meiosis 1.  At this time the oocyte (diploid cell) divides into two haploid 
(23 chromosomes) daughter cells in which each chromosome contains two chromatids. 
One daughter cell becomes the secondary oocyte, the other cell forms the first polar body 
(PB-I), contains the excess DNA from the reductive division and is an indication that 
meiosis 1 has been completed successfully. 
The secondary oocyte then activates meiosis 2 resulting in metaphase II (MII) arrest which 
will not continue until fertilization occurs.  At this time meiosis 2 will be completed, 
extruding the second polar body (PB-II). 
Morphology/shape/appearance: 
Xia (1997), reported a significant correlation between normal PB-I morphology and 
fertilization rate as well as embryo quality after ICSI. In a study by Younis et al., (2009) 
oocytes with normal round intact polar bodies were compared with abnormal fragmented 
polar bodies.  They concluded that the morphology was related to oocyte maturity and 
significantly correlated to clinical implantation and pregnancy rates in ICSI cycles.  Using 
morphologic features such as fragmented, intact, rough-surfaced and enlarged PB-I, 
Ebner et al., (2000) reported a strong correlation between these criteria and fertilization 
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rates as well as embryo quality.  In contrast, Ten et al., (2007) concluded that PB-I 
morphology shape (intact/fragmented or irregular) did not affect fertilization rates and 
embryo quality.  Investigating PB-I size, fragmentation and surface appearance, 
Chamayou et al., (2006) found no influence on implantation and pregnancy rates, but 
reported a “slight” influence on embryo quality.  Studies involving ICSI looked at polar body 
"quality" and concluded that PB-I morphology is related to mature oocyte viability and has 
the potential to predict oocyte fertilization, implantation rates and pregnancy potential 
(Younis et al., 2009; Ebner et al., 2000).  Verlinsky et al., (2003) found no relation between 
fragmented or uneven-shaped PB-Is and embryo quality, blastocyst developmement, 
implantation rates and aneuploidies.  Ciotti et al., (2004) used similar criteria but added the 
size of the polar body and reported no effect on fertilization, embryo cleavage, embryo 
quality, implantation rates and pregnancy rates. Fertilization rates, embryo quality and 
subsequent blastocyst formation were not associated with PB-I fragmentation and surface 
appearance (De Santis et al., 2005). Large and degenerated polar bodies were associated 
with decreased fertilization rates or embryo quality; however, fragmentation had no 
influence any of these outcomes (Rienzi et al., 2008).  In a contrasting study by Fancsovits 
et al., (2006) they reported that degeneration/fragmentation of the PB-I was related to 
improved fertilization and improved embryo quality (less fragmentation).  However, PB-I 
with increased size was associated with lower fertilization and poorer embryo quality. 
Oocytes were thus classified using characteristics for extracytoplasmic abnormalities or 
cytoplasmic abnormalities. 
 
o Extracytoplasmic abnormalities included: ZP abnormalities (thick and/or dark), 
abnormal oocyte shape (oval oocytes), size of PV-space, PB-I normal (intact) or 
abnormal (fragmented, large or degenerative), as mentioned above. 
 
o Cytoplasmic abnormalities included:  granular cytoplasm, centrally located granular 
area, vacuoles, smooth endoplasmatic reticulum (SER) clusters, and refractile 
bodies.  A “normal good quality” metaphase II oocyte has clear, moderately 
granular cytoplasm, a relatively small PV-space, surrounded by a clear/colourless 
ZP (Veeck, 1988). Morphological variations most frequently observed in oocytes are 
intra-cytoplasmic and include changes in colour, granularity and homogeneity of the 
cytoplasm, and cytoplasmic inclusions. Variations from normal PV-space, ZP colour 
and oocyte shape were considered extra-cytoplasmic (Van Blerkom, 1990). Oocyte 
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grading based on PB-I, size of PV-space and cytoplasmic inclusions had a 
significant effect on fertilization rate and embryo quality after ICSI (Xia et al., 1997).  
In a study by Balaban et al., (1998), when patients underwent ICSI, abnormal 
oocyte morphology was not associated with decreased fertilization rate or poor 
embryo quality. However, clinical pregnancy and implantation rates when 
transferred were similar between embryos derived from abnormal versus normal 
oocytes. Oocytes undergoing in vitro maturation (IVM) without anomalies produced 
improved quality embryos and cleavage rates, compared to those with anomalies 
(Mikkelson & Lindenberg, 2001). 
 
Based on the above-mentioned studies regarding oocyte morphology, only severe 
deviations from cytoplasmic normality should be considered as abnormal and should be 
taken into consideration for the selection of the viable oocyte that would result in an 
embryo with a higher implantation potential (Balaban, 2006). However, whether these 
abnormalities could be phenotypical or genotypical cannot be predicted without sufficient 
genetic screening of the whole embryo’s genome. 
 
Ovally shaped ooplasma and/or ZP were associated with delayed developmental progress 
in vitro.  The higher the degree of dysmorphism, the more likely the chance was that the 
cleaving pattern of the corresponding zygote was not a tetrahedron.  Consequently, this 
abnormal cleavage was associated with delayed compaction and blastocyst formation, but 
subsequent blastocyst quality was not affected (Ebner et al., 2008). 
 
o Cytoplasmic infarctions: Rienzi et al., (2011) published an excellent review in which 
they defined cytoplasmic inclusions (refractile bodies, dark incorporations, 
fragments, spots, dense granules, lipid drops, lipofusion and vacuoles (saccules, 
smooth endoplasmic reticulum clusters) and their subsequent effect on ART 
outcome.  Studies by De Sutter et al., (1996) and Balaban et al., (1998) reported no 
correlation between cyotoplasmic inclusions and fertilization, implantation and 
embryo quality rates.  However, Xia et al.,(1997) and Otsuki et al., (2007) reported 
a decrease in fertilization rate and subsequent embryo development.  Furthermore, 
the presence of vacuoles in an oocyte’s cytoplasm had a negative effect on embryo 
development potential (Balaban et al., 2008), but did not have an effect on 
fertilization rates and embryo quality (Ten et al., 2007).  Embryos transferred from 
vacuolated oocytes resulted in increased biochemical pregnancy rates, but were 
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followed by a decrease in clinical pregnancy rates (Otsuki et al. 2004).  It can thus 
be concluded that such embryos contribute to an increase in early pregnancy loss.  
Loutradis et al. 1999 reported decreased pregnancy rates when both inclusions and 
vacuoles were present in the original oocytes.   
 
Meiotic spindle  
 
Definition:  Birefringence has been mentioned earlier and was associated with the 
presence of the meiotic spindle as reported in studies by Wang et al., (2001), Moon et al., 
(2003), Cohen et al., (2004), Konc et al., (2004), Fang et al., (2007), Rama Raju et al., 
(2007), Braga et al., (2008) and Madashi et al., (2008).  Furthermore, the presence of the 
meiotic spindle was associated with improved fertilization rates.  In studies by Moon et al., 
(2003), Rama Raju et al., (2007) and Madashi et al., (2008) a positive correlation was 
reported between the presence of the meiotic spindle and early embryo development.  
However, these findings were contradicted by Cohen at al., (2004) who reported no 
association.  Higher pregnancy rates were reported when embryos originated from oocytes 
when the spindle was present (Konc et al., 2004; Madashi et al., 2008; Madashi et al., 
2009).  If the spindle was positioned close to the polar body, an improved fertilization and 
embryo cleavage rate was reported by Fang et al., (2007).  Furthermore, improved early 
embryo development and subsequent embryo development was associated with spindle 
position by Cooke at al., (2003).  In contrast, Moon et al., (2003) reported no association 
between spindle position and fertilization and embryo cleavage rates or embryo quality.  
Rienzi et al., (2003) associated abnormal fertilization with “misalignment” between the 
meiotic spindle and polar body.  However, embryo development was not affected if the 
fertilization was “normal” despite misalignment. PolScope imaging of oocyte spindle 
retardance is an optical property of organized macromolecular structures that can be 
observed in living cells without fixation or staining. The meiotic spindles during the initial 
stages of oocyte activation showed a dynamic increase in meiotic spindle retardance, 
particularly of the mid-region, before spindle rotation and PB-II extrusion. The pronounced 
increase in spindle retardance was quantified for the first time in living oocytes by Liu et 
al., (2000). Furthemore, post PB-II extrusion and spindle retardance of fertilized oocytes 
(zygotes) were significantly higher than that of MII oocytes. These results establish that 
increased spindle retardance precedes polar body extrusion and pronuclear formation. 
Therefore, increased birefringence of the spindle provides an early indicator of oocyte 
activation. This noninvasive quantitative imaging of oocytes might provide information 
Stellenbosch University  http://scholar.sun.ac.za
44 
 
regarding an oocytes/zygotes developmental potential in vitro. Chen et al., (2006) 
associated higher retardance with a higher pregnancy rate and Kilani et al., (2009) found a 
strong relationship when the meiotic spindle was “normal” (complete barrel-shaped with 
strong birefringence) and retardance with subsequent pregnancy rates.  Rama Raju et al., 
(2007) reported improved blastocyst formation with higher retardence. However, De Santis 
et al., (2006) found no correlation between spindle retardance and embryo quality. 
PRONUCLEAR MORPHOLOGY 
In a study by Lundqvist et al., (2001) zygotes were evaluated for alignment and 
polarization of nucleolar precursor bodies (NPB) as well as early cleavage and their effect 
on implantation and pregnancy rates were reported. They found pregnancy rates were 
significantly higher when transferring one or two embryos when polarization and/or early 
cleavage occurred.  They concluded that a cohort of morphologically good embryos, 
assessed for alignment/polarization of NPB and/or early cleavage, together with 
conventional morphological criteria, were produced, and suggested this noninvasive 
method for identifying embryos with high implantation potential.  Scott (2003a/b) reported 
that the pattern of the NPB or Z-score and the presence/absence of a halo had a 
significant effect on the rate of embryo development as well as overall embryo morphology 
score. Poor Z-score resulted in delayed development, poor blastocyst development and 
low subsequent morphology scores. Furthermore, the absence of a halo also resulted in 
delayed and poor development, resulting in poor morphology, increased fragmentation and 
increased numbers of poor Z-scored embryos. They concluded that using the pronuclear 
(PN) scoring to predict embryos with poor developmental potential might also be a tool by 
which to evaluate oocyte health.  Chen et al., (2003) reported that a high probability of 
subsequent normal diploid embryos resulted when good zygote pronuclear morphology 
(Z1) was used as a selection criterion. 
In a study by Balaban et al., (2004) (applying Tesarik and Greco’s PN score), they 
reported that both embryo cleavage characteristics and chromosome constitution were 
related to PN morphology. Embryos originating from zygotes with the normal PN pattern 
(pattern 0) cleaved faster and developed into embryos with better morphology compared 
to zygotes with abnormal PN patterns.  Furthermore, aneuploidy rates of embryos derived 
from zygotes with the normal PN pattern were more than three times less compared to 
zygotes with multiple PN anomalies. Lastly, embryos of normal PN pattern progressed to 
the blastocyst stage twice as rapidly as embryos with multiple PN anomalies. The same 
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relationship applied to chromosomally abnormal embryos. They concluded that PN 
morphology predicts both the risk of embryo developmental arrest and that of 
chromosomal abnormalities.  Payne et al., (2005), using the Z-score, concluded that Z1 
and Z3 scoring embryos resulted in similar morphology and pregnancy rates. Furthermore, 
decisions based on the Z-score did not improve embryo morphology and did not predict 
pregnancy outcome.  Borges et al., (2005) found that about half fertilized oocytes resulted 
in zygotes with good pronuclear-nuleoli morphology, which mostly developed into good-
quality Day 3 embryos.  Furthermore, when good-quality Day 3 embryos (originating from 
good pronuclear-nucleoli zygotes), underwent biopsy and pre-implantation genetic 
screening (PGS) lower chromosomal abnormalities were reported. They concluded that 
zygote pronuclear-nucleoli morphology seems to be correlated with PGD results and 
therefore could be a useful embryo selection criterion for patients who refuse PGD testing. 
Chen et al., (2006) reported no significant difference between PN morphology and early 
cleavage rate in terms of implantation and pregnancy outcome.  However, they concluded 
that PN morphology is a better criterion than early cleavage to assist in embryo selection 
on Day 3. Their theory is that zygotes with early cleavage ability can be identified from 
their PN morphology and therefore observation for early cleavage at 24-26 hours post 
fertilization in addition to PN morphology scoring is unnecessary when selecting embryos 
on day 3 for transfer. Shen et al., (2006) used noninvasive polarization microscopy 
(PolScope to assess spindle integrity compared with PN score after fertilization.  They 
reported that oocytes with mean retardance of light by birefringence developing into 
zygotes with a good PN score after ICSI and was significantly higher compared with 
oocytes developing into a lower PN score zygotes.  When transfer cohorts included 
oocytes with high retardance and at least one good PN score embryo, conception resulted 
more frequently compared to transfer cohorts consisting of oocytes with a lower mean light 
retardance of the spindle and lower PN score embryos. This study suggested that 
quantitative evaluation of mean retardance of light by the oocyte spindle might reveal the 
oocyte’s health which could be related to PN score of the embryo and its subsequent 
potential. 
 
In a study by Nicoli et al., (2007), they confirmed other findings that Z-score did not 
correlate with implantation and pregnancy rates when the “best” scores were compared to 
the “worst”. They concluded that PN morphology alone cannot be considered superior to 
standard morphologic criteria applied as a tool for identifying/selecting embryos that have 
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a better chance of resulting in an ongoing pregnancy.  Depa-Martynow et. al., (2007) 
reported that when polarization of NPB and pronuclei exist, and they are similar in size 
(Z1and a cytoplasmic halo is present, embryo quality and development were improved. 
The Z-score (Scott-modified) and halo score, combined with Day 3 embryo morphology, 
are useful criteria to identify embryos for transfer to achieve optimal pregnancy rates and 
minimize high-order multiple pregnancies. 
 
This study affirmed findings in previous studies about a positive correlation between the 
appearance of a cytoplasmic halo and embryo quality (Van Blerkom et al., 2002; Ebner et 
al., 2003; Scott, 2003).  Furthermore, Payne et al., (1997) reported that the cytoplasmic 
halo effect attributes to cytoplasmic rotation/movement and/or to the differential distribution 
of mitochondria.  
 
Alvarez et al., (2008) associated both nucleolar pattern 0 (modified Tesarik and Greco 
scoring system) and equal size pronuclei with improved embryo quality.  Furthermore, 
when at least 1 embryo classified as pattern 0 was included in the cohort of embryos 
transferred, they reported higher pregnancy rates.  In contrast to other studies, Arroyo et 
al., (2010) reported that when PN patterns (according to the classifications of Tesarik and 
Scott) were assessed together with embryo quality and chromosome constitution, no 
correlation between PN pattern and embryo quality was found. Interestingly, no significant 
differences were reported when comparing the distribution of chromosomally normal and 
abnormal embryos in respect of embryo quality.  However, differences were observed 
when distinguishing between normal, aneuploid and polyploid embryos. This study’s 
results show that Tesarik’s and Scott’s PN classification systems are not related to the 
embryo developmental potential or its chromosome constitution and cannot replace PGS 
to predict an embryo’s chromosomal status.  Pronuclei positioning within the ooplasm, 
their size, nucleoli distribution, and their orientation in respect of the polar bodies were 
highly predictive of complex chromosomal abnormalities in subsequent embryos.  Zygotes 
displaying juxtaposed pronuclei, oversized-size nucleoli, and small angles between 
pronuclei and polar bodies were associated with the highest rates of euploidy as confirmed 
by embryos generated from PGD cycles (Gianaroli et al., 2003).  Reichman et al., (2010) 
reported that abnormally fertilized 1PN and 3PN zygotes tend to develop into poorer-
quality embryos when compared to normally fertilized 2PN control zygotes. They 
furthermore suggested proper counselling regarding the very low likelihood of viable 
pregnancy after transfer of abnormally developing zygotes. 
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EMBRYO FRAGMENTATION 
 
Introduction to embryo fragmentation 
 
The completion of meiosis 1 (extrusion of the PB-I), fertilization with IVF/ICSI, and 
completion of meiosis 2 (extrusion of the PB-II and appearance of the male and female 
pronucleus) which is considered a “normally fertilized oocyte and is usually checked 
between 16 and 20 hours post insemination. The subsequent zygote next undergoes 
mitosis, resulting in multiple blastomeres [Day 2 (2-5) and Day 3 (6-10)]. The goal is even-
sized, mono-nucleated blastomeres, without fragmentation, on Day 4 blastomeres 
compaction starts (morula), and on Day 5 early cavitation and the beginning of cell 
separation, dividing into trophectoderm (TE) and inner cell mass (ICM) respectively.  Many 
embryos contain some fragments surrounding blastomeres of various sizes, some 
nucleated and others non-nucleated.  Fragmented embryos can also contain multi-
nucleated blastomeres, blastomeres of variable sizes and uneven shapes, “loosely 
floating” blastomeres (poor inter-cell connections) and possibly thick zonas. 
 
The cause of fragmentation, its influence on embryo competency and its effect on ART 
outcome are ongoing topics of interest.  Embryo fragmentation was mentioned as early as 
1954 by Hertig et al., as well as by Edwards et al., (1970), Ortiz et al., (1979) and Alikani et 
al., (2001).  Fragmented embryos have been associated with low embryo viability and 
decreased ability to develop into a viable pregnancy (Puissant et al., 1987). 
 
Several researchers have speculated about the origin of fragments: 
 
 Poor follicular conditions (Van Blerkom et al., 1997) 
 Poor culture conditions (Pickering et al., 1990) 
 Poor culture medium – reactive oxygen species (Yang et al., 1998) 
 Apoptotic and necrotic processes (Juriscova et al., 1996c) 
 Chromosomal anomalies (aneuploidy) (Pellestor et al., 1994) 
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Classification of different fragment types  
 
Cleavage stage embryo grading criteria are based on the number of blastomeres, their 
evenness (size) and percentage of fragmentation present.  Fragmentation should be 
measured/quantified as a percentage of the whole embryo’s volume. Alikani et al., (1999) 
concluded that anucleated blastomeres resulted in a higher percentage of embryos 
containing fragments. 
 
 Classification I (Alikani et al., 1999) 
 Alikani et al., (1999) used fragmentation size and position of blastomeres (nucleated 
cells) versus the distribution of fragments (anucleated cells) to classify fragmentation: 
 
 Type I: one blastomere surrounded by few small fragments. 
 
 Type II: one/more blastomere/s surrounded by many small and localized fragments. 
 
 Type III: small fragments scattered across the all blastomeres. 
 
 Type IV: uneven-sized blastomeres surrounded by larger fragments scattered across 
the embryo. 
 
 Type V:  fragments that appear like granularity in the cytoplasm and surrounding all 
blastomeres – this type of fragmentation does not allow clear visualization of 
blastomeres and is considered a non-distinct pattern. 
 
 They reported that Type III was the most common and Type V the least common.  
Furthermore, they found that maternal age was not associated with any pattern of 
fragmentation, but interestingly the percentage of fragmentation actually decreased 
with an increase of maternal age.  Fragment Types II and IV have been associated 
with a reduced number of blastomeres, which could be due to losing a blastomere to 
fragments and/or retarded cell-division due to loss of cytoplasm space, being filled up 
by fragments. 
 
 Classification II (Antczak & Van Blerkom, 1999) 
 Antczak & Van Blerkom (1999) also developed a fragmentation classification: 
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 Type I:  mono layer carpet of small fragments, coating only a modest portion of the 
blastomere surface with little or no reduction of blastomere size. 
 
 Type II:  multiple layer of fragments, covering a considerable portion of blastomere 
surface and a significant reduction of blastomere size. 
 
 Type III:  embryo with a blastomere showing complete fragmentation which had no 
fragmentation the previous day. 
 
 Type IV:  occasional fragments of variable size scattered over blastomeres 
developmentally in otherwise normally progressing embryos. 
 
More on embryo fragmentation:   
 
The presence of anucleated cells surrounding blastomeres during the early stages of an 
embryo’s development is an important indicator by which to evaluate its subsequent 
implantation potential was reported (Edwards et al. 1984, Trounson et al. 1984, Cummins 
et al. 1986 and Puissant et al. 1987). 
 
The morphological evaluation has been integral to embryo selection criteria since the 
study of embryology began – evaluating and grading of embryos have been part of a 
subjective evaluation of an embryo based on the number of blastomeres, symmetry (size 
and shape), cleaveage rate and fragmentation percentage.  Scoring of Day 2 embryos was 
reported as early as 1986 by Cummins et al., and subsequently by Pruissant et al. (1987), 
Steer et al., (1992), Visser and Fourie (1993), Giorgetti et al., (1995) and Roseboom et al., 
(1995). 
 
Scott and Smith (1998) introduced a corrected embryo score – based on combination of 
pronuclear morphology and early embryo cleavage.  Desai et al., (2000) were the first to 
report on a day3 embryo scoring system, followed by (Fisch et al., 2001, 2003, De Placido 
et al., 2002, Lan et al., 2003, Nagy et al., 2003, Ciray et al., 2005, Chen et al., 2006).  The 
combination of day 3 morphology with embryo scoring has also shown correlations with 
implantation (Steer et al., 1992; Rijnders and Jansen; 1998; Van Royen et al., 1999; Desai 
et al., 2000; Van Royen et al., 2001; Rienzi et al., 2002). During embryo cleavage 
(mitosis), the shape or symmetry of blastomere division (Roux et al., 1995a/b; Hardarson 
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et al., 2001), the fragmentation patterns (Antczak & Van Blerkom, 1999; Alikani et al., 
2000; Van Blerkom et al., 2001) and the embryo’s developmental rate (Racowsky et al., 
2000; Shapiro et al., 2000; Check et al., 2001) had an effect on its implantation potential.  
The effect of fragmentation on embryo viability was reported by several researchers – 
(Erenus et al., 1991, Giorgetti et al., 1995 , Ziebe et al., 1997, Alikani et al., 1999, Antczak 
et al., 1999, Racowsky et al., 2003 and Ciray et al., 2005) – they found that when embryos 
with no fragmentation were transferred the outcome was associated with higher pregnancy 
rates compared to fragmented embryos; however, Hoover et al., (1995) controversially 
claimed that fragmentation had no influence on implantation/pregnancy rates. 
 
In a large study Alikani et al., (1999) reported that embryos transferred from the same 
category (degree or percentage of fragmentation, type of fragmentation ie.Type I (0-5% 
fragmentation), resulted in higher implantation and pregnancy rates established a clear 
relationship between a percentage of fragmentation and embryo viability. In this cohort 
more blastomeres per embryo were present compared to other groups. The presence of 
all other types of fragments resulted in a decrease in implantation and pregnancy rates 
and Type IV (the highest percentage fragmentation) had the lowest.  Racowsky et al., 
(2003) reported that fragmentation higher than 25% of the number of blastomeres and 
asymmetric blastomeres were associated with lower embryo viability and very low 
implantation rates, concluding that the optimal day 3 embryos therefore must contain more 
than seven evenly sized blastomeres with less than 20% fragmentation.  It had been 
reported that pregnancies could derive from highly fragmented embryos (Scott et al., 1991; 
Staessen et al., 1992; Alikani et al., 1999; Ebner et al., 2001). 
 
An inverse relationship between embryo fragmentation and maternal age was reported by 
Alikani et al., (1999) in contrast to Ziebe et al., (2001) Stone et al., (2005) and Keltz et al., 
(2006) that reported and increase in fragmentation with increased maternal age; however 
Giorgetti et al., (1995) and Stensen et al., (2010) found no correlation between maternal 
age and embryo fragmentation. 
 
Embryo fragmentation and embryo ploidy 
 
Munne and Cohen (1998) reported the following to be associated with a high percentage 
of aneuploidy when embryos were screened by FISH:  embryos that were arrested or 
retarded in their development; contained uneven pro-nuclei, multi-nucleated blastomeres 
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or fragmentation; giant eggs or dominant blastomere embryos.  In another study, Ebner et 
al., (2001) reported that transferral of highly fragmented embryos (≥ 25%) resulted in 
pregnancies with significantly higher fetal abnormalities compared to embryos with less 
than 25% fragmentation. However, aneuploidy was not related to an embryo’s morphology 
but to the maternal age and led to increased pregnancy loss when highly fragmented 
embryos were transferred. In contrast, Plachot et al., (1987), Pellestor et al., (1994) and 
Munne and Cohen (1998) reported that highly fragmented embryos were associated with a 
higher rate of chromosome abnormalities, in particular mosaicism.  
 
A correlation between embryo development and chromosomal complement makes the 
incidence of chromosomal abnormalities significantly higher in embryos dividing according 
to a time frame and a symmetry plan which is different from expected. The type of 
fragmentation is also related to chromosomal status, which explains why the extrusion of 
fragments might severely affect embryo viability. Magli et al., (2007) applying FISH 
screening (13,15,16,18,21,22 and XY) found that embryos undergoing retarded or excelled 
division and with an uneven number of blastomeres as well as the presence of fragments 
inside the PV-space, were associated with a significantly higher incidence of chromosomal 
abnormalities; this possibly explains why these anomalies profoundly affect an embryo's 
viability.  
 
Interestingly Gianaroli et al., (2005) and Munné et al., (2006) reported that up to 50% of 
embryos were genetically abnormal, despite the fact that they were graded on Day 3 as 
eight cells without fragmentation - optimal morphology according to Racowsky et al., 
(2003). 
 
The effect of embryo fragmentation and blastocyst formation 
 
Alikani et al., (2000) reported that largely scattered fragments plus uneven blastomeres 
caused decrease in blastocyst formation.  Hardy et al., (2003) reported that embryos with 
severe fragmentation lead to lower blastocyst formation as well as poor ICM formation and 
low numbers of TE cells. Moderate fragmentation, however, leads to a lower TE cell count 
but normal ICM formation. Furthermore, the fragmentation pattern influenced the 
distribution of cells to the ICM or TE during blastocyst formation.  
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Using embryo compaction criteria to determine blastocyst development has been 
researched.  Nikas et al., (1996) suggested that compaction on Day 4 could reveal an 
embryo’s ability to develop into a normal blastocyst. Complete compaction is more 
successful than partial compaction, which excludes some cells/fragments. These findings 
were confirmed by Alikani et al., (2000) who reported 50% of completely compacted, 33% 
of partially compacted and 10% of non-compacted embryos on Day 4 developed into 
blastocysts, respectively and concluded that compaction could be used as a prognostic 
tool for normal blastocyst formation.  
Antzak & Van Blerkom (1999) applied their fragmentation grading criteria and reported that 
the presence of Types 2 and 3 fragments on Day 2 did continue to develop past the 4-cells 
stage; of these about 50% advanced to blastocysts, however, delayed by 12-24 hours.  
They also reported that fragmentation present at the 8-cells stage did not hinder 
development to the blastocyst, concluding that the influence of fragmentation might have a 
more detrimental effect on developmental potential at an earlier stage.  Alikani et al., 
(1999) reported that no fragmentation and Type 1 fragmentation led to the highest 
blastocyst development.  In another study by Stone et al., (2005), they reported similar 
findings, that no fragments and Type I fragments had the highest number of blastocysts, 
whereas Types 2 and 3 (moderately fragmented) resulted in fewer blastocysts. Type 4 
(severely fragmented) resulted in no normal blastocyst development.   
 
Van Blerkom et al., (2001) and Hardarson et al., (2001) both suggested that reabsorption 
of fragments occurs during embryo development.  Furthermore, Van Blerkom et al., (2001) 
speculated that the disappearance of fragments could be due to lyzing of small fragments 
and larger fragments might inflate and burst.  It is assumed that, to a certain degree, 
affected blastomeres can be entirely excluded from further development by selective 
fragmentation (Warner et al., 1998). Cellular fragmentation is likely to be related to 
programmed cell death (Jurisicova et al., 1996c; Warner et al., 1998). 
 
Yang et al., (1998) reported that the majority of fragments do not persist during the 
embryo’s developmental term but are separated at the compaction stage and pushed 
aside or they might be present in the blastocoel cavity at the blastocyst stage.  Hnida et 
al., (2004) reported that the blastomere size will decrease when more than 50% of 
fragmentation is present, which can lead to the arrest of these small “blastomeres”. Alikani 
et al., (1999) classified cells without a nucleus, either to be fragmented or abnormally 
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formed blastomeres and further speculated that degenerating material could be excreting 
toxicities that could potentially negatively affect healthy blastomeres.  Antzak & Van 
Blerkom (1999) suggested that certain fragmentation patterns could decrease regulatory 
proteins and subsequently starve the surrounding blastomeres of essential nutrients. In 
light of the potential side-effects of fragmentation, removal might be beneficial and improve 
pregnancy outcome, as suggested by Rienzy et al., (2002) and Nagy et al., (2005).  
Interestingly Alikani et al., (2002, 2005) and Keltz et al., (2006) conducted experiments to 
evaluate the effects of fragments on surrounding blastomeres, where blastomeres were 
removed and cultured separately or by “transplanting” the blastomeres into surrogate 
zonas. In the first group, Type IV fragmented embryos underwent biopsy to remove 
blastomeres and were cultured individually; 40% arrested, 60% continued to divide. In the 
second group, highly fragmented embryos were biopsied and the removed blastomeres 
were transplanted into surrogate zonas; one third developed into viable blastocysts with 
normal ICM and TE and the majority was diploid, however, chaotic mosaicism was the 
most common chromosomal abnormalitiy present in these embryos.  Poor development of 
fragmented embryos might be due to the effect of the fragments combined with abnormally 
anucleated blastomeres. 
 
How does fragmentation affect blastomere to blastomere intra/inter communication? All 
blastomeres are connected by microbules and tight bindings – fragmentations might cause 
separation by wedging in between blastomeres and therefore interfere with 
communications between blastomeres.  
 
Communication and exchange of growth factors might be influenced by the spatial 
separation as suggested by Alikani et al., (1999).  Van Blerkom et al., (2001) speculated 
that fragments between blastomeres obstructed the contact point between adjacent 
blastomeres.  Alikani et al., (2000) reported that even though the mechanism by which 
fragmentation affects embryo development is unknown, it is clear that fragmented embryos 
result in less compaction and that at this time the embryo can also extrude some 
fragments/cells. 
 
The presence of E-cadherin protein plays a critical role in the formation of a blastocyst. 
The protein is transported from the cytoplasm of each blastomere to the contact point 
between adjacent blastomeres.  This relocation is critical in the formation of the TE cell line 
surrounding each blastocyst. This distribution of the E-cadherin protein might be negatively 
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affected by fragments between blastomeres and interfere with its expression, 
location/distribution and subsequently causing failed blastocyst formation.  All these 
adverse effects on blastocyst development could be related to the disruption of critically 
needed inter-cell communication mediated by E-cadherin (Johnson et al., 1985; Vestweber 
et al., 1987; Alikani et al., 2005). 
 
Conclusion 
 
An embryo containing fragmentation is capable – even though at a lesser rate – of 
developing into a viable pregnancy.  Fragmentation should be evaluated and graded in 
order to predict what its potential effect might be on embryo viability.  The effect that 
transfer of highly fragmented embryos has on pregnancy outcome in this review, suggests 
that an increase in pregnancy loss as well as higher fetal anomalies might be the result of 
transferring such an embryo population. This fact is of concern and needs to be studied by 
multiple centres and in large numbers.  To establish a correlation between a standard 
fragmentaion grading systems and establish its subsequent effect on an embryo’s ploidy 
and viability could be of great interest to ART programs worldwide. 
 
BLASTOCYST MORPHOLOGY AND CULTURE 
 
Introduction 
 
The ultimate goal of any ART clinic is to find specific embryo selection criteria in order to 
optimize implantation and pregnancy rates and simultaneously avoid/reduce high order 
multiple pregnancies.  Several scoring systems evaluating pronuclei, early cleavage and 
cleavage stage embryo morphology have markedly improved ART outcome (Cummins et 
al., 1986; Balakier et al., 1997; Alikani et al., 1999; Van Rooyen et al., 1999; Ebner et al., 
2003; Fisch et al., 2003; Scott et al., 2003b; Rienzi et al., 2005; Sakkas et al., 2005; Windt 
et al., 2004). Improved culture conditions, systems and media over the last decade have 
further improved the ability and effectiveness of extended culture of embryos to the 
blastocyst stage (Gardner et al., 1997/1998a/b/2000, Menezo et al., 1998; Pool et al., 
2002). 
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Factors associated with blastocyst transfer: 
 
 A reduction in number of cleavage stage embryos that will develop/convert to 
blastocyst stage in vitro and leaving fewer embryos for transfer and/or 
cryopreservation – the worst scenario is in some cases no embryos might be 
available for the latter purposes.  However, it has been suggested that this 
reduction of available embryos in most cases leads to fewer, but improved embryo 
quality, by weaning out the embryos of which the embryonic genome was not 
capable of supporting successful conversion to the blastocyst stage (extended 
culture might eliminate non-viable embryos). 
 Sex-ratio imbalances have been associated with blastocyst transfer as reported by 
Luna et al., (2007).  
 Blastocyst transfer might decrease ectopic pregnancies, because the larger 
diameter of an expanded blastocyst might help prevent retroflux into the fallopian 
tubes as suggested by Schoolcraft et al., (2001). 
 Fachin et al., (2001) reported that uterine contractility decreased by Day 7 or 8 post 
hCG when embryos are at the blastocyst stage versus Day 3 embryos. 
 There might be additional cost added for extending culture to Day 5/6. 
 Need to distinguish between embryos with a poor or high developmental potential 
(Tesarik at al., 1994; Van Blerkom, 1994).  
 The uterine environment is more synchronized or receptive to a blastocyst stage 
embryo by reduction of cellular stress (Croxatte et al., 1978; Gardner et al., 2000). 
 Reduces the embryo’s exposure to possible detrimental effect of hyperstimulation of 
the uterine lining (Simon et al., 1995; Pellicier et al., 1996; Ertzeid et al., 2001; 
Kelley et al., 2006).  
 Less uterine contraction prevents expelling the embryo (Lesny et al., 1998; Fachin 
et al., 2001). 
 A blastomere biopsy can be performed on Day 3, the biopsied embryos remain in 
culture until the completion of the genetic screening and a fresh blastocyst transfer 
can be performed (Munné et al., 2002). 
 Embryos convert from maternal genome to embryonic genome control between the 
4- and 9-cell stages; the health of the embryo’s genome will determine its viability 
and ability to grow into a blastocyst (Taylor et al., 1997; Braude et al., 1988). 
Stellenbosch University  http://scholar.sun.ac.za
56 
 
 Improved implantation rates with a reduced number of embryos needed for transfer 
and subsequently a reduction of multiple pregnancies (Gardner et al., 1998 and 
2003/2004). 
 Blastocysts have a higher potential to be viable post cryopreservation (Veeck et al., 
2003).  
 Gardner et al., (2004) suggested that transferring embryos at the blastocyst stage 
might eliminate some chromosomally abnormal embryos for transfer.  
 
Some studies have speculated that extended embryo culture results in higher quality 
embryos and more chromosomally normal embryos compared to cleavage stage embryos, 
leading to increased implantation.  However, many early embryos with a ”normal” 
morphology on Day 3 are actually chromosomally abnormal due to mosaicism, as reported 
by Magli et al., (2000).  However, once the oocyte is aneuploid the genetic status of an 
embryo is not influenced by extended culture --- many chromosomally abnormal Day 3 
embryos develop into top quality chromosomally abnormal blastocysts (Kotze et al., 2012  
Gynecol Obstet Invest DOI: 10.1159/000339632 Accepted (Chapter 4).  Furthermore, 
although extended embryo culture does provide information about an embryo’s viablity in 
vitro, therefore, it should not be directly associated with pregnancy outcome.  Reduction in 
the number of embryos to transfer might reduce multiple pregnancy outcomes; however, 
the transfer of a single blastocyst could result in monozygotic twins. 
Blastocyst morphology 
Early in the evolution of extended embryo culture to the blastocyst stage, non-invasive 
morphological and biochemical markers for blastocyst selection prior to transfer were 
suggested (Renard et al., 1980, Gardner et al., 1987 and Lane et al., 1996). Blastocyst 
grading systems were developed by Cohen et al., (1985), Dokras et al., (1993), Gardner 
and Schoolcraft (1999), Richter et al., (2001) and Kovacic et al., (2004).  These 
morphological grading systems take into account expansion of the blastocoel cavity, 
characteristics of the ICM and the TE.  Balaban et al., (2000) reported that the transfer of 
good quality blastocysts was associated with improved implantation rates compared to that 
of poor quality blastocysts. In another study, Gardner et al., (2000) reported that applying 
their blastocyst grading system resulted in improved ART outcome. 
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Theoretically, after 5-6 days of in-vitro embryo culture, a healthy human embryo should be 
at the blastocyst stage, comprised of some 25 to 50 cells of the ICM and 55 to 110 cells of 
TE.  The blastocyst could start hatching on Day 5 and should be completely hatched from 
the ZP on Day 6 and ready to undergo implantation into the uterine mucosa. Blastocyst 
grading should accommodate a measure of the three parameters: blastocoel expansion 
(ZP thinning), ICM and TE-layer. 
Earlier, mouse and bovine embryos were the only sources of information regarding the 
morphology and rate of development of the blastocyst.  At that time it was presumed that 
human embryos/blastocysts produced in vivo develop more rapidly than those produced in 
vitro and furthermore, it was assumed that extended culture of the human embryo could be 
a detrimental approach; therefore the reason for transferring early cleaved embryos on 
Day 2-3, (Buster et al., 1985).  More recently, with improved culture medium and 
conditions, IVF laboratories seem to be able to apply extended embryo culture to cleavage 
stage embryos with a consistent rate of blastocyst formation. Some clinics moved all ETs 
to the blastocyst stage (Marek et al., 1999), although some centres still report no major 
benefits gained by extended culture (Huisman et al., 2000). Embryo morphology on Day 3 
predicted approximately 50% of embryos that will eventually develop into blastocysts 
(Rijnders & Jansen, 1998). 
Graham et al., (2000) reported that blastocyst scoring was used as a tool that contributed 
to discrimination against poor viability and earlier morphological scoring (Scott et al., 
2000), when evolving from routine Day 3 transfers to the blastocyst stage approach. 
Individually cultured embryos graded as good quality on Day 3 can be tracked and are 
associated with ability to convert to blastocyst and their quality on Day 5-6.  Improved 
pregnancy rate after blastocyst transfer is solely related to improved selection of embryos 
and by no means through intrinsic improvement of embryonic quality through extended 
culture. 
 
In 2000, Racowsky et al. suggested that extended culture of at least two, but preferably 
three or more high quality eight-cell embryos on Day 3, should result in sufficient 
blastocyst development for transfer and/or cryopreservation.  Papanikolalaou et al., 
(2005), similarly suggested that four good quality Day 3 embryos should undergo extended 
culture and be transferred at the blasocyst stage, with a better chance of achieving a live 
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birth compared to cleavage stage ET. Shapiro et al., (2001) reported that blastocysts were 
twice more likely on Day 5 to implant, compared to delayed blastocyst transferred on  
Day 6. 
 
At present the main drive to move to blastocyst transfer is to reduce the number of 
embryos transferred routinely, in an attempt to reduce multiple implantations after IVF-ET 
therapy. A blastocyst's quality is very much determined by the quality of the gametes from 
which it came (Janny & Menezo, 1994, 1996), tempered by the in vitro environment in 
which it was cultured. It is doubtful that we can currently actually improve embryo quality 
beyond that which might be provided in vivo; consequently the only potential way for 
embryo quality to go is down! Thus, we as embryologists have a very real responsibility to 
"do no harm" while nurturing the pre-implantation human embryo; conversely, extended 
culture is a real privilege that allows us access to study the complete pre-implantation 
period of development in the human. 
Is morphological assessment of blastocysts a measure of quality? Dokras et al., (1993) 
(Table 1) proposed a fairly simple approach to blastocyst grading which incorporated both 
morphology and rate of development. Its simplicity to some extent, however, compromises 
its usefulness, as it does not allow sufficient flexibility of description. Gardner & Lane 
(2000), on the other hand, have suggested an approach to grading that is more 
comprehensive; it also incorporates assessment of rate of development and independent 
comment on the ICM and TE (Table 2). The best morphological assessments are based 
on photographic images. While numeric and alphabetic scores can be ascribed, a photo-
library for embryo grading leaves little to the imagination (Menezo et al., 1999). 
In a study by Richter et al., (2001), they added additional parameters to the “regular” 
blastocyst grading criteria: blastocyst diameter (measured from outer zona to outer zona); 
ICM - measured across the widest and longest length (calculated as square micrometers); 
an ICM roundness index (RI - length divided by width; example - an ICM with an RI of 1 
would be perfectly round, whereas a larger RI-score would indicate progressively more 
elongated ICM); and recording the number of TE cells in a cross-sectional circumference.  
Blake et al., (2004) revealed a significant increase in implantation rate when blastocysts 
were transferred compared with cleavage stage embryos. Does this benefit outweigh the 
fact that some patients might have no blastocyst to transfer as mentioned earlier?  These 
contradictory findings can be used to advise clinics that consider an “all blastocyst 
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approach”, since scientific evidence does not support it. Every case should be evaluated 
on its own merits before deciding the optimal stage at which to transfer embryo(s) for each 
patient.  Furthermore, they reported no significant difference in live birth rate and no 
reduction in multiple births between cleavage stage and blastocyst transfers.  Finally this 
review did not report on monozygotic twinning.  In a follow up review, Blake et al., (2005), 
confirmed previous findings, but additionally concluded that the implantation potential of 
blastocysts was more obvious when extended culture took place in sequential culture 
media compared to a single medium.  In 2007 Blake et al., in a continuation of their series 
about cleavage stage versus blastocyst stage embryo transfer (ET), concluded that in 
“good prognosis” category patients, pregnancy and live birth rates were significantly higher 
in the blastocyst transfer compared to the cleavage stage group.  Based on these findings, 
they suggest extended culture and single blastocyst transfer for a selected patient 
population, and thereby support findings by: The Practice Committee of the American 
Society for Reproductive Medicine and the Practice Committee of the Society for Assisted 
Reproductive Technology 2008. 
 
Controversially compared to other findings, Levron et al., (2002) reported a significant 
decrease in implantation rates associated with blastocyst transfer and a negative effect on 
clinical pregnancy rates. Schwarzler et al., (2004) evaluated pregnancy rates when 
embryos were transferred at the cleavage stage or morula/blastocyst stage and reported 
improved pregnancy rates in the morula/blastocyst group compared to the cleavage stage 
embryos.  The birth rate in the morula/blastocyst stage was significnaly higher.  However, 
the multiple pregnancy rates were significantly higher for morula/blastocyst stage transfer. 
They concluded that morula/blastocyst transfer may lead to a higher pregnancy rate with 
an overall better live birth rate but potentially at a higher multiple gestations rate.  In 2005, 
Barrenetxea et al. reported on a patient population that had previous failed IVF outcomes 
when their embryos were transferred at the cleavage stage.  In subsequent cycles the 
same patients received blastocyst transfers and interestingly they found that when the 
transfer was on Day 5, implantation rates were nearly five times higher and pregnancy 
rates were nearly three times higher compared to Day 6, respectively.  They concluded 
that blastocyst transfer on Day 5 after retrieval successfully improved pregnancy outcome 
in patients with prior multiple failed IVF attempts and limited the risk of multiple 
pregnancies because fewer embryos would be transferred. 
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Reports from a few prospective randomized studies 
 
Van der Auwera et al., (2002) concluded in their randomized study that a significantly 
higher clinical pregnancy rate was achievable when blastocysts compared with Day 2 
embryos were transferred.  In 2005 Papanikolaou et al., reported that blastocyst-stage 
transfer resulted in a significantly higher ongoing pregnancy rate and live birth rates 
compared with Day 3 ET. However, a high twin birth rate was observed in both groups.  
Furthermore a minimum of four good embryos on Day 3 followed by extended embryo 
culture to the blastocyst stage will have a better chance of a live delivery compared to 
cleavage-stage ET.  In another study by Papanikolaou et al., (2008) they performed a 
meta-analysis to compare studies where equal numbers of embryos in both the cleavage-
stage and the blastocyst-stage were transferred, and compared clinical pregnancy rate, 
multiple pregnancy rate and live birth rates.  They found that clinical pregnancy rates were 
significantly higher in patients with a blastocyst-stage ET as compared to patients in whom 
a cleavage-stage ET was performed. Live birth rate per randomized patient was 
significantly higher in patients who had a blastocyst-stage transfer compared to patients 
with cleavage-stage ETs. They concluded that the probability of live birth is significantly 
higher after blastocyst-stage as compared to cleavage-stage ET when equal numbers of 
embryos are transferred in each group.  Levitas et al., (2004) compare blastocyst-stage 
ETs with Day 2-3 ETs in patients who failed to conceive in three or more Day 2-3 IVF-ET 
cycles in a prospective, randomized study.  They reported higher clinical pregnancy rates 
per blastocyst versus Day 2-3 transfers. Furthermore, a significantly higher implantation 
rate for blastocyst embryos as compared with Day 2-3 was reported. However, the multiple 
pregnancy rates was not significantly different between the two groups. They concluded 
blastocyst-stage embryos had a significantly higher implantation and higher pregnancy 
rate, even though statistical significance was not reached because of a small patient 
population. 
 
A few studies reported no difference between blastocyst and cleavage stage ETs. 
Utsunomiya et al., (2004) concluded that the pregnancy rate and implantation rate of ET 
with hatching stage blastocysts had no advantage compared with the conventional Day 3 
ET.  In a prospective, randomized study by Bungum et al., (2003) the implantation and 
pregnancy potential of embryos transferred on Day 3 or Day 5 were compared. Equal 
numbers of embryos (two) were replaced in each group. No statistically significant 
difference between chemical, clinical pregnancy, implantation rates, twinning rates and 
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early pregnancy loss rates were found between Day 3 or Day 5 groups. Implantation rates 
were similar when equal numbers of embryos were transferred. They concluded that ETs 
at the blastocyst stage have no advantage over Day 3 transfers.  In a prospective 
randomized study by Hreinsson et al., (2004) they compared the implantation and 
pregnancy rates after cleavage stage and blastocyst-stage (days 5-6) embryos were 
transferred. They found no significant difference in implantation rates and clinical 
pregnancy rates between the two groups; however, they concluded that blastocyst transfer 
might be a good alternative for couples with many good quality embryos on Day 2. 
 
Finally a few studies suggested that transferring of a single blastocyst could effectively 
reduce multiple pregnancies without compromising the live birth rates, as reported by the 
Criniti et al., (2005), Henman et al., (2005) American Society for Reproductive Medicine 
62nd Annual Meeting, 2006 and Zech et al., ( 2007). 
 
Conclusion 
 
Overall, when looking at the meta-analysis (Papanikolaou et al., 2008) blastocyst transfer 
increased implantation rates and live birth rates compared to cleavage stage embryos.  In 
a population of good prognosis patients, transferring fewer blastocysts could be 
considered to reduce the rate of multiple births without compromising live birth rates.  In all 
cases the potential risks associated with prolonged culture should be considered.  Lastly, 
successful blastocyst development depends on optimal culture conditions and selection of 
a specific patient population.  
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TABLE 1 
Dokras Blastocyst grading:  
Blastocyst grading according to Dokras et al. 1993 was performed as follows:  
Grade 1 blastocysts were characterized by early cavitation resulting in the formation of an 
eccentric and then expanded cavity lined by a distinct inner cell mass region and 
trophectoderm layer. 
 
Grade 2 blastocysts exhibited a transitional phase where single or multiple vacuoles were 
seen which over subsequent days developed into the typical blastocyst appearance of 
grade 1 blastocysts. 
 
Grade 3 blastocysts were defined as blastocysts with several degenerative foci in the 
inner cell mass with cells appearing dark and necrotic 
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TABLE 2 
Gardner blastocyst grading/developmental criteria/explanation (Gardner & 
Schoolcraft, 1999) 
Expansion grade 
Blastocyst expansion grade Description of blastocyst stage/development criteria 
Grade 1 Early blastocyst: the blastocoel is less than half the volume of the 
embryo 
Grade 2 Blastocyst: the blastocoel is greater than or equal to half of the 
volume of the embryo 
Grade 3 Full blastocyst: the blastocoel completely fills the embryo 
Grade 4  Expanded blastocyst: the blastocoel volume is larger than that of the 
early embryo and the zona pellucida is thinning. 
Grade 5 Hatching blastocyst: the trophectoderm has started to herniate 
through the zona pellucida 
Grade 6  Hatched blastocyst: the blastocyst has completely escaped from the 
zona pellucida 
 
Inner cell mass (ICM) Grade Description of ICM quality criteria  
Grade A Tightly packed, many cells 
Grade B Loosely grouped, several cells 
Grade C Very few cells 
 
Trophectoderm (TE) Grade Description of TE quality criteria  
Grade A Many cells forming a tightly knit epithelium 
Grade B Few cells 
Grade C Very few cells forming a loose epithelium 
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GENOMICS, TRANSCRIPTOMICS, PROTEOMICS, AND METABOLOMICS  
 
Introduction 
 
Over the last 30 years assisted reproductive technology (ART) has been lacking an 
international standard by which to select an embryo with optimal potential to develop into a 
live baby. Multiple embryos have been transferred in an effort to optimize pregnancy rates. 
Adamson et al., (2004) concluded that a lack of knowledge about the reproductive 
potential of embryos exist, resulting into failed ART cycles and/or multiple pregnancies. 
With the introduction of extended embryo culture to the blasotcyst stage, fewer embryos 
are being transferred; however, the ideal of a single-embryo transfer without compromising 
pregnancy rates has still not been attained as reported by Van Montfoort et al., (2006). 
Early stage embryo morphology, cleavage stage embryos and blastocyst embryos 
currently provides insufficient information to the embryologist in order to accurately select 
a single embryo for transfer. 
 
 Lately, advances in genomics, transcriptomics, proteomics, and metabolomics might be a 
helpful addition to current embryo selection criteria.  
 
Proteomics - (non-invasive) - describes the changes in all proteins expressed and 
translated from a single genome. Currently little is known about either the genome or 
proteome of human gametes or the pre-implantation embryo. The dialogue between the 
developing embryo and the maternal endometrial environment needs a much better 
understanding. Proteomics technology might be a futuristic tool to select competent 
embryos for transfer.  Proteomics alone involves several sophisticated techniques 
including imaging, mass spectrometry and bioinformatics to identify, quantify and 
characterize a proteome. Continuous research can lead to profiling the proteome of 
individual human oocytes and embryos, as well as the proteins produced by the embryo 
into the surrounding medium (the secretome). Furthermore, the identification of proteins 
that are involved in oocyte maturation, embryo development and implantation could lead to 
further improvements in assisted reproduction techniques as well as the development of 
new diagnostic tests. Finally, proteomics may contribute in the design of a non-invasive 
viability assay to assist in the selection of embryos for transfer in human assisted 
reproduction.   
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Transcriptomic - (non-invasive) - studies that evaluate cumulus masses surrounding 
oocytes for the presence of specific messenger RNA (mRNA).  Katz-Jaffe et al., (2008) 
reported that when these embryos were transferred, live births resulted compared with 
those that failed to deliver.  Assou et al., (2010) in a review study reported on the cumulus 
cells (CCs) transcriptomic profiling that predict oocyte and embryo competence.  Using 
RT–PCR or DNA microarrays, evidence of genes expressed in CCs might present 
potential biomarkers to predict embryo quality and pregnancy outcomes.  
 
Proteomics - (non-invasive) - is the measurement of amino acids or proteins in spent 
culture media. Brison et al., (2004) found that changes in the levels of some amino acids 
are associated with implantation rates. Sturmey et al., (2008) reviewed amino acid profiling 
as possible predictor early embryo viability. Amino acid supplementation of embryo culture 
media and the role of amino acids in early embryo development were reviewed as well as 
methods to quantify amino acid depletion and production by single embryos. They 
concluded that improved metabolic assay methods and provided great potential to improve 
the selection of single embryos for transfer in vitro.  
 
Metabolomics – (non-invasive) - evaluates how the embryo alters its surrounding 
microenvironment and is evaluated in spent culture medium surrounding embryos.  Scott 
et al., (2008) used a Raman spectroscope to determine if varying spectral patterns predict 
ongoing pregnancies. Initial studies to measure metabolomic changes in the culture 
medium of embryos and oocytes have demonstrated that different types of 
spectrophotometric tests, including Raman and near-infrared (NIR) techniques, are 
similarly well capable of detecting specific changes of the 'secretome' It has been 
demonstrated that metabolomic measurements correlate well with embryo development 
and morphology assessment. The viability index on oocytes/embryos established by 
metabolomic tests may be a stronger predictor for implantation potential than traditional 
morphological assessment. Gardner et al., (2011) reported that glucose consumption by 
embryos which resulted in a pregnancy was significantly higher at the morula and 
blastocyst stage compared to those that failed to develop into a pregnancy. Interestingly, 
female embryos consumed 28% more glucose compared to male embryos. They 
concluded that a human embryos glucose metabolism could be used as selection criteria 
and hypothesized that male and female human embryos differ in their physiology and 
glucose consumption. 
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Genomics - (invasive) - was used as early as 1989 by Handyside et al., when they 
introduced PGD.  FISH has been applied to identify aneuploidy and known single-gene 
disorders and using genomics to prevent the transmission genetic disorders. However, the 
latter did not improve pregnancy rates among infertile couples as reported by Mastenbroek 
et al., (2007). A few years later Kallioniemi et al., (1992) developed comparative genome 
hybridization (CGH) to screen the whole genome’s DNA in tumors. This technique was 
modified to study the DNA of single cells (like blastomeres) by Voullaire et al., (1999) and 
Wells et al., (1999).  Lately, a more rapid technology has been developed, allowing a more 
rapid and more detailed analysis of PB-I, PB-II, Day 3 blastomeres and trophectoderm 
cells, namely array-CGH (Hu et al., 2004; Wells et al., 2004; Le Caignec et al., 2006; Treff 
et al., 2010, 2011). More recently Treff et al., 2012 introduced real-time qPCR . 
 
We conclude that although the results of these initial investigations are promising, further 
prospective studies are required to define the potential benefits of this novel non-invasive 
technology.  
 
SOLUBLE HUMAN LEUKOCYTE ANTIGEN –G (sHLA-G)  
 
Background 
 
The search for a non-invasive embryo marker that can identify embryos with high 
implantation potential is continuing. 
Human leukocyte antigen-G (HLA-G) is a non-classic type I human leukocyte antigen 
produced by the embryo (Neumann et al., 1994; Menicucci et al., 1999; Salihu et al., 2003) 
and by thymus cells (Mallet et al., 1999). It probably plays a pivotal role in the development 
of pregnancy. Soluble HLA-G (sHLA-G) has been identified in the media surrounding 
groups of embryos in culture for several days, where its concentration has been found to 
be related both to cleavage rate (Menicucci et al., 1999) and implantation potential (Fuzzi 
et al., 2002). 
The detection of sHLA-G (a major histocompatibility complex [MHC]) in culture medium 
surrounding embryos was first reported by Jurisicova et al., (1996a/b), Menicucci et al. 
(1999) and Fuzzi et al., (2002).  sHLA-G was expressed during preimplantation human 
embryo development and was detected in culture medium surrounding groups of  
embryos.  Sher et al., (2004) was the first to detect sHLA-G in the culture medium of 
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individually cultured early cleaving embryos (as early as 44–46 h after insemination).  This 
early expression of sHLA-G provided evidence that embryos could be selected based on a 
healthy maternal genomic function.  sHLA-G expression by an embryo has been 
associated with an embryo’s potential to reach a pregnancy. 
The greater the sHLA-G expression, the more superior the embryo competency, as 
evidenced by implantation and pregnancy rates (Roussev et al., 2003). Early studies 
suggested that HLA-G was expressed and secreted by the extravillous trophoblast, and by 
thymus cells (Ellis et al., 1990; Chu et al., 1998). In later studies evidence indicated that 
the syncytiotrophoblast also secretes this compound (Chu et al., 1998). HLA-G is believed 
to play a pivotal role in immunoprotection of the semi-allogenic embryo (Jurisicova et al., 
1996a; Fernandez et al., 1999). Its role is to prevent allo-recognition by maternal cytotoxic 
lymphocytes and to protect against natural killer (NK) cell-mediated lysis of target cells 
(Choudhury & Knapp, 2001; Kanai et al., 2001). HLA-G has been found to cause a 
polarizing shift of two subtypes of T helper cells (Th1 and Th2), in the embryo-decidual 
interphase (Jurisicova et al., 1996b). Th1 predominates in the non-pregnant state and 
expresses interferon (IFN) and tumor necrosis factor (TNF) beta, the cytokines 
predominantly involved in cellular immunity, delayed hypersensitivity, tissue injury in 
infection and autoimmune disease. Th2 cells secrete interleukin (IL)-4, IL-5, IL-6, IL-9, IL-
10 and IL-13, cytokines that are involved in antibody production. Th2 response down-
regulates the Th1 response and vice versa (Choudhury & Knapp, 2001). The balance 
between Th1 and Th2 cytokines largely determines whether an immune response is 
protective or pathological. The HLA-G-induced shift toward Th2 during pregnancy 
establishes and perhaps coordinates a cytokine network that protects the developing 
embryo from the maternal immune system (Makhseed et al., 1999 and Hunt et al., 2005). 
(Figure 1a/b:  sHLA-G mechanism schematics) 
The implantation mechanism has been a very poorly understood aspect of reproduction.  It 
is a highly complex dialogue (cross-talk) between the embryo and the endometrium, 
(Simón et al., 1995a/b; Hill. 2001; Viganò et al., 2003; Shimomura et al., 2006). 
Implantation requires the successful suppression of the maternal immune system. The 
human body will identify and discriminate against foreign tissue by MHC, HLA originated 
from a group of genes located on the short arm of chromosome six (6).  The MHC evokes 
T-cell intervention to non-self antigens expressed by an individual of the same species.  
The human fetus is considered a non-self tissue by the maternal uterus because of 
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paternal MHC antigens; however, during pregnancy the immune system develops fetal 
tolerance (Saito et al., 2007).  HLA-G produced by the extra-villous cytotrophoblast (the 
only fetal contact with maternal uterine cells), confers immuno-tolerance through 
interaction with maternal uterine membrane lymphocytes.  This scenario would suggest 
that HLA-G protects the fetus from maternal immune response attack.  HLA-G is 
expressed by the placenta throughout gestation and is also present in amniotic fluid.  
sHLA-G (a spliced iso-form of membrane-bound HLA-G) is in suspension and can be 
detected in culture medium. sHLA-G, a non-classic type I HLA, was first identified in the 
media surrounding groups of embryos and blastocysts in culture by Jurisicova  et al., 
(1996).  Menicucci et al., (1999) first identified, sHLA-G in the culture media surrounding a 
group of Day 3 embryos. Fuzzi et al., (2002) showed that the presence of sHLA-G in the 
culture media harbouring groups of 3-day-old cleaved embryos correlated both with their 
cleavage rate and with their overall subsequent implantation potential. Hviid et al, (2004) 
postulated that the presence of sHLA-G protected the conceptus from destruction by the 
maternal immune response.  Several studies regarding sHLA-G and its effect on 
pregnancy outcome have been reported since (Sher et al., 2004, Criscuoli et al., 2005; 
Noci et al., 2005; Sher et al., 2005a; Sher et al., 2005b; Yie et al., 2005; Desai et al., 2006; 
Fisch et al., 2007; Rebmann et al., 2007; Kotze et al., 2010). In review studies by Sargent 
et al., (2007) and Vercammen et al., (2008) they thoroughly evaluated and discussed 
previous studies regarding sHLA-G and ART outcome.  Furthermore, Rebmann et al.,  
(2004) addressed specific issues dealing with sHLA-G enzyme-linked immunosorbent 
assay (ELISA) protocols. 
 
There has been some criticism of use of the optical density (OD) value as our sHLA-G unit 
value; no previous reported studies (Fournel et al., 2000; Criscuoli et al., 2005; Noci et al., 
2005; Yie at al., 2005; Rebmann et al., 2004; Desai et al., 2006; Rebmann et al., 2007; 
Sargent et al., 2007; Vercammen et al., 2008) performing sHLA-G analysis have reached 
consensus on the appropriate way to report these results. In the only prospective 
randomised controlled study, Kotze et al., (2010) emphasized the benefit of transferring 
sHLA-G positive embryos and predicting pregnancy outcome in ART.  Kotze’s data from a 
multi-centre sHLA-G study furthermore suggested that the presence of sHLA-G is a 
valuable non-invasive embryo marker to assist in improving pregnancy outcome with the 
theoretical potential to reduce multiple pregnancies.  A combination of sHLA-G expression 
and extended embryo culture to the blastocyst stage might provide future tools by which to 
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select single embryos for transfer and reduce the risk of multiple gestation, without 
compromising pregnancy rates. 
 
EMBRYO PRE-IMPLANTATION GENETIC SCREENING (PGS)  
 
Aneuploidy screening in embryos is applied to patients at risk ie advanced maternal age 
(AMA) recurrent pregnancy loss, repeat IVF failure or severe male factor infertility (Baruch 
et al., 2008) However, according to 2009 European Society for Human Reproduction and 
Embryology PGD consortium data collection revealed that after PGS embryos were 
transferred, only 14.3% 2433/16975 resulted into fetal heart rates (Goossens et al., 2009. 
In the past the most common technique used for PGS was fluorescence in situ-
hybridization (FISH) – a fast and relatively easy procedure to perform. Recently the validity 
of FISH PGS was scrutinized by Staessens et al., 2008 since this procedure did not 
improve implantation and delivery rates in women <36. Furthermore, it caused a decrease 
in women with advanced maternal age (AMA) as reported by Hardarson et al., 2008. Was 
that cleavage stage embyos are affected by mosaicism that affected the accuracy of PGS. 
(Munne et al., 1994, Bielanska et al., 2002 and Li et al., 2005) Finally another reason why 
FISH PGS does not improve pregnancy/implantation rates is because the complete 
genome (22 pairs of outosomal and the two sex chromosomes) are not all screened – 
leaving the potential to transfer aneuploid embryos, which could potentially influence 
embryo development and implantation. Initially, Kallioneni et al., 1992 developed 
comparative genome hybridization (CGH) to screen the whole genome’s DNA in tumors. 
This technique was adopted to study the DNA of single cells – (like blastomeres) by 
Voullaire et al., 1999 and Wells et al., 1999.  The CGH technique is superior to FISH since 
it screens the whole genome for anomalies such as chromosome imbalances due to 
aberrant segregation and structural imbalances (gains/losses) larger than 10-20 Mb as 
reported by Griffin et al., 1998 and Malmgren et al., 2002. A disadvantage of CGH is that it 
is very time/labor intensive – it takes up to 4 days to obtain results after hybridization and 
amplification of the DNA and comparing the test DNA to to that of a normal template of 
chromosomes. The approach of PB-1 and PB-II screening and evaluating the oocyte and 
zygote’s genome (in order to perform of fresh transfer) has been reported by Wells et al., 
2002, Sher et al., 2007, Obrados et al., 2008 and 2009 and Fragouli et al., 2009 Day 3 
blastomere was evaluated to detect the influence of patenternal contribution as reported 
by Wilton et al., 2001, Voullaire et al., 2002 Sher et al., 2007 and 2009 and Kotze et al., 
2012. Kotze et al., 2012 (GOI accepted for publication) reported no association between 
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the chromosomal status of PB-1, PB-II and Day 3 blastomeres and subsequent blastocyst 
formation.  However, they reported respectable live birth outcome when sequential 
screening was applied and normal embryos developed into blastocyst and were 
transferred. 
 
Lately, the removal of several trophectoderm cells at the blastocyst stage has been 
reported by Fragouli et al., 2009 and Schoolcraft et al., 2010.  Day 3 and blastocyst 
embryo biopsy required embryo cryopreservation allowing time to complete CGH analysis.  
In a follow-up FET cycle (frozen embryo transfer) euploid embryos can be thawed and 
transferred.  The potential detrimental effects of cryopreservation post PGD has been 
reported by Joris et al., 1999, Edgar et al., 2000 and Zheng et al., 2005, resulting in a 30-
40 % reduction in implantation potential.   
 
However, recently the introduction of vitrification of blastocyst by Mukaida et al., 2003 and 
Zhang et al., 2009 has significantly improved the survival of warmed embryos.  Kotze et 
al., 2012 in press, reported 50% live birth rates after the transfer of PGS vitrified/warmed 
blastocyst.  This ideal scenario for embryos undergoing PGS, would be to have results on 
the analysis in sufficient time for a fresh transfer and avoid cryopreservation. 
 
However, a faster technology emerged, allowing a more rapid and more detailed analysis 
of PB-I, PB-II, Day 3 blastomeres and trophectoderm cells, namely array-CGH (Hu etal., 
2004, Wells et al., 2004, Le Caignec et al., 2006, Treff et al., 2010 and 2011).  Different 
approaches to screen the whole genome compliment within 16 hours, by modifying earlier 
procedures – to potentially avoid embryo cryopreservation of PGS embryos has been 
suggested by Gutierrez-Mateo et al., (2004a) and  Landwehr et al., (2008). 
 
FISH based technology has been superseded by technology that is able to screen all 22 
pairs of autosomal chromosomes and 2 pairs of sex chromomes. Screening the whole 
genome has indicated that anomalies could be present in any of an embryo’s 
chromosomes. In the study by Koze et al., 2012 (GOI accepted for publication) and 
Traversa et al., 2011 it has been shown that aneuploid embryos have the potential to 
develop to a blastocyst. These findings contradict the belief that aneuploidy of the larger 
chromosomes (1-12) are less likely to develop into a blastocyst. FISH indentifies a single 
point on a chromosome while CGH-probes cover the entire length of a chromosome, 
therefore structural anomalies can be detected such as partial duplications and deletions. 
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Translocation errors can be detected by the ability of CGH to determine a loss/gain of 
parts of chromosomes. Traversa et al., 2010 has shown that FISH suffers from high false 
positive abnormality rates. Improved PCR technologies (array-CGH) have been reported 
by Traversa et al., 2010 to improve translocation screening.  Furthermore, CGH can detect 
translocation in cases where the fragments are large enough – balanced translocation can 
thus be determined as well as the ploidy status of all other chromosomes. FISH analyzes 
each cell individually for the specific probe(s) that are applied 
 
Traversa et al., 2010 demonstrated the reliability and feasibility of CGH to detect 
aneuploidy in blastocysts.  Kotze et al 2012 used sequential CGH screening of PBI, PBII 
and blastomere to identify aneuploid embryos, subsequent blastocysts were vitrified.  
Blstocysts that were classified as euploid were warmed and transferred, resulting in 
improved implantation and pregnancy outcomes. 
 
Recently a more rapid method to perform cyto-genetic screening has been introduced – 
array CGH. Currently there are two approaches that are being applied – single nucleotide 
polymorphism array (SNP –array) and CGH-array. 
 
 SNP-array:- Common polymorphic DNA sequences found throughout the genome 
is used to detect any chromosome imbalances and genome wide linkage analysis. 
  Handyside et al., 2009 Vanneste et al., 2009 and Treff et al., 2010/2011.   
  CGH-array:- test and reference DNA is hybridized to DNA probes fixed to a slide. 
Several reports on the successful use of array-CGH   Hu et al 2004. Wells et al., 
2004 and Le Caignec et al., 2006. Furthermore, some clinical applications have 
been reported by Hellani et al., 2008, Fishel et al., 2009 and Rius et al., 2010. 
 
The latest studies to improve the efficiency of PGS is the use of BAC microarrays in order 
to detect aneuploidy in all chromosomes as reported by Fragouli et al., 2011, Guiterrez-
Mateo et al., 2011 as well as segmental errors during chromosomal rearrangement as 
reported by Alfarawati et al., 2011 and Fiorentino et al., 2011. 
 
Array-CGH technology can be applied to improve the identification process of 
aneuploidy/anomalies of the whole genome’s chromosomes.  The transfer of embryos 
deemed euploid should improve pregnancy outcome in patients where aneuploidy 
contributed to their IVF failure.  
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In this chapter a literature review was performed to research the impact of the 
oocyte/zygote and the embryo on implantation/pregnancy rates.  The morphologic 
characteristics of the oocyte;- cumulus –oocyte-complex (COC), zona pellucida, 
perivitelline space, cytoplasm, meiotic spindle and the polar body and its appearance was 
studied. The morphologic characteristics of the zygote;- pronuclei orientation, the embryo 
and its effect on embryo development, ploidy and blastocyst formation and its effect on 
implantation and pregnancy outcome was also reviewed. The pronuclear morphology, 
early cleavage and a biochemical marker that is expressed by developing embryos 
(soluble Human Leucocyte-Antigen-G) and its role in predicting pregnancy outcome 
predict outcome was discussed as non-invasive markers. The value of blastocyst transfer 
and the improved ongoing pregnancy rate compared to cleavage stage embryos was also 
highlighted based on a recent meta-analysis.  Genetic testing using FISH, CGH and array-
CGH and the future of genomics was discussed as invasive markers. 
 
We conclude that despite all the above mentioned parameters to select an embryo for 
transfer that will develop into a live baby, extensive research and international 
corroboration is needed in order to improve and standardize such criteria. 
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 Figure 1a/b:  sHLA-G mechanism schematics (Hunt et al., (2005) 
 
 
 
Figure 1a. Multiple mechanisms underlie maternal tolerance of the fetus. Mothers, via 
changes that occur in the uterus, and embryo/fetuses, via special adaptations of the 
placenta, contribute to the establishment of an immune privileged environment within 
which the semiallogeneic fetus resides safely until termination. NK cells, natural killer cells; 
Treg, CD4_ regulatory T cells; TNF superfamily, tumor necrosis factor superfamily. 
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Figure 1b. A schematic illustration of the human fetus, placenta and extraplacental 
membranes, and modified endometrium known as decidua. The fetus developing within 
the amniotic sac is surrounded and encased by trophoblast cells in the placenta and 
chorion membrane (red). Upper insert: Cytotrophoblast (CTB) cells within the placental villi 
serve as the progenitors for all differentiated trophoblast cell subpopulations, including the 
syncytiotrophoblast (sTB) layer, which is continuously exposed to maternal blood. This 
single cell layer is responsible for transfer of maternal-fetal nutrients and wastes, synthesis 
of placental hormones, and providing a physical barrier to maternal cell traffic into the 
fetus. CTB cells proliferate and migrate into the decidua, attaching the placenta to the 
mother and facilitating certain crucial physiological events required for successful 
pregnancy. Lower insert: The amnion membrane comprised of a single layer of epithelial 
cells is a strong sac holding the fetus in amnionic fluid. The chorion membrane CTB cells, 
derived from the migrating extravillous CTB cells, interface directly with maternal 
decidual cells.  (Hunt et al., (2005) 
 
Stellenbosch University  http://scholar.sun.ac.za
75 
 
References 
 
Adamson D, Baker V. Multiple births from assisted reproductive technologies: a challenge 
that must be met. Fertil Steril 2004;81:517–22. 
 
Albertini DF, Rider V.  Patterns of intercellular connectivity in the mammalian cumulus-
oocyte complex.  Microsc Res Tech 1994;27(2):125-33. 
 
Alfarawati S, Fragouli E, Colls P, Wells D. First births after preimplantation genetic 
diagnosis of structural chromosome abnormalities using comparative genomic 
hybridization and microarray analysis. Hum Reprod 2011;26:1560–1574. 
 
Alikani M, Cohen J, Tomkin G., et al. Human embryo fragmentation in vitro and its 
implications for pregnancy and implantation. Fertil Steril 1999;71:836-842. 
 
Alikani M, Calderon G, Tomkin G, et al. Cleavage anomalies in early human embryos and 
survival after prolonged culture in-vitro. Hum Reprod 2000;15(12):2634-43. 
 
Alikani M. Cytoplasmic fragmentation in human embryos in vitro: implications and the 
relevance of fragment removal. In: Gardner D, Weissman A, Howles C, Shoham Z (eds). 
Textbook of Assisted Reproductive Techniques, Laboratory and Clinical Perspectives. 
London, Martin Dunitz 2001:169-82. 
 
Alikani M, Willadsen SM. Human blastocysts from aggregated mononucleated cells of two 
or more non-viable zygote-derived embryos.RBM Online 2002;5:56–58 
  
Alikani M, Schimmel T, Willadsen S.M. Cytoplasmic fragmentation in activated eggs 
occurs in the cytokinetic phase of the cell cycle, in lieu of normal cytokenisis, and in 
response to cytoskeletal disorder. Mol Hum Reprod 2005;11:335-44. 
 
Álvarez C, Taronger R, García-Garrido C, González de Merlo G.  Zygote score and status 
1 or 2 days after cleavage and assisted reproduction outcome.  Int J Gyne Obst 
2008;101(1):16-20. 
 
Stellenbosch University  http://scholar.sun.ac.za
76 
 
American Society for Reproductive Medicine 62nd Annual Meeting Supplement. Fertil 
Steril 2006;86(3)Suppl1. 
 
Antczak M, Van Blerkom J. Temporal and spatial aspects of fragmentation in early human 
embryos: possible effects on developmental competence and association with the 
differential elimination of regulatory proteins from polarized domains. Hum Reprod 
1999;14:429-447. 
 
Arroyo G, Santaló J, Parriego M, et al. Pronuclear morphology, embryo development and 
chromosome constitution.  RBM Online 2010;20(5):649-655. 
 
Assou S, Haouzi D, De Vos J, Hamamah S.  Human cumulus cells as biomarkers for 
embryo and pregnancy outcomes. Mol Hum Reprod. 2010 Aug;16(8):531-8. Epub 2010 
Apr 29. 
 
Balaban B, Urman B, Sertac A, et al. Oocyte morphology does not affect fertilization rate, 
embryo quality and implantation rate after intracytoplasmic sperm injection. Hum Reprod 
1998;13:3431–3433   
 
Balaban B, Urman B, Sertac A, et al. Blastocyst quality affects the success of blastocyst-
stage embryo transfer. Fertil Steril 2000;74:282-287. 
 
Balaban B, Yakin K, Urman,B, et al. Pronuclear morphology predicts embryo development 
and chromosome constitution.  RBM Online 2004; 8(6):695-700. 
 
Balaban B,Urman B. Effect of oocyte morphology on embryo development and 
implantation. RBM Online 2006;12:608–15. 
 
Balaban B, Ata B, Isiklar A, et al. Severe cytoplasmic abnormalities of the oocyte decrease 
cryosurvival and subsequent embryonic development of cryopreserved embryos. Hum 
Reprod 2008;23:1778–1785. 
 
Balakier H, Cadesky K. The frequency and developmental capability of human embryos 
containing multinucleated blastomeres. Hum Reprod 1997;12:800-4. 
 
Stellenbosch University  http://scholar.sun.ac.za
77 
 
Barrenetxea G, López de Larruzea A, Ganzabal T, et al. Blastocyst culture after repeated 
failure of cleavage-stage embryo transfers: a comparison of day 5 and day 6 transfers. 
Fertil Steril 2005;83(1):49-53. 
 
Baruch S, Kaufman DJ, Hudson KL. Preimplantation genetic screening: a survey of in vitro 
fertilization clinics. Genet Med 2008;10(9):685-90. 
 
Bertrand E, Van den Bergh M, Englert Y. Does zona pellucid thickness influence the 
fertilization rate? Hum Reprod 1995;10(5):1189-93. 
 
Bielanska M, Tan SL, Ao A. Chromosomal mosaicism throughout human preimplantation 
development in vitro: incidence, type, and relevance to embryo outcome.  Hum Reprod 
2002;17:413–419. 
 
Blake DA, Proctor M, Johnson NP. The merits of blastocysts versus cleavage stage 
embryo transfer: a Cochrane review. Human Reprod 2004;19(4):795-807. 
 
Blake D, Proctor M, Johnson N, Olive D. Cleavage stage versus blastocyst stage embryo 
transfer in assisted conception. Cochrane Database Syst Rev 2005;19(4): CD0022118. 
 
Blake DA, Farquhar CM, Johnson N, Proctor M. Cleavage stage versus blastocyst stage 
embryo transfer in assisted conception. Cochrane Database Syst Rev 
2007;(4):CD002118. 
 
Borges E, Rossi LM, Farah S, et al.  The impact of pronuclear orientation to select 
chromosomally normal embryos. J Assist Reprod Genet 2005;22(3):107-114 
 
Braga DP, Figueira Rde C, Rodrigues D, et al. Prognostic value of meiotic spindle imaging 
on fertilization rate and embryo development in in vitro-matured human oocytes. Fertil 
Steril 2008;90(2):429-33. 
 
Braude P, Bolton V, Moore S. Human gene expression first occurs between the four- and 
eight-cell stages of preimplantation development.  
Nature 1988;31:459–61. 
 
Stellenbosch University  http://scholar.sun.ac.za
78 
 
Brison DR, Houghton FD, Falconer D, Roberts SA, Hawkhead J, Humpherson PG, et al. 
Identification of viable embryos in IVF by non-invasive measurement of amino acid 
turnover. HumReprod 2004;19:2319–24  
 
Bungum M, Bungum L, Humaidan P, Yding Andersen C. Day 3 versus day 5 embryo 
transfer: a prospective randomized study. RBM Online 2003;7(1):98-104. 
 
Buster JE, Bustillo M, Rodi IA. Biologic and morphologic development of donated human 
ova recovered by non surgical lavage. Am J Obstet Gynecol 1985;153:211-7.  
 
Chamayou S, Ragolia C, Alecci C, et al. Meiotic spindle presence and oocyte morphology 
do not predict clinical ICSI outcomes: a study of 967 transferred embryos. RBM Online 
2006;13(5):661-7. 
 
Check JH, Lurie D, Locuniak J, et al. Relationship of subnormal semen parameters and 
subsequent zona pellucida thinning following in vitro fertilization. Arch Androl 
1998;41(3):145-50. 
 
Check JH, Wilson C, Summers-Chase D, et al. Pregnancy rates (prs) according to embryo 
cell number at time of embryo transfer (ET). Clin Exp Obstet Gynecol 2001;28(2):73-7. 
 
Chen C, Kattera S. Comparison of pronuclear zygote morphology and early cleavage 
status of zygotes as additional criteria in the selection of day 3 embryos: a randomized 
study.  Fertil Steril 2006;85(2):347-352.  
 
Chen C-K, Shen G-Y, Horng S-G, Wang C-W.  The Relationship of Pronuclear Stage 
Morphology and Chromosome Status at Cleavage Stage.  J Assist Reprod Genet. 2003 
Oct;20(10):413-20.  
 
Cheng J, Huang L, He B, et al. Quantitative analysis of the intensity of zona pellucid 
birefringence of oocytes during IVF cycles. Reprod Fertil Devel 2010;22:1167–1174. 
 
Choudhury SR, Knapp LA. Human reproductive failure II: immunogenetic and interacting 
factors. Hum Reprod Update 2001;7:135–160. 
 
Stellenbosch University  http://scholar.sun.ac.za
79 
 
Chu W, Fant ME, Geraghty DE, Hunt JS. Soluble HLA-G in human placentas: synthesis in 
trophoblasts and interferon-gamma-activated macrophages but not placental fibroblasts. 
Hum Immunol 1998;59:435–442. 
 
Chung MK, Chiu PCN, Lee CL, et al. Cumulus-associated alpha2-macroglobulin derivative 
retains pro-conceptive glycodelin-C in the human cumulus matrix. Hum Reprod 
2009;24:2856–2867. 
 
Ciotti PM, Notarangelo L, Morselli-Labate AM, et al. First polar bodymorphology before 
ICSI is not related to embryo quality or pregnancy rate. Hum Reprod 2004;19:2334–9. 
 
Ciray H N, Karagenç L, Ulug U, et al. Use of both early cleavage and day 2 
mononucleation to predict embryos with high implantation potential in intracytoplasmic 
sperm injection cycles. Fertil Steril 2005;84(5):1411-1416. 
 
Cohen J, Simons RF, Edwards RG, et al. Pregnancies following the frozen storage of 
expanding human blastocysts. J In Vitro Fert Embryo Transf 1985;2(2):59-64. 
 
Cohen J, Inge KL, Suzman M, et al. Videocinematography of fresh and cryopreserved 
embryos: A retrospective analysis of embryonic morphology and implantation. Fertil Steril 
1989;51:820–7. 
 
Cohen Y, Malcov M, Schwartz T, et al. Spindle imaging: a new marker for optional timing 
of ICSI?  Hum Reprod 2004;19:649–54. 
 
Cohen J. Zona thinning: 'laying it on thick'. RBM Online 2010;20(2):169. 
 
Cooke S, Tyler JPP, Driscoll GL. Meiotic spindle location and identification and its effect 
on embryonic cleavage plane and early development. Hum Reprod 2003;18:2397–405. 
 
Criniti A, Thyer A, Chow G, et al. Elective single blastocyst transfer reduces twin rates 
without compromising pregnancy rates. Fertil Steril 2005;84(6):1613-1619. 
 
Criniti A, Thyer A, Chow G, et al. Elective single blastocyst transfer reduces twin rates 
without compromising pregnancy rates. Fertil Steril 2005;84(6):1613-1619. 
Stellenbosch University  http://scholar.sun.ac.za
80 
 
Criscuoli L, Rizzo R, Fuzzi B, et al.  Lack of Histocompatibility Leukocyte Antigen-G 
expression in early embryos is not related to germinal defects or impairment of interleukin-
10 production by embryos. Gynecol Endocrinol 2005;20(5):264-9. 
 
Croxatto HB, Ortiz ME, Díaz S, et al.Studies on the duration of egg transport by the human 
oviduct. II. Ovum location at various interval following lutinizing hormone peak. Am J 
Obstet Gynecol 1978;132:629-34. 
 
Cummins J, Breen T, Harrison K. A formula for scoring human embryo growth rates in vitro 
fertilization: its value in predicting pregnancy and in comparison with visual estimates of 
embryo quality. J In Vitro Fert Embryo Transf 1986;3:284–95. 
 
Dandekar P and Talbot P. Perivitelline space of mammalian oocytes: extracellular matrix 
of unfertilized oocytes and formation of a cortical granule envelope following fertilization. 
Mol Reprod 1992;31:135–143. 
 
Danfour M, Elmahaishi M. Human oocyte oolemma characteristic is positively related to 
embryo developmental competence after ICSI procedure. MEFS J 2010; 15(4):269-273. 
 
De Almeida Ferreira Braga DP, de Cássia Savio Figueira R, Queiroz P, et al.  Zona 
pellucida birefringence in in vivo and in vitro matured oocytes. Fertil Steril 
2010;94(6):2050-3. 
 
De Placido G, Wilding M, Strina I, et al. High outcome predictability after IVF using a 
combined score for zygote and embryo morphology and growth rate. Hum Reprod 
2002;9:2402-2409. 
 
De Santis L, Cino I, Rabellotti E, et al. Polar body morphology and spindle imaging as 
predictors of oocyte quality. RBM Online 2005;11(1):36-42. 
 
De Sutter P, Dozortsev D, Qian C, Dhont M. Oocyte morphology does not correlate with 
fertilization rate and embryo quality after intracytoplasmic sperm injection. Hum Reprod 
1996;11:595-597.  
 
Stellenbosch University  http://scholar.sun.ac.za
81 
 
Depa-Martynow M, Jedrzejczak P, Pawelczyk L. Pronuclear scoring as a predictor of 
embryo quality in in vitro fertilization program. Folia Histochem et Cytobiol 2007;45(1): 87-
91. 
 
Desai NN, Goldstein J, Rowland DY, Goldfarb JM. Morphological evaluation of human 
embryos and derivation of an embryo quality scoring system specific for day 3 embryos: a 
preliminary study. Hum Reprod 2000;15:2190-6. 
 
Desai N, Filipovits J, Goldfarb J. Secretion of soluble HLA-G by day 3 human embryos 
associated with higher pregnancy and implantation rates: assay of culture media using a 
new ELISA kit. RBM Online 2006;13(2):272-7. 
 
Dokras A, Sargent I, Barlow DI. Human blastocyst grading: an indicator of developmental 
potential? Hum Reprod 1993;8:2119-27. 
 
Donoso P, Devroey P. PGD for aneuploidy screening: an expensive hoax? Best Pract Res 
Clin Obstet Gynaecol 2007;21(1):157-68. 
 
Ebner T, Yaman C, Moser M, et al. Prognostic value of first polar body morphology on 
fertilization rate and embryo quality in intracytoplasmic sperm injection. Hum Reprod 
2000;15(2);427-30. 
 
Ebner T, Yaman C, Moser M,et al. Embryo fragmentation in vitro and its impact on 
treatment and pregnancy outcome. Fertil Steril 2001;76:281-285. 
 
Ebner T, Moser M, Sommergruber M, et al. Presence, but not type or degree of extension, 
of a cytoplasmic halo has a significant influence on preimplantation development and 
implantation behaviour. Hum Reprod 2003;18(11):2406-12. 
 
Ebner T, Moser M, Shebl O, et al. Blood clots in the cumulus–oocyte complex predict poor 
oocyte quality and post-fertilization development.  RBM Online 2008;16:801–807.  
 
Ebner T, Balaban B, Moser M, et al. Automatic user-independent zona pellucida imaging 
at the oocyte stage allows for the prediction of  preimplantation development. Fertil Steril 
2010;94(3):913-20. 
Stellenbosch University  http://scholar.sun.ac.za
82 
 
Edgar DH, Bourne H, Speirs AL, McBain JC. A quantitative analysis of the impact of 
cryopreservation on the implantation potential of human early cleavage stage embryos. 
Hum Reprod 2000;15:175-179. 
 
Edwards RG, Steptoe PC, Purdy JM. Fertilization and cleavage in vitro of preovulator 
human oocytes. Nature 1970;227:1307-9. 
 
Edwards RG, Fishel SB, Cohen J, et al. Factors influencing the success of in vitro 
fertilization for alleviating human infertility. J In Vitro Fertil Embryo Transf 1984;1:3-23. 
 
Ellis SA, Palmer MS, McMichael AJ.  Human trophoblast and the choriocarcinoma cell line 
BeWo express a truncated HLA class I molecule. J Immunol 1990;15:731-735. 
 
Erenus M, Zouves C, Rajamahendran P, et al. The effect of embryo quality on subsequent 
pregnancy rates after in vitro fertilization. Fertil Steril 1991;56(4):707-10. 
 
Erickson GF, Shimasaki S. The role of the oocyte in folliculogenesis. Trends Endocrinol 
Metab 2000;11:193–8. 
 
Ertzeid G, Storeng R. The impact of ovarian stimulation on implantation and fetal 
development in mice. Hum Reprod 2001;16:221-5. 
 
Esfandiari N, Burjaq H, Gotlieb L, Casper RF. Brown oocytes: implications for assisted 
reproductive technology. Fertil Steril 2006;86:1522–1525. 
 
Fanchin R, Ayoubi JM, Righini C, et al.Uterine contracility decreases at the time of 
blasocyst transfers. Hum Reprod 2001;16:1115-9. 
 
Familiari G, Heyn R, Relucenti M,et al. Structural changes of the zona pellucida during 
fertilization and embryo development. Front Biosci 2008;13:6730–6751. 
 
Fancsovits P, Tóthné ZG, Murber A, et al. Acta Biol Hung 2006;57(3):331-8. 
 
Stellenbosch University  http://scholar.sun.ac.za
83 
 
Fang C, Tang M, Li T, et al. Visualization of meiotic spindle and subsequent embryonic 
development in in vitro and in vivo matured human oocytes. J. Assist Reprod Genet 
2007;24:547–51. 
 
Farhi J, Nahum H, Weissman A, et al. Coarse granulation in the perivitelline space and 
IVF-ICSI outcome. J Assist Reprod Genet 2002;19:545–549. 
 
Fernandez N, Cooper J, Sprinks M, et al. A critical review of the role of the major 
histocompatibility complex in fertilization, preimplantation development and feto-maternal 
interactions. Hum Reprod Update 1999;5:234–248. 
 
Fiorentino F, Spizzichino L, Bono S, et al. PGD for reciprocal and Robertsonian 
translocations using array comparative genomic hybridization. Hum Reprod 
2011;26:1925–1935. 
 
Fisch J, Rodriguez H, Ross R, et al. The graduate embryo scoring system (GES) predicts 
blastocyst formation and pregnancy rates from cleaved-stage embryos. Hum Reprod 
2001;16(9):1970–5. 
 
Fisch JD, Sher G, Adamowicz M, Keskintepe L. The graduated embryo score predicts the 
outcome of assisted reproductive technologies better than a single day 3 evaluation and 
achieves results associated with blastocyst transfer from day 3 embryo transfer.  Fertil 
Steril 2003;80:1352-8. 
 
Fisch JD, Keskintepe L, Ginsburg M, et al. Graduated Embryo Score and soluble human 
leukocyte antigen-G expression improve assisted reproductive technology outcomes and 
suggest a basis for elective single-embryo transfer.  Fertil Steril 2007;87(4):757-63. 
 
Fishel S, Gordon A, Lynch C, et al. Live birth after polar body array comparative genomic 
hybridization prediction of embryo ploidy-the future of IVF? Fertil Steril 
2010;93(3):1006.e7-1006.e10.  
 
Fournel S, Huc X, Aguerre-Girr M, et al. Comparative reactivity of different HLA-G 
monoclonal antibodies to soluble HLA-G molecules. Tissue Antigens 2000;55:510–518. 
 
Stellenbosch University  http://scholar.sun.ac.za
84 
 
Fragouli E, Katz-Jaffe M, Alfarawati S, et al.Comprehensive chromosome screening of 
polar bodies and blastocysts from couples experiencing repeated implantation failure. 
Fertil Steril 2010;94(3):875-87. 
 
Fragouli E, Alfarawati S, Daphnis DD, et al. Cytogenetic analysis of human blastocysts 
with the use of FISH, CGH and aCGH: scientific data and technical evaluation. Hum 
Reprod 2011;26:480–490. 
 
Frattarelli JL, Miller KA. Fletcher-Holmes. The use of quantitative birefringence imaging to 
assess oocyte competence. Hum Reprod 2007;22(1):i166. 
 
Fuzzi B, Rizzo R, Criscuoli L, et al. HLA-G expression in early embryos is a fundamental 
prerequisite for the obtainment of pregnancy.  Eur J Immunol 2002;32(2):311-5. 
 
Gabrielsen A, Bhatnager P.R, Petersen K, Lindenberg S. "Influence of zona pellucida 
thickness of human embryos on clinical pregnancy outcome following in vitro fertilization 
treatment", J Assist Reprod Genet 2000;17(6):335-343. 
 
Gabrielsen A, Lindenberg S, Petersen K. The impact of the zona pellucid thickness 
variation of human embryos on pregnancy outcome in relation to suboptimal embryo 
development. A prospective randomized controlled study. Hum Reprod 2001;16:2166–70. 
 
Ganguly A, Bansal P, Gupta T, Gupta SK. ‘ZP domain of human zona pellucid 
glycoprotein-1 binds to human spermatozoa and induces acrosomal exocytosis. Reprod 
Biol Endocrinol 2010;8:110. 
 
Gardner A, J, Evans JP. Mammalian membrane block to polyspermy: new insights into 
how mammalian eggs prevent fertilisation by multiple sperm. Reprod Fertil Dev 
2006;18(1):53-61. 
 
Gardner D.K, Leese HJ. Assessment of embryo viability prior to transfer by the 
noninvasive measurement of glucose uptake. J Exp Zool 1987;242:103–5. 
 
Stellenbosch University  http://scholar.sun.ac.za
85 
 
Gardner D.K, Pawelczynski M, Trounson A.O. Nutrient uptake and utilization can be used 
to select viable day 7 bovine blastocysts after cryopreservation. Mol Reprod Dev 
1996;44:472–5. 
 
Gardner DK, Lane M. Culture and selection of viable blastocysts: a feasible proposition for 
human IVF? Hum Reprod Update1997;3:367-382. 
 
Gardner DK, Lane M. Culture of viable human blastocysts in defined sequential serum-free 
media. Hum Reprod 1998a;13(3):148-159.  
 
Gardner DK. Development of serum-free media for the culture and transfer of human 
blastocysts. Hum Reprod 1998b;13:4:218-25.  
 
Gardner D.K, Schoolcraft W. In vitro culture of human blastocysts. In: Jansen R, Mortimer 
D (eds). Toward reproductive certainty: fertility and genetics beyond 1999. Carnforth, UK: 
Parthenon Publishing, 1999:378–88 
 
Gardner D.K, Lane M, Stevens J, et al. Blastocyst score  affects implantation and 
pregnancy outcome: towards a single blastocyst transfer. Fertil Steril 2000a;73(6):1155-
1158.  
 
Gardner D.K. and Lane M. Embryo culture systems. In: Handbook of In Vitro Fertilization, 
2nd Ed. Trounson AO & Gardner DK (eds). CRC Press, Boca Raton, FL, USA, 
2000b;11:205-64 
 
Gardner D.K, Lane M. Towards a single embryo transfer. RBM Online 2003;6:470-81. 
 
Gardner D.K, Surrey E, Minjarez D, et al. "Single blastocyst transfer: a prospective 
randomized trial", Fertil Steril 2004; 81(3):551-555. 
 
Gardner D.K, Wale, P.L, Collins R. and Lane M.  Glucose consumption of single post-
compaction human embryos is predictive of embryo sex and live birth outcome. Hum 
Reprod (2011)26(8):1981-1986. 
 
Stellenbosch University  http://scholar.sun.ac.za
86 
 
Garside WT, Loret de Mola JR, Bucci JA, et al. Sequential analysis of zona thickness 
during in vitro culture of human zygotes: correlation with embryo quality, age, and 
implantation. Mol Reprod Dev 1997;47(1):99-104.  
 
Gianaroli L, Magli C, Ferraretti AP, et al. Pronuclear morphology and chromosomal 
abnormalities as scoring criteria for embryo selection. Fertil Steril 2003;80(2):341-349. 
 
Gianaroli L, Magli MC, Ferraretti AP, et al. The beneficial effects of PGD for aneuploidy 
support extensive clinical application. RBM Online 2005;10:633–40. 
 
Giorgetti C, Terriou P, Auquier P, et al. Embryo score to predict implantation after in-vitro 
fertilization: based on 957 single embryo transfers. Hum Reprod 1995;10:2427-2431. 
 
Goossens V, Harton G, Moutou C, et al. ESHRE PGD Consortium data collection IX: 
cycles from January to December 2006 with pregnancy follow-up to October 2007. Hum 
Reprod 2009;24:1786–1810. 
 
Graham J, Han T, Porter R, et al. Day 3 morphology is a poor predictor of blastocyst 
quality in extended culture. Fertil Steril 2000;74:495–497.  
 
Gregory L.  Ovarian markers of implantation potential in assisted reproduction. Hum 
Reprod 1998;13:117–32. 
 
Griffin DK, Sanoudou D, Adamski E, et al. Chromosome specific comparative genome 
hybridisation for determining the origin of intrachromosomal duplications. J Med Genet 
1998;35:37–41. 
 
Gutierrez-Mateo C, Wells D, Benet J, et al. Reliability of comparative genomic 
hybridization to detect chromosome abnormalities in first polar bodies and metaphase II 
oocytes. Hum Reprod 2004;19:2118–2125.  
 
Gutierrez-Mateo C, Colls P, Sanchez-Garcıa J, et al. Validation of microarray comparative 
genomic hybridization for comprehensive chromosome analysis of embryos. Fertil Steril 
2011;95:953–958. 
 
Stellenbosch University  http://scholar.sun.ac.za
87 
 
Handyside AH, Pattinson JK, Penketh RJ,Delhanty JD, Winston RM, Tuddenham EG. 
Biopsy of human preimplantation embryos and sexing by DNA amplification. Lancet 
1989;1:347–9. 
 
Handyside AH, Harton GL, Mariani B, et al. Karyomapping: a Universal Method for 
Genome Wide Analysis of Genetic Disease based on Mapping Crossovers between 
Parental Haplotypes. J Med Genet 2009;25. 
 
Hardarson T, Hanson C, SjoÈgren A, Lundin K. Human embryos with unevenly sized 
blastomeres have lower pregnancy and implantation rates: indications for aneuploidy and 
multinucleation. Hum. Reprod 2001;16:313-318. 
 
Hardarson T, Hanson C, Lundin K, et al. Preimplantation genetic screening in women of 
advanced maternal age caused a decrease in clinical pregnancy rate: a randomized 
controlled trial. Hum Reprod 2008;23:2806–2812. 
 
Hardy K, Stark J, Winston RM. Maintenance of the inner cell mass in human blastocysts 
from fragmented embryos. Biol Reprod 2003;68:1165-9. 
 
Hassan-Ali H, Hisham-Saleh A, El-Gezeiry D, et al. Perivitelline space granularity: a sign 
of human menopausal gonadotrophin overdose in intracytoplasmic sperm injection. Hum 
Reprod 1998;13:3425–3430. 
 
Hellani A, Abu-Amero K, Azouri J, El-Akoum S. Successful pregnancies after application of 
array-comparative genomic hybridization in PGS-aneuploidy screening. RBM Online 
2008;17:841–847. 
 
Henman M, Catt JW, Wood T, et al. Elective transfer of single fresh blastocysts and later 
transfer of cryostored blastocysts reduces the twin pregnancy rate and can improve the in 
vitro fertilization live birth rate in younger women. Fertil Steril 2005;84(6):1620-1627. 
 
Herrler A, Beier H.M. Early embryonic coats: morphology, function, practical zona 
birefringence of fresh and frozen-thawed human embryos applications. An overview. Cells 
Tissues Organs 2000;166:233-246. 
 
Stellenbosch University  http://scholar.sun.ac.za
88 
 
Hertig AT, Rock J, Adams EC, Menkin MC. On the preimplantation stages of the human 
ovum: a description of four normal and four abnormal specimens ranging from the second 
to the fifth day of development. Contrib Embryol 1954;35:199-220. 
 
Hill JA. Maternal-embryonic cross-talk. Ann N Y Acad Sci 2001;943:17-25. 
 
Hnida C, Engenheiro E, Ziebe S. Computer-contrelled, multilevel, morphometric analysis 
of blastomere size as biomarker of fragmentation and multinuclearity in human embryos. 
Hum Reprod 2004;19(2):288-293. 
 
Hong SJ, Chiu P, Lee KF, et al. Cumulus cells and their extracellular matrix affect the 
quality of the spermatozoa penetrating the cumulus mass. Fertil Steril 2009;92:971–978. 
 
Hoover L, Baker A, Check JH, Lurie D, O'Shaughnessy A. Evaluation of a new embryo-
grading system to predict pregnancy rates following in vitro fertilization. Gynecol Obstet 
Invest 1995;40:151-157. 
 
Høst E, Gabrielsen A, Lindenberg S, Smidt-Jensen S. Apoptosis in human cumulus cells 
in relation to zona pellucida thickness variation, maturation stage, and cleavage of the 
corresponding oocyte after intracytoplasmic sperm injection. Fertil Steril 2002;77:511–515. 
 
Hreinsson J, Rosenlund B, Fridström M, et al. Embryo transfer is equally effective at 
cleavage stage and blastocyst stage: a randomized prospective study. Eur J Obstet 
Gynecol Reprod Biol 2004;117(2):194-200. 
 
Hu D G, Webb G, Hussey N. Aneuploidy detection in single cells using DNA array-based 
comparative genomic hybridization. Mol Hum Reprod 2004;10:283–289. 
 
Huisman GJ, Fauser BCJM, Eijkemans MJC, Pieters MHEC. Implantation rates after in 
vitro fertilization and transfer of a maximum of two embryos that have undergone three to 
five days of culture. Fertil Steril 2000;73:117-22. 
 
Hunt J.S, Petroff M.G, McIntire R.H, Ober C. HLA-G and immune tolerance in pregnancy. 
Review. FASEB J. 2005 May;19(7):681-93. 
 
Stellenbosch University  http://scholar.sun.ac.za
89 
 
Hussein TS, Thompson JG, Gilchrist RB. Oocyte-secreted factors enhance oocyte 
developmental competence. Develop Biol 2006;296:514–521. 
 
Hviid TV, Hylenius S, Lindhard A, Christiansen OB. Associationbetween human leukocyte 
antigen-G genotype and success of in vitro fertilization and pregnancy outcome. Tissue 
Antigen 2004;64:66–9. 
 
Janny L, Menezo YJR. Evidence for a strong paternal effect on human preimplantation 
embryo development and blastocyst formation. Mol Reprod Dev 1994;38:36-42. 
 
Janny L, Menezo YJR. Maternal age effect on early human embryonic development and 
blastocyst formation. Mol Reprod Dev 1996;45:31-7. 
 
Johnson MH, Maro B. A dissection of the mechanisms generation and stabilizing polarity 
in mouse 8- and 16- cell blastomeres: the role of cytoskeletal elements. J Embryol Exp 
Morphol 1985;90:311-34. 
 
Joris H, Van den Abbeel E, Vos A. D, Van Steirteghem A. Reduced survival after human 
embryo biopsy and subsequent cryopreservation. Hum Reprod 1999;14:2833–2837. 
 
Jurisicova A, Casper RF, MacLusky NJ, et al. HLA-G expression during preimplantation 
human embryo development. Proc Natl Acad Sci USA 1996a;93:161–165.  
 
Jurisicova A, Casper RF, MacLusky NJ, Librach CL. Embryonic human leukocyte antigen-
G expression: possible implications for human preimplantation development. Fertil Steril 
1996b;65:997–1002. 
 
Jurisicova A, Varmuza S, Casper RF. Programmed cell death and human embryo 
fragmentation. Mol Hum Reprod 1996c;2:93-98. 
 
Kallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for 
molecular cytogenetic analysis of solid tumors. Science 1992;258:818–821. 
 
Stellenbosch University  http://scholar.sun.ac.za
90 
 
Kanai T, Fujii T, Kozuma S, et al. HLA-G influences the release of cytokines from 
allogeneic peripheral blood mononuclear cells in culture. Mol Hum Reprod 2001;7:195–
200. 
 
Katz-Jaffe M, McCallie BR, Treff NR, Miller KA, Scott RT Jr, Schoolcraft WB. A novel 
profile of cumulus cell transcripts is associated with oocyte aneuploidy. Fertil Steril 
2008;90(Suppl 1):S36. 
 
Kelley RL, Kind KL, Lane M, et al. Recombinant human follicle stimulating hormone alters 
maternal ovarian hormone concentrations and the uterus, and perturbs fetal 
developmentin mice. AM J Physiol Endocrinol Metab 2006;291:E761-70. 
 
Keltz MD, Skorupski JC, Bradley K, Stein D. Predictors of embryo fragmenttion and 
outcome after fragment removal in in vitro fertilization. Fertil Steril 2006;86:321-4. 
 
Kilani S, Cooke S, Kan A, Chapman M. Are there non-invasive markers in human oocytes 
that can predict pregnancy outcome? RBM Online 2009;18(5):674-80. 
 
Konc J, Kanyó K, Cseh S. Visualization and examination of the meiotic spindle in human 
oocytes with Polscope. J Assist Reprod Genet 2004;21:349–53. 
 
Kotze DJ, Hansen P, Keskintepe L, et al. Embryo selection criteria based on morphology 
VERSUS the expression of a biochemical marker (sHLA-G) and a graduated embryo 
score: prediction of pregnancy outcome.  J Assist Reprod Genet 2010;27(6):309-16.  
 
Kotze D, Keskintepe L, Sher G, et al. A linear karyotypic association between PB-I, PB-II 
and blastomere using sequentially performed comparative genome hybridization (CGH) 
with no association established between karyotype, morphologic, biochemical (sHLA-G-
expression) characteristics, blastocyst formation and subsequent pregnancy outcome. 
Accepted for publication in GOI 2012. 
 
Kovacic B, Vlaisavljevic V, Reljic M, Cizek-Sajko M. Developmental capacity of different 
morphological types of day 5 human morulae and blastocysts. RBM Online 2004;8(6):687-
94. 
 
Stellenbosch University  http://scholar.sun.ac.za
91 
 
Kutlu P, Atvar O, Vanlioglu O.F.  Laser assisted zona thinning technique has no beneficial 
effect on the ART outcomes of two different maternal age groups. J Assist Reprod Genet 
2010;27(8):457–461. 
 
Lan KH, Huang FJ, Lin YC, et al. The predictive value of using a combined Z-score and 
day 3 embryo morphology score in the assessment of embryo survival on day 5. Hum 
Reprod 2003;18:1299-1306. 
 
Landwehr C, Montag M, Van der Ven K, Weber R.G. Rapid comparative genomic 
hybridization protocol for prenatal diagnosis and its application to aneuploidy screening of 
human polar bodies. Fertil Steril 2008;90:488–496. 
 
Lane M, Gardner DK. Selection of viable mouse blastocysts prior to transfer using a 
metabolic criterion. Hum Reprod 1996;11:1975– 8. 
 
Lanzendorf SE, Maloney MK, Veeck LL, et al. A preclinical evaluation of pronuclear 
formation by microinjection of human spermatozoa into human oocytes. Fertil Steril 
1988;49:835–42. 
 
Le Caignec C, Spits C, Sermon K, et al. Single-cell chromosomal imbalances detection by 
array CGH.  Nucleic Acids Res 2006;34(9):e68. 
 
Lefievre L, Conner SJ, Salpekar A, et al: Four zona pellucida glycoproteins are expressed 
in the human. Hum Reprod 2004;19:1580-1586. 
 
Lesny P, Killick SR, Tetlow RL, et al. Uterine junctional zone contrations during assisted 
reporduction cycles. Hum Reprod Update 1998;4:440-5. 
 
Levitas E, Lunenfeld E, Har-Vardi I, et al. Blastocyst-stage embryo transfer in patients who 
failed to conceive in three or more day 2-3 embryo transfer cycles: a prospective, 
randomized study. Fertil Steril 2004;81(3):567-71. 
 
Levron J, Shulman A, Bider D, et al. A prospective randomized study comparing day 3 with 
blastocyst stage embryo transfer. Fertil Steril 2002;77:1300-1301. 
 
Stellenbosch University  http://scholar.sun.ac.za
92 
 
Li M, DeUgarte CM, Surrey M,  et al. Fluorescence in situ hybridization reanalysis of day-6 
human blastocysts diagnosed with aneuploidy on day 3. Fertil Steril 2005;84(5):1395-400. 
 
Lin YC, Chang SY, Lan KC, et al. Human oocyte maturity in vivo determines the outcome 
of blastocyst development in vitro. J Assist Reprod Genet 2003;20:506–512. 
 
Liu L, Trimarchi J.R, Oldenbourg R, et al.. Increased birefringence in the meiotic spindle 
provides a new marker for the onset of activation in living oocytes. Biol Reprod 
2000;63(1):251-8. 
 
Lorenzo P.L, Illera M.J, Illera J.C, et al. Enhasment of cumulus expansion and nuclear 
maturation during bovine oocyte IVM with the addition of epidermal growth factor and 
insulin-like growth factor I. J Reprod Fertil (1994) 101: 697-701. 
 
Loutradis D, Drakakis P, Kallianidis K, et al. Oocyte morphology correlates with embryo 
quality and pregnancy rate after intracytoplasmic sperm injection. Fertil Steril 
1999;72:240–244. 
 
Luna M, Duke M, Copperman A, et al. Blastocyst embryo transfer is associated with a sex-
ratio imbalance in favor of male offspring. Fertil Steril 2007;87(3):519-23. 
 
Lundqvist M, Johansson U, Lundkvist Ö, et al. Does pronuclear morphology and/or early 
cleavage rate predict embryo implantation potential? RBM Online 2001;2(1):12-16. 
 
Madaschi C, de Souza Bonetti TC, de Almeida Ferreira Braga DP, et al. Spindle imaging: 
a marker for embryo development and implantation. Fertil Steril 2008;90:194–8. 
 
Madaschi C, Aoki T, de Almeida Ferreira Braga DP, et al. Zona pellucida birefringence 
score and meiotic spindle visualization in relation to embryo development and ICSI 
outcomes. RBM Online 2009;18:681–686. 
 
Magli MC, Jones GM, Gras L, et al. Chromosome mosaicism in day 3 aneuploid embryos 
that develop to morphologically normal blastocysts in vitro. Hum Reprod 2000;15(8):1781-
6. 
 
Stellenbosch University  http://scholar.sun.ac.za
93 
 
Magli MC, Gianaroli L, Ferraretti AP, et al. Embryo morphology and development are 
dependent on the chromosomal complement. Fertil Steril 2007;87(3):534-41 
 
Makhseed M, Raghupathy R, Azizieh F, et al. Mitogen-induced cytokine responses of 
maternal peripheral blood lymphocytes indicate a differential Th-type bias in normal 
pregnancy and pregnancy failure. Am J Reprod Immunol 1999;42:273–281. 
 
Mallet, V., Blaschitz, A., Crisa, L.et al.HLA-G in the human thymus: asubpopulation of 
medullary epithelial but not CD83+ dendritic cellsexpresses HLA-G as a membrane-bound 
and soluble protein. Int. Immunol.,(1999) 11, 889-898. 
 
Malmgren H, Sahlen S, Inzunza J, et al. Single cell CGH analysis reveals a high degree of 
mosaicism in human embryos from patients with balanced structural chromosome 
aberrations. Mol Hum Reprod 2002;8:502–510. 
 
Mantoudis E, Podsiadly BT, Gorgy A, et al. A comparison between quarter, partial and 
total laser assisted hatching in selected infertility patients. Hum Reprod 2001;16(10):2182-
6. 
 
Marek D, Langley M, Gardner DK, et al. Introduction of blastocyst culture and transfer for 
all patients in an in vitro fertilization program. Fertil Steril 1999;72:1035-40. 
 
Mastenbroek S, Twisk M, van Echten-Arends J, Sikkema-Raddatz B, Korevaar JC, 
Verhoeve HR, et al. In vitro fertilization with preimplantation genetic screening. New Engl J 
Med 2007;357:9–17. 
 
Ménézo YJ, Hamamah S, Hazout A, Dale B. Time to switch from co-culture to sequential 
defined media for transfer at the blastocyst stage. Hum Reprod 1998;13:2043-4. 
 
Menezo YJR, Kauffman R, Veiga A, Servy E. A mini-atlas of the human blastocyst in vitro. 
Zygote 1999;7:61-5. 
 
Menicucci A, Noci I, Fuzzi B, et al. Non-classic sHLA class I in human oocyte culture 
medium. Hum Immunol 1999;60:1054–1057. 
 
Stellenbosch University  http://scholar.sun.ac.za
94 
 
Mikkelsen AL, Lindenberg S. Morphology of in-vitro matured oocytes: impact on fertility 
potential and embryo quality. Hum Reprod 2001;16:1714-1718. 
 
Montag M, Schimming T, Zhou C. Validation of an automatic scoring system for prognostic 
qualitative zona imaging in human oocytes. Hum Reprod 2007;22(1):i11. 
 
Montag M, Schimming T, Köster M, et al. Oocyte zona birefringence intensity is associated 
with embryonic implantation potential in ICSI cycles. RBM Online (2008);16:239–44  
 
Moon J-H, Hyun C-S, Lee S-W, et al. Visualization of the metaphase II meiotic spindle in 
living human oocytes using the Polscope enables the prediction of embryonic 
developmental competence after ICSI. Hum Reprod. 2003;18:817–20. 
 
Mukaida T, Nakamura S, Tomiyama T, et al. Vitrification of human blastocysts using 
cryoloops: clinical outcome of 223 cycles. Hum Reprod 2003;18:384–391. 
 
Munné S, Lee A, Rosenwaks Z, et al. Diagnosis of major chromosome aneuploidies in 
human preimplantation embryos. Hum Reprod 1993;8(12):2185-91. 
 
Munné S, Weier HU, Grifo J, Cohen J. Chromosome mosaicism in human embryos.  Biol 
Reprod 1994;51:373–379. 
 
Munné S, Cohen J. Chromosome abnormalities in human embryos. Hum Reprod Update 
1998;4(6):842-55. 
 
Munné S, Wells D. Preimplantation genetic diagnosis. Curr Opin Obstet Gynecol 
2002;14:239-44. 
 
Munné S. Chromosome abnormalities and their relationship to morphology and 
development of human embryos. RBM Online 2006;12:234-53 
 
Nagy Z.P, Dozortsev D, Diamond M, et al. Pronuclear morphology evaluation with 
subsequent evaluation of embryo morphology significantly increases implantation rates. 
Fertil Steril 2003;80(1):67-74. 
 
Stellenbosch University  http://scholar.sun.ac.za
95 
 
Nagy Z.P, Taylor T, Elliott T, et al. Removal of lysed blastomeres from frozen-thawed 
embryos improves implantation and pregnancy rates in frozen embryo transfer cycles. 
Fertil Steril 2005;84:1606-12. 
 
Neumann PJ, Gharib SD, Weinstein MC. The cost of a successful delivery with in vitro 
fertilization. N Engl J Med1994;28:239–243. 
 
Ng ST, Chang TH, Wu TC. Prediction of the rates of fertilization, cleavage, and pregnancy 
success by cumulus-coronal morphology in an in vitro fertilization program. Fertil Steril 
1999;72:412–417. 
 
Nicoli A, Valli B, Di Girolamo R, et al. Limited importance of pre-embryo pronuclear 
morphology (zygote score) in assisted reproduction outcome in the absence of embryo 
cryopreservation. Fertil Steril 2007;88(4):1167-1173. 
 
Nikas G, Ao A, Winston R, Handyside AH. Compation and surface polarity in the human 
embryo in-vitro. Biol Reprod 1996;55:32-7. 
 
Noci I, Fuzzi B, Rizzo R, et al. Embryonic soluble HLA-G as a marker of developmental 
potential in embryos. Hum Reprod 2005;20(1):138-46.  
 
Obradors A, Fernandez E, Oliver-Bonet M, et al. Birth of a healthy boy after a double 
factor PGD in a couple carrying a genetic disease and at risk for aneuploidy: case report. 
Hum Reprod 2008;23:1949–1956. 
 
Obradors A, Fernandez E, Rius M, et al. Outcome of twin babies free of Von Hippel-Lindau 
disease after a double-factor preimplantation genetic diagnosis: monogenetic mutation 
analysis and comprehensive aneuploidy screening. Fertil Steril 2009;91:933e931–937. 
 
Oehninger S. Biochemical and functional characterization of the human zona pellucida. 
RBM Online 2003;7:641–648.  
 
Ortiz ME, Croxatto HB. Observations on the transport, againg, and development of ova in 
the human genital tract. In: Talwar GP (ed). Recent Advances in Reproduction and 
Regulation of Fertility. Elsevier/North-Holland Biomedical Press, New York, 1979:307-17. 
Stellenbosch University  http://scholar.sun.ac.za
96 
 
Otsuki J, Okada A, Morimoto K, et al. The relationship between pregnancy outcome and 
smooth endoplasmic reticulum clusters in MII human oocytes. Hum Reprod 2004;19:1591-
1597. 
 
Otsuki J, Nagai Y, Chiba K. Lipofuscin bodies in human oocytes as an indicator of oocyte 
quality. J Assist Reprod Genet 2007;24:263-270. 
 
Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancy after intracytoplasmic 
sperm injection of a single spermatozoon into an oocyte. Lancet 1992;340:17-18. 
 
Palmstierna M, Murkes D, Csemiczky G, et al. Zona pellucida thickness variation and 
occurrence of visible mononucleated blastomeres in preembryos are associated with a 
high pregnancy rate in IVF treatment. J Assist Reprod Genet 1998;15:70–5. 
 
Papanikolaou, EG, D’haeseleer E, Verheyen G, et al.  Live birth rate is significantly higher 
after blastocyst transfer than after cleavage stage embryo transfer when at least four 
embryos are available on day 3 of embryo culture. A randomized prospective study. Hum 
Reprod 2005;(11), 3198-3203. 
 
Papanikolaou EG, Kolibianakis EM, Tournaye H, et al. Live birth rates after transfer of 
equal number of blastocysts or cleavage-stage embryos in IVF. A systematic review and 
meta-analysis. Hum Reprod 2008;23(1):91-9.  
 
Payne D, Flaherty SP, Barry MF, Mathews CD. Preliminary observations on polar body 
extrusion and pronuclear form score as a prognostic tool in IVF treatment. Hum Reprod 
1997;12:705-708. 
 
Payne JF, Raburn DJ, Couchman GM, et al. Relationship between pre-embryo pronuclear 
morphology (zygote score) and standard day 2 or 3 embryo morphology with regard to 
assisted reproductive technique outcomes. Fertil Steril 2005;84(4):900-909. 
 
Pellestor F, Girardet A, Andreo B, et al. Relationship between morphology and 
chromosomal constitution in human preimplantation embryo. Mol Reprod Dev 
1994;39:141-146. 
 
Stellenbosch University  http://scholar.sun.ac.za
97 
 
Pelletier C, Keefe DL, Trimarchi JR. Noninvasive polarized light microscopy quantitatively 
distinguishes the multilaminar structure of the zona pellucida of living human eggs and 
embryos. Fertil Steril 2004;81:850–6. 
 
Pellicer A, Valbuena D, Cano F, et al. Lower implantation rates in high responders: 
evidence for an altered enocrine milieu during the preimplantation period. Fertil Steril 
1996;65:1990-5. 
 
Pickering S.J, Braude P.R, Johnson M.H, et al. Transient cooling to room temperature can 
cause irreversible disruption of the meiotic spindle in the human oocyte. Fertil Steril 
1990;54:102-108. 
 
Plachot M, Junca AM, Mandelbaum J, et al. Chromosome investigation in early life. 
Human preimplantation embryos. Hum. Reprod 1987;1:29-35. 
Pool TB. Recent advances in the production of viable human embryos in vitro. RBM Online 
2002;4:294-302. 
 
Prasad SV, Skinner SM, Carino C,  et al. Structure and function of the proteins of the 
mammalian zona pellucida. Cells Tissues Organs 2000;166:148-164. 
 
Sinowatz F, Kolle S,Topfer-Petersen E. Biosynthesis and expression of zona pellucida 
glycoproteins in mammals. Cells Tissues Organs 2001;168:24–35. 
 
Preis KA, Seidel G, Gardner DK. Metabolic markers of developmental competence for in 
vitro-matured mouse oocytes. Reprod 2005;130:475–83. 
 
Puissant F, Van Rysselberg M, Barlow P, et al. “Embryo scoring as a prognostic tool in IVF 
treatment". Hum Reprod 1987;2:705-708. 
 
Racowsky C, Jackson KV, Cekleniak NA, et al. The number of eight-cell embryos is a key 
determinant for selecting day 3 or day 5 transfer. Fertil Steril 2000;73:558–564. 
 
Racowsky C, Combelles C.M, Nureddin A,et al.Day 3 and day 5 morphological predictors 
of embryo viability.Reprod Biomed Online. 2003 Apr-May;6(3):323-31. 
 
Stellenbosch University  http://scholar.sun.ac.za
98 
 
Rama Raju GA, Prakash GJ, Krishna KM, Madan K. Meiotic spindle and zona pellucida 
characteristics as predictors of embryonic dvelopment: a preliminatry study using 
PolScope imaging. RBM Online 2007;14:166–74. 
 
Rankin T, Talbot P, Lee E, Dean J. Abnormal zonae pellucidae in mice lacking ZP1 result 
in early embryonic loss. Development 1999;126:3847-3855 
 
Rankin T, Soyal S, Dean J. The mouse zona pellucida, folliculogenesis, fertility and pre-
implantation development. Mol Cell Endocrinol. (2000);163:21–25. 
 
Rattanachaiyanont M, Leader A, Leveille MC. Lack of correlation between oocyte–corona–
cumulus complex morphology and nuclear maturity of oocytes collected in stimulated 
cycles for intracytoplasmic sperm injection. Fertil Steril 1999;71:937–940. 
 
Rebmann V, LeMaoult J, Rouas-Freiss N,et al. Report of the Wet Workshop for 
Quantification of Soluble HLA-G in Essen. Hum Immuno 2004;66:853–863. 
 
Rebmann V, Switala M, Eue I, et al. Rapid evaluation of soluble HLA-G levels in 
supernatants of in vitro fertilized embryos. Hum Immunol. 2007;68(4):251-8. 
 
Reichman D E, Jackson K V, Racowsky C.  Incidence and development of zygotes 
exhibiting abnormal pronuclear disposition after identification of two pronuclei at the 
fertilization check. Fertil Steril 2010;94(3):965-970. 
 
Renard JP, Philippon A, Menezo Y. In-vitro uptake of glucose by bovine blastocysts. J 
Reprod Fertil 1980;58(1):161-4. 
 
Richter KS, Harris DC, Daneshmand ST, Shapiro BS. Quantitave grading of a human 
blastocyst: optimal inner cell mass size and shape. Fertil Steril 2001;76(6):1157-1167. 
 
Rienzi L, Ubaldi F, Iacobelli M,et al. Day 3 embryo transfer with combined evaluation at the 
pronuclear and cleavage stages compares favourably with day 5 blastocyst transfer. Hum. 
Reprod 2002;17:1852–1855. 
 
Stellenbosch University  http://scholar.sun.ac.za
99 
 
Rienzi L, Ubaldi F, Martinez F, et al. Relationship between meiotic spindle location with 
regard to the polar body position and oocyte development potential after ICSI. Hum 
Reprod 2003;18:1289–1293. 
 
Rienzi L, Ubaldi F, Iacobelli M, et al. Significance of morphological attributes of the early 
embryo. RBM Online 2005;10:669-81. 
 
Rienzi L, Ubaldi F M, Iacobelli M, et al. Significance of metaphase II human oocyte 
morphology on ICSI outcome. Fertil Steril 2008;90:1692–1700. 
 
Rienzi L, Vajta G, Ubaldi F. Predictive value of oocyte morphology in human IVF: a 
systematic review of the literature. Hum Reprod Update 2011;17(1):34–45.  
 
Rijnders PM, Jansen CA. The predictive value of day 3 embryo morphology regarding 
blastocyst formation, pregnancy and implantation rate after day 5 transfer following in-vitro 
fertilization or intracytoplasmic sperm injection. Hum Reprod 1998;13:2869–2873. 
 
Rius M A. Obrador A, Daina G,et al. Reliability of short comparative genomic hybridization 
in fibroblasts and blastomeres for a comprehensive aneuploidy screening: first clinical 
application.  Hum Reprod 2010;25(7):1824–1835. 
 
Robker RL, Richards JS. Hormone-induced proliferation and differentiation of granulosa 
cells: a coordinated balance of the cell cycle regulators cyclin D2 and p27Kip1. Mol 
Endocrinol 1998;12:924–40. 
 
Roseboom TJ, Vermeiden JP, Schoute E, iet al. The probability of pregnancy after embryo 
transfer is affected by the age of the patient, cause of infertility, number of embryos 
transferred and the average morphology score, as revealed by multiple logistic regression 
analysis. Hum Reprod 1995;10:3035-41. 
 
Roussev R, Keskintepe L, Coulam C, et al. Soluble HLA-G (sHLA-G) in human embryo 
culture media: a useful marker for assessing embryo quality, and implantation potential for 
IVF. Fertil Steril 2003;80(3):12–13. 
 
Stellenbosch University  http://scholar.sun.ac.za
100 
 
Roux C, Joanne C, Agnani G, et al. Morphometric parameters of living human in-vitro 
fertilization embryos; importance of asynchronous division process. Hum Reprod 
1995a;10:1201-1207. 
 
Roux C, Borodkine R, Joanne C, et al. Morphological classification of human in-vitro 
fertilization embryos based on the regularity of asynchronous division process. Hum 
Reprod Update 1995b;1(5):488-496. 
 
Russell DL, Robker RL. Molecular mechanisms of ovulation: co-ordination through the 
cumulus complex. Human Reprod Update 2007;13 (3):289–312  
 
Sageshima N, Shobu T, Awai K, et al.  Soluble HLA-G is absent from human embryo 
cultures: a reassessment of sHLA-G detection methods. J Reprod Immunol 2007;75(1):11-
22. 
 
Saito S, Shiozaki A, Sasaki Y, et al. Regulatory T cells and regulatory natural killer (NK) 
cells play important roles in feto-maternal tolerance. Semin Immunopathol 2007;29:115-
122. 
 
Sakkas D, Gardner SK. Noninvasive methods to assess embro qulaity. Curr Opinion 
Obstet Gynecol 2005;17:283-8. 
 
Salihu HM, Aliyu MH, Rouse DJ, et al. Potentially preventable excess mortality among 
higher-order multiples. Obstet Gyne 2003;102:679–684. 
 
Sargent I, Swales A, Ledee N, et al. sHLA-G production by human IVF embryos: can it be 
measured reliably? J Reprod Immunol 2007;75(2):128-32. 
 
SART Data ASRM Bulletin 2010;14(9).  
 
Schoolcraft WB, Gardner DK, Lane M, et al. Blastocyst culture and transfer: analysis of 
results and parameters affecting outcome in two in vitro fertilization programs. Fertil Steril 
1999;72(4):604-9. 
 
Stellenbosch University  http://scholar.sun.ac.za
101 
 
Schoolcraft WB, Surrey ES, Gardner DK. Embryo transfer: techniques and variables 
affecting success. Fertil Steril 2001;76:863–870. 
Schoolcraft WB, Fragouli E, Stevens J, et al. Clinical application of comprehensive 
chromosomal screening at the blastocyst stage. Fertil Steril 2010;94:1700-1706. 
 
Schwärzler P, Zech H, Auer M, et al. Pregnancy outcome after blastocyst transfer as 
compared to early cleavage stage embryo transfer. Hum Reprod 2004;19(9):2097-2102. 
 
Scott L.A, Smith S. The successful use of pronuclear embryo transfers the day following 
oocyte retrieval. Hum Reprod 1998;13:1003-13. 
 
Scott L.A., Alvero R, Leondires M, Miller, B. The morphology of human pronuclear 
embryos is positively related to blastocyst development and implantation. Hum Reprod 
2000;15:2394-2403. 
 
Scott L.A The biological basis of non-invasive strategies for selection of human oocytes 
and embryos. Hum Reprod Update 2003a;9:237–49 
 
Scott L. A. Pronuclear scoring as a predictor of embryo development. RBM Online 
2003b;6(2):201-214 
 
Scott R.T, Jones H, Hofmann GE, et al. Embryo quality and pregnancy rates in patients 
attempting pregnancy through in vitro fertilization. Fertil Steril 1991;44:426-428. 
 
Scott R, Seli E, Miller K, Sakkas D, Scott K, Burns DH. Noninvasive metabolomic profiling 
of human embryo culture media using Raman Spectroscopy predicts embryonic 
reproductive potential: a prospective blinded pilot study. Fertil. Steril. 2008;90:77–83. 
 
Shapiro BS, Harris DC, Richter KS. Predictive value of 72-hr blastomere cell number on 
blastocyst development and success of subsequent transfer based on the degree of 
blastocyst development. Fertil Steril 2000;73:582-586. 
 
Shapiro BS, Richter KS, Harris DC, Daneshmand ST. A comparison of day 5 and 6 
blastocyst transfers. Fertil Steril 2001;75:1126 –30. 
 
Stellenbosch University  http://scholar.sun.ac.za
102 
 
Shen Y, Stalf T, Mehnert C et al. High magnitude of light retardance by the zona pellucida 
is associated with conception cycle. Hum Reprod 2005;20:1596-1606. 
Shen Y, Stalf T, Mehnert C, et al. Light retardance by human oocyte spindle is positively 
related to pronuclear score after ICSI. RBM Online 2006;12:737–51. 
 
Sher G. Controlled Ovarian Hyperstimulation (COH) in Preparation for In Vitro Fertilization 
and Embryo Transfer. In: Foundations of In Vitro Fertilization. Freder CM, Paulson JD, 
DeCherney AH (eds). Hemisphere Publishing, 1987  
 
Sher G, Keskintepe L, Nouriani M, et al. Expression of sHLA-G in supernatants of 
individually cultured 46-h embryos: a potentially valuable indicator of embryo competency' 
and IVF outcome. RBM Online 2004;9(1):74-8. 
 
Sher G, Keskintepe L, Batzofin J, et al. Influence of early ICSI-derived embryo sHLA-G 
expression on pregnancy and implantation rates: a prospective study. Hum Reprod 
2005a;20(5):1359-63. 
 
Sher G, Keskintepe L, Fisch J.D, et al. Soluble human leukocyte antigen G expression in 
phase I culture media at 46 hours after fertilization predicts pregnancy and implantation 
from day 3 embryo transfer.  Fertil Steril 2005b;83(5):1410-3. 
 
Sher G, Keskintepe L, Keskintepe M, et al. Oocyte karyotyping by comparative genomic 
hybridization [correction of hybrydization provides a highly reliable method for selecting 
‘competent’ embryos, markedly improving in vitro fertilization outcome: a multiphase study. 
Fertil Steril 2007;87:1033–1040. 
 
Sher G, Keskintepe L, Keskintepe M, et al. Genetic analysis of human embryos by 
metaphase comparative genomic hybridization (mCGH) improves efficiency of IVF by 
increasing embryo implantation rate and reducing multiple pregnancies and spontaneous 
miscarriages. Fertil Steril 2009;92:1886–1894. 
 
Shimomura Y, Ando H, Furugori K, et al. Possible involvement of crosstalk cell-adhesion 
mechanism by endometrial CD26/dipeptidyl peptidase IV and embryonal fibronectin in 
human blastocyst implantation. Mol Hum Reprod 2006;12(8):491-5.  
 
Stellenbosch University  http://scholar.sun.ac.za
103 
 
Simón C, Pellicer A, Polan ML. Interleukin-1 system crosstalk between embryo and 
endometrium in implantation. Hum Reprod 1995a;10(2):43-54 
Simon C, Cano F, Valbuena D, et al. Clinical evidence for a detrimenal effect on uterine 
receptivity of high serum oestradiol concentrations in high and normal responder patients. 
Hum Reprod 1995b;10:2432-7. 
 
Sinowatz F, Töpfer-Petersen E, Kölle S, Palma G. Functional morphology of the zona 
pellucida. Anat Histol Embryol 2001;30(5):257-63. 
 
Somfai T, Kikuchi K, Onishi A, et al. Relationship between the morphological changes of 
somatic compartment and the kinetics of nuclear and cytoplasmic maturation of oocytes 
during in vitro maturation of porcine follicular oocytes. Mol Reprod Dev 2004;68:484–91. 
 
Soupart P, Strong P. Ultrastructural observations on polyspermic penetration of zona 
pellucida-free human oocytes inseminated in vitro. Fertil Steril 1975;26:523-537 
 
Staessen C, Devroey P, Camus M,  et al. The relationship between embryo quality and the 
occurrence of multiple pregnancies. Fertil Steril 1992;57:626-630. 
 
Staessen C, Verpoest W, Donoso P, et al. Preimplantation genetic screening does not 
improve delivery rate in women under the age of 36 following single-embryo transfer. Hum 
Reprod 2008;23:2818–2825. 
 
Steer C.V, Mills C.L, Tan SL, et al. The cumulative embryo score: a predictive embryo 
scoring technique to select the optimal number of embryos to transfer in an in-vitro 
fertilization and embryo transfer programme. Hum Reprod 1992;7:117-9. 
 
Stensen MH, Tanbo T, Storeng R, et al. Routine morphological scoring systems in 
assisted reproduction treatment fail to reflect age-related impairment of oocyte and embryo 
quality. RBM Online 2010;21(1):118-25. 
 
Steptoe PC, Edwards RG. Birth after re-implantation of a human embryo. Lancet 
1978;2:366. 
 
 
Stellenbosch University  http://scholar.sun.ac.za
104 
 
Stone BA, Greene J, Vargyas JM, et al. Embryo fragmentation as a determinant of 
blastocyst development in vitro and pregnancy outcomes following embryo transfer. Am J 
Obstet Gynecol 2005;192(6):2014-9; discussion 2019-20. 
 
Sturmey, R.G.; Brison, D.R.; Leese, H.J.  Assessing embryo viability by measurement of 
amino acid turnover. Reproductive BioMedicine Online (Reproductive Healthcare Limited). 
Oct 2008, Vol. 17 Issue 4, p486-496.  
 
Talbot P, Dandekar P. Perivitelline Space: Does It Play a Role in Blocking Polyspermy in 
Mammals? Microsc Res Tech 2003;61:349–357 . 
 
Taylor DM, Ray PF, Ao A, et al. Paternal transcripts for glucose-6-phosphate 
dehydrogenase and adenosine deaminase are first detectable in the human 
preimplantation embryo at the three- to four-cell stage. Mol Reprod Dev 1997;48:442-448. 
 
Ten J, Mendiola J, Vioque J, et al. Donor oocyte dysmorphisms and their influence on 
fertilization and embryo quality. RBM Online 2007;14:40–48. 
 
Tesarik J. Developmental failure during the preimplantation period of human 
embryogenesis. In: Van Blerkom J (ed). The biological basis of early human reproductive 
filure. Oxford University Press, New York, 1994;327-44. 
 
Tesarik, J. and Greco, E.The probability of abnormal preimplantation development can be 
predicted by a single static observation on PN stage morphology. Hum. Reprod.(1999) 14, 
1318–1323. 
 
The Practice Committee of the American Society for Reproductive Medicine and the 
Practice Committee of the Society for Assisted Reproductive Technology. Blastocyst 
culture and transfer is clinical assisted reproduction. Fertil Steril 2008;90(3):S174-7. 
 
Traversa MV, Carey L, Leigh D. A molecular strategy for routine preimplantation genetic 
diagnosis in both reciprocal and Robertsonian translocation carriers. Mol Hum Reprod 
2010;16:329-337. 
 
Stellenbosch University  http://scholar.sun.ac.za
105 
 
Traversa MV, Marshall J, McArthur S, Leigh D. The genetic screening of preimplantation 
embryos by comparative genomic hybridisation. Reprod Biol 2011;11(3):51-60.  
 
Treff NR, Su J, Tao X, et al. Accurate single cell 24 chromosome aneuploidy screening 
using whole genome amplification and single nucleotide polymorphism microarrays. Fertil 
Steril 2010;94(6):2017-21. 
 
Treff NR, Tao X, Schillings WJ, et al. Use of single nucleotide polymorphism microarrays 
to distinguish between balanced and normal chromosomes in embryos from a 
translocation carrier. Fertil Steril 2011;96(1):e58-65. 
 
Treff N.R, Tao X, Ferry K.M, Su J,et al.  Development and validation of an accurate 
quantitative real-time polymerase chain reaction-based assay for human blastocyst 
comprehensive chromosomal aneuploidy screening.Fertil Steril. 2012 Apr;97(4):819-24. 
Epub 2012 Feb 18. 
 
Trounson A, Sathananthan A. The application of electron microscopy in the evaluation of 
two and four cell human embryos cultured in vitro for embryo transfer. J In Vitro Fert 
Embryo Transf 1984;1:153–165. 
 
Ueno S, Niimur S. Size of Perivitelline Space and Incidence of Polyspermy in Mouse 
Oocytes Matured In Vivo and In Vitro.  J Mamm Ova Res 2008;25(1):44-49.  
 
Utsunomiya T, Ito H, Nagaki M, Sato J. A prospective, randomized study: day 3 versus 
hatching blastocyst stage.  Hum Reprod 2004;19(7):1598-1603. 
 
Van Blerkom J. Occurrence and developmental consequences of abberant cellular 
organization in meiotically mature oocytes after exogeneous ovarian hyperstimulation. J 
Electron Microsc Tech 1990;16:324-346. 
 
Van Blerkom J. Developmental failure in human reproduction associated with 
chromosomal abnormalities and cytoplasmic pathologies in meiotically mature oocytes. In 
Van Blerkom J (ed). The Biological Basis of Early Human Reproductive Failure. Oxford 
University Press, New York 1994:283. 
 
Stellenbosch University  http://scholar.sun.ac.za
106 
 
Van Blerkom J, Antczak M, Schrader R. The developmental potential of the human oocyte 
is related to the dissolved oxygen content of follicularfluid: association with vascular 
endothelial growth factor levels and perifollicular bloodflow characteristics. Hum Reprod 
1997;12:1047-1055. 
 
Van Blerkom J, Davis P, Alexander S. A microscopic and biochemical study of 
fragmentation phenotypes in stage appropriate human embryos. Hum Reprod 
2001;16:719-729. 
 
Van Blerkom J, Davis P, Mathwig V, Alexander S. Domains of high-polarized and low-
polarized mitochondria may occur in mouse and human oocytes and early embryos. Hum 
Reprod 2002;17(2):393-406. 
 
Van der Auwera I, Debrock S, Spiessens C, et al. A prospective randomized study: day 2 
versus day 5 embryo transfer. Hum Reprod 2002;17(6):1507-1512. 
 
Van Montfoort A.P, Fiddelers A.A, Janssen J.M, et al. In unselected patients, elective 
single embryo transfer prevents all multiples, but results in significantly lower pregnancy 
rates compared with double embryo transfer: a randomized controlled trial. Hum Reprod 
2006;21:338–43. 
 
Van Royen E, Mangelschots K, De Neubourgh D, et al. Characterization of a top quality 
embryo, a step towards single-embryo transfer. Hum Reprod 1999;14(9):2345-2349. 
 
Van Royen E, Mangelschots K, De Neubourg D, et al. Calculating the implantation 
potential of day 3 embryos in women younger than 38 years of age: a new model. Hum 
Reprod 2001;16:326-332. 
 
Vanneste E, Voet T, Le Caignec C, et al. Chromosome instability is common in human 
cleavage-stage embryos. Nat Med 2009;15:577–583. 
 
Veeck LL. Oocyte assessment and biological performance.  Ann N Y Acad Sci 
1988;541:259–274. 
 
Stellenbosch University  http://scholar.sun.ac.za
107 
 
Veeck LL. Does the developmental stage at freeze impact on clinical results post-thaw? 
RBM Online 2003;6:367-74. 
 
Vercammen MJ, Verloes A, Van de Velde H, Haentjens P. Accuracy of soluble human 
leukocyte antigen-G for predicting pregnancy among women undergoing infertility 
treatment: metaanalysis. Hum Reprod Update 2008;14:209–18. 
 
Verlinsky Y, Lerner S, Illkevitch N, et al. Is there any predictive value of first polar body 
morphology for embryo genotype or developmental potential? RBM Online 2003;7:336–41. 
 
Vestweber D, Gossler A, Boller K,et al..Expression and distribution of cell adhesion 
molecule uvomorulin in mouse preimplantation embryos.Dev Biol. 1987 Dec;124(2):451-6. 
 
Viganò P, Mangioni S, Pompei F, Chiodo I.  Maternal-conceptus cross talk--a review. 
Placenta 2003;24(SupplB):S56-61. 
 
Visser DS, Fourie FR. The applicability of the cumulative embryo score system for embryo 
selection and quality control in an invitro fertilization/embryo transfer programme. Hum 
Reprod 1993;8:1719-22. 
 
Voullaire L, Wilton L, Slater H, Williamson R. Detection of aneuploidy in single cells using 
comparative genomic hybridization. Prenat Diagn 1999;19:846–851. 
 
Voullaire L, Wilton L, McBain J, et al. Chromosome abnormalities identified by comparative 
genomic hybridization in embryos from women with repeated implantation failure. Mol Hum 
Reprod 2002;8:1035–1041. 
 
Wang WH, Meng L, Hackett RJ, Keefe DL. Developmental ability of human oocytes with or 
without birefringent spindles imaged by Polscope before insemination. Hum Reprod 
2001;16:1464-1468. 
 
Warner CM, Cao W, Exley GE, et al. Genetic regulation of egg and embryo survival. Hum 
Reprod 1998;13(Suppl3):178-190. 
 
Stellenbosch University  http://scholar.sun.ac.za
108 
 
Wassarman P, Chen J, Cohen N, et al. Structure and function of the mammalian egg zona 
pellucida. J Exp Zool 1999;285:251–258. 
 
Wassarman P.M, Jovine L and Litscher E.S. Mouse zona pellucida genes and 
glycoproteins. Cytogenet Genome Res(2004) 105,228–234. 
 
Wells D, Sherlock JK, Handyside AH, Delhanty JD. Detailed chromosomal and molecular 
genetic analysis of single cells by whole genome amplification and comparative genomic 
hybridisation. Nucleic Acids Res 1999;27:1214–1218. 
 
Wells D, Escudero T, Levy B, et al. First clinical application of comparative genomic 
hybridization and polar body testing for preimplantation genetic diagnosis of aneuploidy. 
Fertil Steril 2002;78:543–549. 
 
Wells D, Steuerwald N, Chu L, et al. Microarrays for analysis and diagnosis of human 
embryos. In: Papp Z and Rodeck C (eds). Recent Advances in Prenatal Genetic 
Diagnosis. Bologna, Italy: Medimond, 2004. 
 
Wilton L, Williamson R, McBain J, et al. Birth of a healthy infant after preimplantation 
confirmation of euploidy by comparative genomic hybridization. N Engl J Med 
2001;345:1537–1541. 
 
Windt ML, Kruger TF, Coetzee K, Lombard CJ. Comparative analysis of pregnancy rates 
after the transfer of early dividing embryos versus slower dividing embryos. Hum Reprod 
2004;19(5):1155-62. 
 
Wright GS, Wiker C, Elsner H, et al. Cohen Observations on the morphology of pronuclei 
and nucleoli in human zygotes and implications for cryopreservation. Hum Reprod 
1990;5:109–115. 
 
Xia P. Intracytoplasmic sperm injection: correlation of oocyte grade based on polar body, 
perivitelline space and cytoplasmic inclusions with fertilization rate and embryo quality. 
Hum Reprod 1997;12:1750–5. 
 
Stellenbosch University  http://scholar.sun.ac.za
109 
 
Yang HW, Hwang KJ, Kwon HC, et al. Detection of reactive oxygen species (ROC) and 
apoptosis in human fragmented embryos. Hum Reprod 1998;13:998-1002. 
 
Yang SH, Son WY, Yoon SH, et al. Correlation between in vitro maturation and expression 
of LH receptor in cumulus cells of the oocytes collected from PCOS patients in HCG-
primed IVM cycles. Hum Reprod 2005;20:2097–103. 
 
Yie SM, Balakier H, Motamedi G, Librach CL. Secretion of human leukocyte antigen-G by 
human embryos is associated with a higher in vitro fertilization pregnancy rate. Fertil Steril 
2005;83(1):30–6. 
 
Younis JS, Radin O, Izhaki I, Ben-Ami M. Does first polar body morphology predict oocyte 
performance during ICSI treatment? J Assist Reprod Genet 2009;26(11-12):561-7. 
 
Zech N,H.,Lejeune B,Puissant F,Vanderzwalmen S,Zech H, Vanderzwalmen P. (2007). 
Prospective evaluation of the optimal time for selecting a single embryo for transfer: day 3 
versus day 5. Fertil Steril 2007;88(1):244-246. 
 
Zhang X, Trokoudes KM, Pavlides C. Vitrification of biopsied embryos at cleavage, morula 
and blastocyst stage. RBM Online 2009;19:526–531. 
 
Zheng WT, Zhuang GL, Zhou CQ, et al. Comparison of the survival of human biopsied 
embryos after cryopreservation with four different methods using non-transferable 
embryos. Hum Reprod 2005;20:1615–1618. 
 
Ziebe S, Petersen K, Lindenberg S, et al. Embryo morphology or cleavage stage: how to 
select the best embryos for transfer after in-vitro fertilization. Hum Reprod 1997;12:1545-
1549. 
  
Ziebe S, Loft A, Petersen JH, et al. Embryo quality and developmental potential is 
compromised by age. Acta Obstet Gynecol Scand 2001;80(2):169-74. 
 
 
Stellenbosch University  http://scholar.sun.ac.za
  
 
 
 
 
 
 
 
CHAPTER 3 
 
 
 
 
 
 
 
 
 
 
 
Published:  
J Assist Reprod Genet (2010) 27:309-316 
Stellenbosch University  http://scholar.sun.ac.za
111 
 
 
 
 
Stellenbosch University  http://scholar.sun.ac.za
112 
 
CHAPTER 3 
 
Embryo selection criteria based on morphology VERSUS the expression 
of a biochemical marker (sHLA-G) and a graduated embryo score: 
prediction of pregnancy outcome 
ABSTRACT 
Purpose 
To compare pregnancy and implantation rates when embryos are selected based on a 
single Day 3 (D 3) morphology score vs. a GES score plus sHLA-G expression. 
 
Methods 
A prospective randomized study (n = 214) undergoing fresh ICSI cycles. Embryos were 
selected for transfer based on either Day 3 morphology score (Group A) or GES-scoring 
plus sHLA-G expression (Group B). 
 
Results 
Clinical [35/107 (33%) vs. 52/107 (49%)] and ongoing pregnancy [20/107 (19%) vs. 52/107 
(49%)] rates were significantly different between Group A and Group B (p < 0.05). 
Implantation rates were not significantly different between Group A [52/353 (15%)] and 
Group B [73/417 (18%)] (p < 0.05). The number of pregnancies lost during the first 
trimester was nearly 12 times higher in Group A [25/52 (48%)]. 
 
Conclusion 
The miscarriage rate was significantly lower in Group B than Group A and the pregnancy 
results were superior when embryos were selected based on GES plus sHLA-G 
expression. 
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INTRODUCTION 
Generating criteria to select ―competent embryos‖ for transfer has become of utmost 
importance. Historically, approaches to identifying the ―competent‖ embryos prior to 
transfer focused mainly on morphological assessment of embryos. Evidently, 
morphological evaluations furnish clues that enhance ability in choosing the best pre-
embryos for transfer. However, it is severely limited to provide reliable evidence for 
predicting subsequent normal embryo implantation (Cummins et al., 1986; Puissant et al., 
1987; Staessens et al., 1992; Steer et al., 1992; Roseboom et al., 1995; Ziebe et al., 1997; 
Visser et al., 1993). Desai et al. 2000 reported the first scoring system for day 3 embryos, 
whereas all previous scoring systems were based on the second day of culture (Day 2). 
Later on the graduated embryo scoring (GES) system was introduced by Fisch et al. 2001 
in which each embryo was individually cultured, allowing for sequential microscopic 
assessment of developmental stages starting on day 1 through day 3 of embryo culture. 
Determining which morphologic evaluation system (Alikani et al., 1999; Sakkas et al., 
1999; Royen et al., 1999; Scott et al., 2000) to use for transferring embryos on Day 2/3, 
and to achieve pregnancy rates similar to embryos that are transferred at the blastocyst 
stage, is a controversial subject (Coskun et al., 2000; Kovacic et al., 2002). Some 
researchers claimed that transferring selected embryos on day 3 yielded a pregnancy rate 
equivalent to embryos transferred on day 5 or 6 (Scholtes et al., 1996; Blake et al., 2002). 
Jurisicova et al. 1996 reported that HLA-G expression was present during preimplantation 
human embryo development. The presence of soluble Human Leukocyte Antigen-G 
(sHLA-G) mRNA was detected in culture medium surrounding grouped embryos (Fuzzi et 
al., 2002). The detection of sHLA-G in the culture medium of individually cultured early 
cleaving embryos (as early as 44–46 h after insemination) provided evidence that embryos 
could be selected by their maternal genomic function. This is due to the correlation 
between sHLA-G expression by an embryo and its potential to reach a pregnancy (Sher et 
al., 2004). 
In our study sHLA-G expression within a range of 0.184–0.196 was considered positive. 
This original optimal range was determined by Keskintepe (unpublished data) and was 
slightly different from other investigators (Sher et al., 2004; Fisch et al., 2007). 
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While several tools are available for the evaluation of embryos for transfer, other unknown 
factors such as oocyte quality and embryo dismorphism, still remain unanswered. The 
purpose of this study was to compare pregnancy and implantation rates when embryos are 
selected based on a single Day 3 (D 3) score vs. sHLA-G expression plus a graduated 
embryo scoring (GES). 
MATERIALS AND METHODS 
Patients 
An initial pilot study was performed on 58 patients to compare pregnancy outcome when 
using a single D 3 morphology versus the GES-scoring system. We reported no statistical 
differences between these two treatment groups. Based on the findings of our pilot study, 
a subsequent study was designed. In Group A, the most common way (morphology and 
developmental rate) by which embryo selection is performed, was compared to Group B, a 
combination of non-invasive criteria ( the expression of soluble HLA-G plus the GES-
score).  
A Statistical program (Epi-info, UMassAmherst) was used to perform a power calculation 
for this study. Using the given parameters—confidence (95%) and the power (80%) and 
the ratio of cases to controls—it was evident that using one hundred and seven patients 
per treatment group would be sufficient. Two hundred and ninety seven (297) patients 
were assessed for eligibility to participate in this study (Fig. 1). Two hundred and thirty 
three (233) patients underwent randomization prior to egg retrieval. At this time, patients 
drew a single tab from a prepared envelope to determine their study group and whether 
their embryos will be transferred based on a single Day 3 score (Group A) or an sHLA-G 
expression plus a GES-score (Group B). (Furthermore, in Group A, the culture medium 
also underwent sHLA-G testing but the embryologist was blinded for the sHLA-G results of 
these embryos prior to transfer). Patient diagnosis included endometriosis, tubal factor, 
PCOS, unknown and male factor. All patients were <39 years of age and had a normal 
uterine cavity and normal endometrial thickness (≥ 9 mm) at the time of hCG 
administration). 
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Fig. 1    
 
CONSORT statement flow diagram 
Individually cultured embryos whose surrounding media expressed sHLA-G with an 
OD = 0.190 ± 0.006 (the geometric mean) were defined as positive for sHLA-G expression, 
whereas those outside the range (0.184–0.196) were designated as negative (Table 2). 
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TABLE 1 
Graduated embryo scoring (GES) of cleavage stage embryos 
 
 
Fisch. Graduated embryo score (GES). Fertil Steril 2003 
aIf the embryo was not cleaved at 25–27 h, grading of fragmentation should occur at the 
64–67 h evaluation if the embryo reached the seven-cell stage and had <20% 
fragmentation 
 
bGrade I = symmetrical blastomeres and absent fragmentation. Grade II = slightly uneven 
blastomeres and <20% fragmentation. Grade III = uneven blastomeres and >20% 
fragmentation. Grade A embryos are seven or more cells with <20% fragmentation. 
(Figure 3  sHLA-G Illustration p.126) 
Evaluation 
Hours after 
insemination 
Developmental milestone Score 
1 16–18 Nucleoli aligned along pronuclear axis 20 
2 25–27 
Cleavage regular and symmetrical 
Fragmentationa 
30 
Absent 30 
<20% 25 
>20% 0 
3 64–67 
Cell number and gradeb 7CI, 8CI, 8CII, 9CI 20 
7CII, 9CII, 10CI, 11CI, Compacting I 10 
Total score   100 
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Table 2 
Comparative analysis data analysis between day 3 score and GES-Score Plus  
sHLA-Ga 
 
aData expressed as means±SD 
bData expressed as (%) 
*Significance p < 0.05 
Parameter 
D.3 Score 
(n = 107) 
GES score plus sHLA-G 
expression (n = 107) 
P-value 
Age (years) 35.2 ± 4.0a 35.1 ± 4.0a 0.58 
Total no. oocytes 9.7 ± 6.2a 11.4 ± 6.2a 0.20 
Mature oocytes 7.3 ± 5.0a 9.2 ± 4.2a 0.30 
No. Ooacytes fertilized 7.1 ± 4.4a 8.5 ± 4.7a 0.36 
Total no. embryos 6.8 ± 3.3a 8.0 ± 3.9a 0.32 
No. embryo transferred 3.3 ± 0.8a 3.9 ± 0.8a 0.15 
Biochemical pregnancies (%) 42 (39)b 60 (56)b 0.05* 
Clinical pregnancies (%) 35 (33)b 52 (49)b 0.05* 
Ongoing pregnancies (%) 20 (19)b 52 (49)b 0.05* 
Implantation rates (%) (15)b (18)b 0.15 
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Stimulation 
 
Patients were pre-treated with oral contraceptives received Lupron (TAP Pharmaceuticals, 
Lake Forest, IL) in a long protocol after pre-treatment with oral contraceptive (OC) birth 
control pills for 1–3 weeks and were treated by a human derived gonadotropin (Bravelle; 
Ferring Pharmaceuticals Inc, Suffern, NY) to activate ovarian follicular stimulation. 
Ovulation was triggered when at least two follicles were 18 mm and half the remaining 
were ≥15 mm. Oocytes were harvested transvaginally using ultrasound guidance 35 h post 
hCG. All patients underwent controlled ovarian hyper-stimulation (COH) by the same 
physician. 
 
Embryo culture 
 
All metaphase II (MII) embryos were injected by ICSI 3–4 hours post retrieval. All zygotes 
were cultured individually in 50 µl droplets of P-1 medium, supplemented with 10% 
Synthetic Serum Substitute (SSS) (Irvine Scientific, Santa Ana, CA). After 44–46 h 
embryos were moved to Complete Blastocyst Medium (Irvine Scientific, Santa Ana, CA). 
At this point, ±35 µl from the remaining P-1 culture media drops were collected in 200 µl 
micro-centrifuge tubes and immediately frozen. All samples were shipped to a central 
location and tested for sHLA-G, using an enzyme-linked immunosorbent sandwich (ELISA) 
assay. All embryos were transferred on day 3. 
 
Embryos scoring 
 
The GES-score  
 
To apply the GES-score, all mature oocytes underwent ICSI with a single sperm and were 
individually cultured. In order to apply the GES-score, oocytes were evaluated at 16–18 h 
post ICSI when the presence of pronuclear as well as nucleoli alignment along the 
pronuclear axis was evident, a score of 20 was allotted where nucleoli alignment was 
prevalent. The second observation took place at 25–27 h, at which time early cleavage 
was noted. A score of 30 was allotted when cleavage was observed. Furthermore, at this 
time a score was given based on the presence/absence of fragmentation. When 
fragmentation was absent a score of 30 was given, <20% fragmentation received a score 
of 25 and >20% received a score of zero (0). The third and final score was given 64–67 h 
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after ICSI and involved the number of blastomeres and embryo grade. Example: six cell 
grade one—6(I),7(I), 8(I), 8(II), 9(I) scored 20 points, seven cell, grade II (7(II)), 9(II), 10(I), 
11(I) and compacting(I) scored ten points. The maximum GES-score totaled 100 points   
 
The Day 3 score  
 
The Day 3 score that was applied in this study was a modification of Veeck’s [21] criteria 
for Day 3 embryos combined with our laboratory’s criteria (unpublished data DK). Embryos 
were scored based on their blastomere number, size and symmetry as well as the 
percentage of fragmentation that was present. Example: a grade one embryo: 8–11 cell 
with even sized blastomeres (+8 points) and without fragmentation (+2 points) scored a 
max of ten points, a grade two embryo: 8–11 cell with even sized blastomeres (+8 points) 
and with <10% fragmentation (0 points) scored a max of eight points, a grade three 
embryo 8–11 cell (+8 points) with uneven blastomere (−1 points) and >10% fragmentation 
(−3 points) scored a max of four points. 
 
The same embryologist preformed all embryology and embryo scoring in this study. 
 
Soluble HLA-G assay 
 
A monoclonal antibody (mAb; MEM-G9 MCA 2044; Serotec, Raleigh, NC) against sHLA-G 
was used to coat a 96-well Nunc-Immunoplate (Fisher Scientific, Chino CA) using a 
concentration of 2 µg/ml in 0.1 mol/l carbonate buffer at pH 9.5 for 1 h at 37°C. The plate 
was then refrigerated overnight at 4°C. On the following day, the plate was thoroughly 
washed using 100 µl of phosphate-buffered saline (PBS) and 0.05% Tween-20. The wash 
was repeated twice using 100 µl PBS and 5% bovine serum albumin (BSA) for 15 min 
each. A 50 µl aliquot of PBS and 5% BSA was added to each well before adding the 
sample of 50 µl of embryo supernatant. Amniotic fluid (AF) was used as a positive control. 
AF (50 µL) and 50 µl of pure Complete Blastocyst culture media (Irvine Scientific) in which 
no embryos had been cultured (the negative control) Samples were incubated for a period 
of 1 h at 37°C. After incubation, the plates were washed three times with PBS, followed by 
incubation with a specific biotin conjugated mAB (w6/32 MCA81B; Serotec) at a 1:1000 
dilution in PBS and 1% BSA for 45 min at 37°C and then washed five times with PBS. 
Streptavidin alkaline phosphatase conjugated (BD Bioscience Pharmigen, San Diego, CA) 
at a concentration of 1:1000 in carbonate buffer was incubated for 30 min at 37°C and 
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washed five times with PBS, after which phosphatase substrate was added at a 
concentration of 1 mg/ml in 10% diethanolamine at pH 9.8 for 30 min. The colorimetric 
reaction was then stopped by the addition of 50 µl of 3 mol/l NaOH. The sHLA-G 
concentration was determined by absorbance at 405 nm on the EL800 Universal 
Microplate Reader (Bio-Tek Instruments Inc., Winooski, VT). 
 
Embryo selection and transfer 
 
Individual embryos were defined as having positive sHLA-G expression if their surrounding 
media expressed sHLA-G with an optical density inside the range of 0.184–0.196. Those 
outside the above mentioned range were designated as sHLA-G negative. In Group A, one 
hundred and seven (107) patients received embryos for transfer and all of these embryos 
were selected by using a Day 3 score only. In Group B, one hundred and seven (107) 
patients received embryos for transfer by first selecting any embryos that had a positive 
sHLA-G expression, and correlating such with the highest available GES score. 
Furthermore, in Group B the patients received embryos containing at least one sHLA-G 
positive in the cohort for transfer. In this study no more than four (4) embryos were 
recommended for transfer. However, the final decision regarding the number of embryos 
for transfer was left to the patient after an informed consent that was based on American 
Society for Reproductive Medicine guidelines. All embryos were transferred on day 3 of 
culture, using ultra sound guidance and an echogenic catheter (Wallace, Smith Medical, 
UK). Serum β-hCG levels were measured 11 days and 13 days after the transfer. The 
patient was considered positive for biochemical pregnancy when the first value was 
>5.0 IU and the next value 2 days later was double the first. Clinical pregnancy rates were 
based on a six (6) week ultrasound with a gestational sac containing a fetal heartbeat. 
Ongoing pregnancy rates were based on a ten to twelve (10–12) week ultrasound with 
gestational sac containing one or more growing fetuses with appropriate heart rates. 
 
Statistical analysis 
 
Statistical analysis was carried out using SPSS version 15 (Statistical Package for the 
Social Science). The number and percentage (%) of categorical data as well as the mean 
and standard deviation (SD) of continuous data were calculated. Comparison between 
mean values of continuous variables was calculated using the Students t-test for 
parametric and the Mann–Whitney-U test for non-parametric data, while the Chi-square 
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was used for categorical data and the Odds ratio and 95% confidence calculated. 
Significance value was set at p < 0.05. 
 
Miscarriage rates between treatment groups were calculated as a percentage of 
pregnancy loss between biochemical, clinical and ongoing rates. Fetal loss between 
treatment groups were calculated between clinical and ongoing pregnancies. 
Retrospective data were calculated as a percentage. 
 
Institutional review 
 
Since January 2005, all embryos at SIRM underwent routine sHLA-G assay to determine 
the expression of this potential biochemical marker in the culture medium surrounding 
embryos. All patients were counseled regarding the risks, benefits, and alternatives to 
sHLA-G testing; however, because it was not considered an experimental component of 
the treatment, a specific institutional review board was not sought. However, for the 
purpose of this PhD study, ethical approval was obtained from the Ethical committee of the 
University of Stellenbosch (N06/07/119). Furthermore, all clinical research conducted was 
in full compliance with guidelines of the American Society of Reproductive Medicine and 
met ethical principles involving human subjects as defined by the Declaration of Helsinki in 
1964. 
 
RESULTS  
 
In the prospective data analysis, no statistical significance was found between the two 
treatment groups in regards to age, total number of oocytes, mature oocytes, number of 
oocytes fertilized, number of embryos, or number of embryos transferred and implantation 
rates. However, significance was reached for biochemical (39.3% vs. 56.1%), clinical 
(32.7% vs. 48.6%), and ongoing pregnancy (18.7% vs. 48.6%) rates between Group A and 
Group B, respectively (Table 2). In this study all embryos underwent sHLA-G testing. 
However, in Group A, sHLA-G results were blinded (therefore, embryos were selected 
without knowing the sHLA-G results prior to transfer).  
 
A total of 770 embryos were transferred in both groups: 
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In Group A, 353 embryos were transferred into 107 patients, 42/107 (39.2%) positive β-
hCG resulted. The 6 week ultrasound revealed that 35/42 (83.3%) pregnancies continued 
since β-hCG testing was performed. The breakdown included 23 singletons, eight sets of 
twins, three sets of triplets and one set of quadruplets, resulting into 52 fetuses with 
heartbeats confirming an implantation rate of 14.7%. Furthermore, the 10–12 week 
ultrasound revealed that 20/35 (57.1%) pregnancies continued since 6 week ultrasound 
was performed. The breakdown included 13 singletons, seven sets of twins, zero triplets 
zero quadruplets, resulting into 27 fetuses with heartbeats. The miscarriage rate (fetal 
loss) between biochemical and clinical pregnancies were 7/42 (16.7%) and between 
clinical and ongoing pregnancies were 15/35 (42.9%). Furthermore, in Group A the total 
pregnancy loss between biochemical and ongoing pregnancies were 20/42 (total number 
of pregnancy losses)/(initial number of biochemical pregnancies) (47.6%). Furthermore, 
there was a loss of 25 fetuses between 6 week and the 10–12 week ultrasound. 
 
In Group B, 417 embryos were transferred into 107 patients, 60/107 (56.1%) patients had 
positive β-hCG results. The 6 week ultrasound revealed that 52/60 (86.7%) pregnancies 
continued since β-hCG testing was performed. The breakdown included 36 singletons, 12 
sets of twins, three sets of triplets and one set of quadruplets, resulting into 73 fetuses with 
heartbeats confirming an implantation rate of 17.5%. Furthermore, the 10–12 week 
ultrasound revealed that 52/60 (86.7%) pregnancies continued since 6 week ultrasound 
was performed. The breakdown included 38 singletons, ten sets of twins, four triplets zero 
quadruplets, resulting into 70 fetuses with heartbeats. The miscarriage rate between 
biochemical and clinical pregnancies were 8/60 (13%) and between clinical and ongoing 
pregnancies were 0/52 (0%). Furthermore, in Group B the total pregnancy loss between 
biochemical and ongoing pregnancies were 8/60 (total number of pregnancy losses)/(initial 
number of biochemical pregnancies) (13.3%). Furthermore, there was a loss of three 
fetuses between 6 week and the 10–12 week ultrasound. 
 
Implantation rates per embryo transferred were not significantly different at 52/353 (14.7%) 
and 73/417 (17.5%) for Group A and Group B, respectively (p > 0.05). However, the 
pregnancy loss rates between biochemical and ongoing pregnancies were significantly 
different at 22/42 (52.3%) and 8/60 (13.3%) for Group A and Group B, respectively 
(p < 0.05). Fetal loss between treatment groups were 25/52 (48.1%) and 3/73 (4.3%) for 
Group A and Group B, respectively and was statistically significant (p < 0.05) (Fig. 2).  
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Fig. 2 Fetal loss rates 
 
 
Prospective data for Group B indicated that ninety three out of one hundred and seven 
(93/107) patients (86.9%) received a cohort of embryos for transfer that contained at least 
one sHLA-G positive embryo combined with the highest available GES-score. This ―sHLA-
G positive sub-group‖ resulted into 55/93 (59.1%) (biochemical), 50/93 (53.8%) (clinical) 
and 50/93 (53.8%) (ongoing pregnancy), respectively. Furthermore, fourteen out of one 
hundred and seven (14/107) patients (13.1%) received embryos for transfer that contained 
ALL sHLA-G negative embryo combined with the highest available GES-score. This 
―sHLA-G negative sub-group‖ resulted into 5/14 (35.7%) (biochemical), 2/14 (14.2%) 
clinical) and 2/14 (14.2%) (ongoing pregnancy), respectively. 
 
Retrospective data for Group A and un-blinding of sHLA-G results revealed that twenty 
seven out of one hundred and seven (27/107) patients (25.2%) received a cohort of 
embryos for transfer that contained at least one sHLA-G positive embryo combined with 
the highest available GES-score. This ―sHLA-G positive sub-group‖ resulted into 17/27 
(63.0%) (biochemical), 14/27 (51.9%) (clinical) and 14/27 (51.9%) (ongoing pregnancy), 
respectively. Furthermore, eighty out of one hundred and seven (80/107) patients (74.8%) 
received embryos for transfer that contained ALL sHLA-G negative embryo combined with 
the highest available GES-score. This ―sHLA-G negative sub-group‖ resulted into 25/80 
(31.2%) (biochemical), 21/80 (26.3%) clinical) and 6/80 (7.5%) (ongoing pregnancy), 
respectively. 
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Combined data regarding the s-HLA-G status from group A and B revealed that 120/214 
(56.1%) of patients received a cohort that included at least one sHLA-G-positive embryo. 
This subgroup resulted in 72/120 (60.0%) biochemical, 64/120 (53.3%) clinical and 64/120 
(53.3%) ongoing pregnancies, respectively. Furthermore, 94/214 (43.9%) of patients 
received a cohort that included ALL sHLA-G-negative embryos. This subgroup resulted in 
30/94 (31.9%) biochemical, 23/94 (24.5%) clinical and 8/94 (8.5%) ongoing pregnancies. 
 
Summarizing: pregnancy outcome for patients that received sHLA-G-positive cohorts for 
transfer versus those that received sHLA-G negative cohorts for transfer were 60.0% vs. 
31.9% (biochemical), 53.3% vs. 24.5% (clinical) and 53.3% vs. 8.5%, respectively and was 
significant (p < 0.05). 
 
DISCUSSION 
 
The aim of this prospective randomized study was to compare a traditional embryo 
selection method (Day 3 morphology) with a novel GES-score plus sHLA-G expression 
and its impact on implantation, pregnancy and miscarriage rates. To find non-invasive 
techniques to improve pregnancy outcome and also reduce high order multiple has been 
an ongoing challenge since the start of IVF in 1988. Earlier studies have outlined different 
criteria for embryo selection, focusing on a variety of parameters. Pronuclear morphology 
such as orientation, surrounding halo, number of nucleoli and its arrangement at the juxta-
junction and the role of precursor bodies, early cleavage, and Day 3 blastomere 
morphology including number of blastomeres, their shape and size, and the percentage of 
fragmentation provided better understanding of embryo development pattern. Whether to 
transfer embryos at the cleaved or the blastocyst stage is still an ongoing argument. 
 
All the above approaches has been based on morphology, however, the detection of 
sHLA-G in culture medium surrounding clusters of developing embryos (Jurisicova et al., 
1996; Fuzzi et al., 2002; Menicucci et al., 1999) sparked a new interest in the search for 
non invasive markers, or so-called proteomics, to assist in the identification of the 
―competent‖ embryos for transfer. In the study presented here, a traditional Day 3 
morphology compared to the sHLA-G expression plus a GES-score in order to identify 
embryos for transfer resulting into favorable clinical and ongoing pregnancy rates. These 
findings are supported by a number of researchers (Sher et al., 2004; Noci et al., 2005; 
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Fisch et al., 2007; Yie et al., 2005; Desai et al., 2006). Furthermore, we reported a 
decrease of fetal loss, in the sHLA-G positive group, between 6 week and 12 week 
ultrasound, a finding supported by Rebmann et al. 2007. 
 
The exact mechanism by which sHLA-G improved the ongoing pregnancy outcome is 
unknown; however, whether it is due to good communication (cross-talk) (Viganò et al., 
2003), or the suppression/masking of the natural immune response (Gal et al., 1999; 
Navarro et al., 1999), the presence of sHLA-G has been postulated to protect the 
conceptus from destruction by the maternal immune response (Hviid et al., 2004). The first 
two cell cycles of human embryogenesis (that is embryonic divisions up to the 4-cell stage) 
are regulated by the maternal genome (Tesarik et al., 1986; Braude et al., 1988). 
Activation of the embryonic genome takes place between the 4-cell and 8-cell stages post 
fertilization in humans and is essential for zygote protein synthesis and subsequent 
embryo development. With these assumptions, we suggest that collecting the culture 
medium surrounding individually cultured embryos at 44–46 h post ICSI and subsequently 
analyzing it for the presence of sHLA-G will help to identify embryos with a ―healthy‖ 
maternal genome, which should convert into a properly activated embryonic genome, 
resulting into a competent developing embryo. 
 
In a recent meta-analysis it was concluded that the presence of sHLA-G in the 
supernatants of cultured embryos is moderately helpful to predict the ability to achieve 
pregnancy in women undergoing IVF treatment (Vercammen et al., 2008).  Additionally 
they suggested it to be more beneficial if the embryos are of good quality. In our study we 
used both the expression of sHLA-G and applied a novel, cumulative embryo score (GES), 
providing detailed information regarding each embryo’s morphology and biochemical 
competency The implantation rates in the groups studied, did not differ significantly but the 
fetal loss rate was significantly lower in the sHLA-G-positive group. Furthermore, data 
revealed a significant increase in the biochemical, clinical and ongoing pregnancies in 
patients that received cohorts containing at least one sHLA-G-positive embryo vs. cohorts 
containing all sHLA-G-negative embryos for transfer. This finding highlights a further 
benefit in performing sHLA-G in an IVF program. This knowledge prior to embryo transfer 
will assist in selecting the better embryo. 
 
This study is a first prospective randomized study comparing the traditional way of embryo 
evaluation versus sHLA-G expression plus a cumulative GES-score on day 3 as selection 
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criteria. It was performed by the same physician, using the same stimulation drug, the 
same embryologist performed the embryology on all the patients and sHLA-G ELISA was 
performed by the same lab in order to minimize as many variables as possible. 
 
We conclude that by combining a positive sHLA-G expression with the highest GES-score 
on Day 3 resulted into significantly improved ART outcome. Furthermore, that the power of 
sHLA-G status is a very important criterion to identify prior to embryo transfer. 
 
 
 
Figure 3 -  GES – SCORE - ILLUSTRATION 
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CHAPTER 4 
 
The prediction of pregnancy outcome using a biochemical marker 
(sHLA-G) – a multi centre study. 
 
 
ABSTRACT 
 
 
Introduction 
Several studies have reported an association between the presence of soluble human 
leukocyte antigen G (sHLA-G) in human embryo culture supernatants (ES) with 
implantation and pregnancy outcome in vitro. However, the actual presence, role during 
implantation and effect on implantation and pregnancy outcome is still controversial at 
best.   
 
Aim 
A retrospective multi-centre study was performed on 2040 ICSI patients in six different 
centers, to determine if the presence of sHLA-G have an effect on implantation and 
pregnancy outcome in vitro. 
 
Methods 
All embryos were individually cultured and a chemiluminescence enzyme-linked 
immunosorbent assay was used to detect the presence sHLA-G in culture medium 
surrounding embryos.  A pregnancy test was performed 10 days after embryo transfer 
(ET) and an ultrasound performed at 7 weeks pregnancy duration. 
 
Results 
In all centers, a positive sHLA-G result was associated with an increase in odds of ongoing 
pregnancies (OR: 3.27, 95% CI: 2.67 to 3.99, p-value: <0.0001), and an increased odds of 
multiple on-going pregnancies (OR: 1.66, 95% CI: 1.10, 2.51, p-value: 0.0170).  
 
Discussion 
Data from this multi centre study emphasize that sHLA-G expression is a valuable non 
invasive embryo marker to assist in improving pregnancy outcome with the theoretical 
potential to reduce multiple pregnancies.  A combination of sHLA-G expression and 
extended embryo culture to the blastocyst stage might provide future tools by which to 
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select single embryos for transfer and reduce the risk of multiple gestational, without 
compromising their pregnancy rates. 
 
BACKGROUND 
 
Despite improvement of in vitro embryo culture conditions, stimulation and transfer 
techniques no significant improvement in implantation rates have been reported over the 
last decade. Early studies using non-invasive criteria by which to select embryos for 
transfer have been reported, morphologically assessing of embryos (Ng et al., 1999, 
Richter et al., 2001, Fisch et al, 2001), extended embryo culture to the blastocyst stage 
(Schoolcraft and Gardner, 2000) and the detection of soluble HLA-G in culture medium 
surrounding embryos, (Jurisicova et al., 1997, Menicucci et al., 1999 and Fuzzi et al., 
2002).  Furthermore, invasive advances in pre-implantation chromosomal screening of 
embryos and aneuploidy have been reported (Gianaroli et al., 1997a/b, Munne S., 
2003a/b, Pehlivan et al., 2003).  However, currently no individual criterion is capable of 
accurately identifying an embryo’s potential to develop into a live birth. In an effort to 
improve IVF success rates, multiple embryos had been transferred, subsequently resulting 
in a risk of high order multiple pregnancies.  In order to limit such risk, the search for an 
accurate and precise “tool” to identify embryos that has an improved chance to develop 
into a live baby, is essential. 
 
The implantation mechanism is a very poorly understood aspect of reproduction.It is a 
highly complex dialog (cross-talk) between the embryo and the endometrium, (Simón et 
al., 1995, Hill 2001, Viganò et al., 2003 and Shimomura et al., 2006). Implantation requires 
the successful suppression of the maternal immune system. The human body will identify 
and discriminate against foreign tissue by major histocompatability complex (MHC), 
human leukocyte antigen (HLA) originated from a group of genes located on the short arm 
of chromosome six (6).  The MHC evokes T-cell intervention to non-self antigens 
expressed by an individual of the same specie.  The human fetus is a considered a non-
self tissue to the maternal uterus due to paternal MHC antigens, however, during 
pregnancy the immune system develops fetal tolerance (Siato et al., 2007).  HLA-G 
produced by the extra-villous cytotrophoblast (the only fetal contact with maternal uterine 
cells), confers immuno-tolerance through interaction with maternal uterine membrane 
lymphocytes.  This scenario would suggest that HLA-G protects the fetus from maternal 
immune response attack.  HLA-G is expressed by the placenta throughout gestation and is 
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also present in amniotic fluid.  Soluble-HLA-G (a spliced iso-form of membrane bound 
HLA-G) is in suspension and can be detected in culture medium.  sHLA-G, a non-classic 
type I human leukocyte antigen, was first identified in the media surrounding groups of 
embryos and blastocysts in culture by Jurisicova et al., 1996.  Menicucci et al 1999, first 
identified, sHLA-G (a non-classic type I human leukocyte antigen), in the culture media 
surrounding a group of day 3 embryos. Fuzzi et al, 2002 has shown that the presence of 
sHLA-G in the culture media harboring groups of three day old cleaved embryos, 
correlated both with their cleavage rate and with their overall subsequent implantation 
potential.  Hviid et al., 2004 postulated that the presence of sHLA-G protected the 
conceptus from destruction by the maternal immune response.  Several studies regarding 
sHLA-G and its effect on pregnancy outcome have been reported since, (Sher et al., 2004, 
2005a,b; Criscuoli et al., 2005, Noci et al., 2005, Yie at al., 2005, Desai et al., 2006, Fisch 
et al. 2007 Rebmann et al., 2007 and Kotze et al., 2010). In a review studies by Sargent et 
al., 2007 and Vercammen et al., 2008 they thoroughly evaluated and discussed previous 
studies regarding sHLA-G and ART outcome.  Furthermore, Rebman et al., 2005 
addressed specific issues dealing with sHLA-G ELISA protocols. 
 
The goal of this multi-center retrospective study was to evaluate how the presence or 
absence of sHLA-G expression and untested culture medium surrounding embryos 
affected IVF outcome.  
 
STATISTICAL METHODS 
 
The data was analyzed, using STATA, through a series of mixed effects logistic regression 
models in which site was included as a random effect. A mixed effects logistic regression 
model was fitted for each of the three outcomes; chemical pregnancy, clinical implantation, 
and on-going pregnancy. Each outcome was regressed against the sHLA-G test result 
with mean age, mean number of embryos utilized per group, and day of transfer included 
as covariates in the analysis. We report each parameter estimate with its 95% confidence 
interval and associated p-value, for each model fitted, as well as the odds ratio for each 
parameter and its corresponding 95% confidence interval.  
 
Embryos were transferred on either the Day 3 or the Day 5/6 (blastocyst) post-fertilization. 
For each clinic, the patients were divided in separate groups based on day of transfer (as 
mentioned above) and sHLA-G results noted (positive, negative, and untested). For each 
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group, the data consists of the number of chemical pregnancies, clinical implantations and 
ongoing pregnancies, respectively. The number of on-going pregnancies was also 
recorded and reported as singleton, twins, triplets or quadruplets pregnancies. In addition, 
we calculated the mean age and standard deviation of the women in each group, as well 
as the average number of embryos utilized per group.  
 
MATERIALS AND METHODS 
 
Patients  
Consenting ART patients between July 2003 and Dec 2010 who underwent 
intracytoplasmic sperm injection (ICSI), the majority used a specific ELISA 46 hours post-
ICSI to determine sHLA-G expression, however, some embryos were transferred as 
“untested”. 
 
The Study design 
Data was retrospectively gathered from six fertility clinics (Los Angeles (LA), Las Vegas 
(LV), New Jersey (NJ), New York (NY), FISCH, and Sacramento (SAC) that performed a 
sHLA-G assay/test on the majority of their consenting ART patients between July 2003 
and Dec 2010.  Since protocols at all clinics were standardized, the procedural variabilities 
were limited. We retrospectively compared IVF outcome in all patients regardless of age 
since the goal was to compare ART outcome for sHLA-G positive, sHLA-G negative and 
untested cohorts.  The majority of clinics transferred embryos on Day 3, however, data for 
embryos transferred on Day 5/6 (blastocyst) as well as single embryo transfer were also 
recorded.  
 
Ovarian Stimulation 
Patients were stimulated using similar protocols at all sites.  All patients received Lupron 
(TAP, Pharmaceuticals) in a long protocol after pretreatment with oral contraceptive pills 
for one to three weeks. Ovarian follicular development was stimulated with recombinant-
FSH at doses of 225-450IU a day. Ovulation was triggered when at least 2 follicles were 
18 mm and half the remainder was ≥15mm. Oocytes were recovered transvaginally under 
ultrasound guidance 34.5 hours later. All monitoring of controlled ovarian hyper stimulation 
(COH) as well as egg retrievals (ER’s) and embryo transfers (ET’s) were performed by the 
same physician at each center.   
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Embryo Culture  
All metaphase II (MII) oocytes were fertilised using ICSI 4-6 hours after retrieval.  All 
embryos were cultured individually in 35µl droplets of P1 (Irvine Scientific) supplemented 
with 10% SSS (Irvine Scientific) using Nunc 60x15mm dishes, since 2007 embryos were 
cultured individually in 35µl droplets of GLOBAL (LifeGlobal) supplemented with 10% SSS 
(Irvine Scientific) using Embryo Corral (SunIVF) dishes under oil at 37°C in a 6% C02, 5% 
O2, 89% N2 environment.  All embryos were sequentially microscopically evaluated over a 
period of 72 hours following ICSI and graded by Graduated Embryo Scoring (GES) (See 
Chapter 3 Table 1). Embryos were transferred into extended culture medium 44 - 46 hours 
post-ICSI, which can improved embryo development, as reported previously (Keskintepe). 
Initially individual embryos whose surrounding media expressed sHLA-G within an optic 
density (OD) range of 0.190  0.006  (the geometric mean) were defined as having 
positive sHLA-G expression while those outside this range were designated as sHLA-G 
negative. Each centers applied different criteria for “negative” to “positive” sHLA-G ranges, 
(Table 2).  
 
The original droplets of culture medium (35µl) were collected in 0.5 ml micro-centrifuge 
tubes with attached cap (VWR-Scientific) – frozen immediately at -20 °C and shipped on 
ice for sHLA-G expression testing – to a central location- were identical sHLA-G Assay 
were used (west of Mississippi to Las Vegas (LV) –east of Mississippi to New York (NY) - 
using the same specific enzyme-linked immunosorbent (ELISA) assay. Furthermore, all 
embryos were graded by applying the GES –score, GES≥70 scoring embryos combined 
with positive sHLA-G expression were selected for transfer (See Chapter 3 Table 1).   
 
Soluble HLA-G Assay  
sHLA-G Assay monoclonal antibody (mAb) (MEM-G9 MCA2044; Serotec, Raleigh, NC, 
USA) against sHLA-G was used to coat a 96-well Nunc-Immunoplate (Fisher Scientific, 
Chino, CA, USA) using a concentration of 2 μg/ml in 0.1 mol/l carbonate buffer pH 9.5 for 
1 h at 37 °C. The plate was then refrigerated at 4 °C overnight. On the following day, the 
plate was thoroughly washed twice using 100 μl phosphate-buffered-saline (PBS) plus 
0.05% Tween-20. The next wash was repeated twice using 100 μl of PBS+5% bovine 
serum albumin (BSA) for 15 min each. A 50 μl aliquot of PBS+5% BSA was added to 
each well prior to adding the sample of 50 μl embryo supernatant. JEG-3 cell line (which 
secretes HLA-G) supernatant was used as a positive control (Bamberger et al., 2000). 
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Fifty microlitres of JEG-3 supernatant and 50 μl of pure blastocyst culture media (Irvine 
Scientific) in which no embryos had been cultured (the negative control) were incubated 
for a period of 1 h at 37 °C.  
 
Following incubation, the plates were washed three times with PBS, followed by incubation 
with a specific biotin-conjugated mAb (w6/32 MCA81B; Serotec) at a 1:1000 dilution in 
PBS+1% BSA for 45 min at 37 °C and then washed five times with PBS. Streptavidin–
alkaline phosphatase conjugate (BD Bioscience PharMigen, San Diego, CA, USA) at a 
concentration of 1:1000 in carbonate buffer was incubated for 30 min at 37 °C and 
washed five times with PBS, after which phosphatase substrate was added at a 
concentration of 1 mg/ml in 10% diethanolamine pH 9.8 for 30 min. The colorimetric 
reaction was then stopped by the addition of 50 μl of 3 mol/l NaOH. The relative 
concentration of sHLA-G was estimated from absorbance measured at 405 nm on an 
EL800-ELISA microplate reader (Bio-Tek Instruments Inc., Winooski, VT, USA). A 
standard supernatant of sHLA-G/.221 transfectant served as reference in standard 
calibration curves. 
  
Embryo transfer  
Embryo transfers were performed on Day 3 (70-72 hours post ICSI) or blastocyts on 
Day5/6 (84-96 hours post ICSI) - depending on each center’s preference.  All centers used 
a Wallace Trail, followed by a Wallace Sure View catheter, both under direct ultrasound 
guidance. 
 
Institutional Review 
Since January 2005, all embryos at SIRM clinics underwent routine sHLA-G assay/testing 
to determine the expression of this potential biochemical marker in the culture medium 
surrounding embryos.  All patients were counseled regarding the risks, benefits, and 
alternatives to sHAL-G testing; For the purpose of this PhD study, ethical approval was 
obtained from the Ethical committee of the University of Stellenbosch (N06/07/119).  
Furthermore, all clinical research conducted was in full compliance with guidelines of the 
American Society of Reproductive Medicine and met ethical principles involving human 
subjects as defined by the Declaration of Helsinki in 1964. 
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RESULTS 
 
The descriptive tabulations: Out of the 3036 women observed, the statistical analyses only 
include the 2040 women with a sHLA-G assay result. Table 3 provides a breakdown of the 
number of patients with a sHLA-G assay result by site. Table 4 provides their mean age, 
mean number of embryos, number of chemical pregnancies, clinical implantations, and on-
going pregnancies by site, day of transfer and sHLA-G asay result. As stated in the last 
row of Table 4, the mean age of patients included in the analysis was 35.8±1.46 years and 
the mean number of embryos utilized per patient, (across sites), were 2.7 ± 0.81 embryos. 
 
A mixed effects logistic regression model was fitted for each of the three outcomes; 
chemical pregnancy, clinical implantation, and on-going pregnancy. Each outcome was 
regressed against the sHLA-G assay result with mean age, mean number of embryos 
utilized per group, and day of transfer included as covariates in the analysis. Site was 
included as a random effect. Table 5 and Table 6 provide the results of these model-
fittings. 
 
All three models indicated that the sHLA-G assay results were associated with the 
outcome of a chemical pregnancy, clinical implantation, and on-going pregnancy. A 
positive sHLA-G result is associated with an increase in odds of a chemical pregnancy 
(OR: 2.47, 95% CI: 2.04 to 3.00, p-value: <0.0001), an increase in odds of a clinical 
implantation (OR: 2.60, 95% CI: 2.14 to 3.15, p-value: <0.0001), and an increased odds of 
an on-going pregnancy (OR: 3.27, 95% CI: 2.67 to 3.99, p-value: <0.0001). 
 
Two additional mixed effects logistic regression models were fitted for the dichotomous 
outcomes; multiple clinical implantations, and multiple on-going pregnancy subgroups. 
Each outcome was regressed against the sHLA-g assay result with mean age, mean 
number of embryos utilized per group, and day of transfer included as covariates in the 
analysis; site was included as a random effect. The multiple clinical implantations model 
only includes the 1027 patients for which a clinical implantation was reported (Table 7). 
The multiple on-going pregnancies model only includes the 924 women for which an on-
going pregnancy was recorded. (Table 8) The two models indicate that the sHLA-G assay 
result is associated with the outcome of multiple clinical implantations and multiple on-
going pregnancies. A positive sHLA-G result is associated with an increase in odds of 
multiple clinical implantations (OR: 1.48, 95% CI: 1.07 to 2.05, p-value: 0.0170), and an 
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increased odds of multiple on-going pregnancies (OR: 1.66, 95% CI: 1.10, 2.51, p-value: 
0.0170). 
 
DISCUSSION   
 
The statistical analysis of the data from 2040 patients in this retrospective multi-centre 
study indicated that a positive sHLA-G test result was statistically associated with an 
increase in chemical pregnancy, clinical implantations, and on-going pregnancy outcomes 
after adjusting for mean age, mean number of embryos utilized and day of transfer. 
Additionally, the positive sHLA-G test result was statistically associated with higher 
multiple clinical implantations and multiple on-going pregnancies.  A positive sHLA-G 
increased the odds of each of these mentioned outcomes. This current study confirms the 
observations of a prospective randomised controlled study by Kotze et al., 2010 
emphesizing the benefit of transferring sHLA-G positive embryos and thus predicting and 
increase pregnancy outcome in ART.  
 
The study has a few limitations. Firstly, this was a retrospective study.  Secondly, the 
majority of centres transferred embryos on Day 3, however, there were two of the six sites 
(FISCH and New Jersey (NJ) that transferred embryos on Day 5/6, therefore day of 
embryo transfer could not be differentiated in all sites. Thirdly, all centres used the same 
sHLA-G assay- however, each clinic applied their own range and threshold values (Table 
2). 
 
There has been some criticism of using the optical density (OD) value as our sHLA-G unit 
value; no previous reported studies (Fournel et al., 2000, Criscuoli et al., 2005, Noci et al., 
2005, Yie at al., 2005, Desai et al., 2006, Rebmann et al., 2005, 2007, Sargent et al., 2007 
and Vercammen et al., 2008), performing sHLA-G analysis have reached consensus on 
the appropriate way to report these results. Even though we would like to report our results 
as an internationally agreed upon unit, no such consensus exists. Other obstacles include 
a lack of commercially available and universally accepted standards in order to generate 
standard curves. Initially, we performed extensive studies and generated our own value 
range of OD=0.170 ± 0.210. With additional data, we expanded the range of positive 
expression to the range used in this study (OD=0.190 ± 0.006) to 0.210 OD. While the 
lower limit had high sensitivity, but the increased range improved the specificity of the test. 
This adjustment allowed for the addition to the “positive” value group, some embryos that 
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would have been considered “negative” but still resulted in an ongoing gestation. 
Furthermore, we have conducted several unpublished in house studies using commercially 
available kits and found that our mean value corresponded to approximately 4.6 ng, or 1 
“Unit” using the standard curve generated by the standards supplied in the commercial kit. 
In future studies, agreements and co-operation between established groups need to be 
reached in order to standardize the use of the sHLA-G assay successfully. Lastly, to 
assure accuracy daily controls were run using amniotic fluid (AF) from a pregnant woman 
as the sHLA-G positive control and culture medium as a negative control.   
 
It is important to note that in case of a positive sHLA-G, the number of embryos selected 
for transfer must be carefully considered since the data indicated an increase in odds of 
multiple clinical implantations. A positive sHLA-G result is associated with an increase in 
odds of multiple clinical implantations (OR: 1.48, 95% CI: 1.07 to 2.05, p-value: 0.0170) 
and an increased odds of multiple on-going pregnancies (OR: 1.66, 95% CI: 1.10, 2.51, p-
value: 0.0170). This is an important finding and in theory, transferring fewer embryos, 
selected based on sHLA-G results combined with morphologic evaluation can be used to 
reduce the risk of higher order pregnancies, without compromizing over all pregnancy 
rates.  
 
Additionally, the results of this retrospective study indicated that transferring embryos on 
Day 3 as opposed to Day 5/6 post-fertilization reduced the odds of a clinical implantation 
and on-going pregnancy. Since not all centers used the same stage at which to transfer 
their embryos, one can therefor not draw any final conclusion reagarding this observation. 
However, it is interesting to look at previosuly reported studies reporting on Day 4 vs 
Day5/6 embryos transfers. In 2000 Coskun reported on data form a randomised trial, 
comparing Day 3 vs Day 5 embryo transfer outcome, they concluded that Day 3 and Day 5 
transfer had similar pregnancy, implantation and twinning rates and therfore Day 5 
transfers have no advantages over Day 3 transfers.  Bungum et al., 2003 reported similar 
findings in a prospecive randomized study. In a COCHRANE review, Blake et al., 2007 
concluded that blastocyst transfer were significantly improving pregnancy rates compared 
to that of cleavage stage embryos and similar findings were also reported by Papanikolaou 
et al. 2008. 
 
This multi centre study indicates the benefit in the use of sHLA-G but the threshold values 
must be standardised. Clinics should consider this assay as a valuable non invasive 
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embryo marker to assist in improving pregnancy outcome and the theoretical potential to 
reduce multiple pregnancies.  A combination of sHLA-G expression and extended embryo 
culture to the blastocyst stage might provide future tools by which to select single embryos 
for transfer and reduce the risk of multiple pregnancies, without compromising the 
pregnancy rates. 
 
 
TABLE 1: GRADUATED EMBRYO SCORING (GES)OF CLEAVAGE STAGE EMBRYOS 
Evaluation  
Hours after 
insemination  Developmental milestone  Score   
    
1  16–18  Nucleoli aligned along pronuclear axis  20  
    
    
2  25–27  Cleavage regular and symmetrical Fragmentationa  30  
    
      Absent  30  
    
      <20%  25  
    
      >20%  0  
    
3  64–67  Cell number and gradeb 7CI, 8CI, 8CII, 9CI  20  
    
      7CII, 9CII, 10CI, 11CI, Compacting I  10  
    
Total score        100  
 
 
Fisch et al., Graduated embryo score (GES). Fertil Steril 2003. 
[a] If the embryo was not cleaved at 25–27 hours, grading of fragmentation should occur at the 64–67 
hour evaluation if the embryo reached the seven-cell stage and had <20% fragmentation. 
[b] Grade I = symmetrical blastomeres and absent fragmentation. Grade II = slightly uneven blastomeres 
and <20% fragmentation. Grade III = uneven blastomeres and >20% fragmentation. Grade A embryos 
are seven or more cells with <20% fragmentation. 
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TABLE 2:  SHLA-G RANGES USED BY EACH CLINIC  
CLINC sHLA-G range Testing Laboratory 
New Jersey 0.190 – 0.210 SIRM-NY 
Las Vegas (Fisch) 0.148 - 0.210 SIRM-LV 
Las Vegas (Sher) 0.150 – 0.210 SIRM-LV 
New York 0.190 - 0.210 SIRM-NY 
LA- Glenndale NEG ≤ 0.99 ≤  POS SIRM-LV 
Sacramento 0.184 - 0.196 SIRM-LV 
 
TABLE 3:  COUNTS OF INDIVIDUALS WITH A SHLAG TEST RESULT AT   
 EACH SITE 
Site 
sHLAg 
Total 
Negative Positive 
FISCH 85 259 344 
LA 65 93 158 
LV 150 237 387 
NJ 134 214 348 
NY 303 286 589 
SAC 94 120 214 
Total 831 1209 2040 
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TABLE 4:  MEAN AGE, MEAN NUMBER OF EMBRYOS, NUMBER OF CHEMICAL PREGNANCIES; CLINICAL PREGNANCIES AND 
  ON-GOING PREGNANCIES BY SITE, DAY, AND SHLAG TEST RESULT 
Site Day sHLAg Mean Age 
Mean number of 
Embryos 
Chemical 
Pregnancy† 
Clinical 
Implantation† 
Multiple 
Clinical† 
On-going 
Pregnancy† 
Multiple  
On-going† 
Total (n) 
FISCH 
  35.1 1.7 277 (80.5) 249 (72.4) 104 (41.8) 247 (71.8) 101 (40.9) 344 
Fifth 
 34.7 1.0 29 (87.9) 27 (81.8) 1 (3.7) 27 (81.8) 0 (0.0) 33 
Negative 35.5 1.0 5 (71.4) 4 (57.1) 0 (0.0) 4 (57.1) 0 (0.0) 7 
Positive 34.5 1.0 24 (92.3) 23 (88.5) 1 (4.3) 23 (88.5) 0 (0.0) 26 
Third 
 35.1 1.8 248 (79.7) 222 (71.4) 103 (46.4) 220 (70.7) 101 (45.9) 311 
Negative 34.7 2.0 55 (70.5) 46 (59.0) 22 (47.8) 44 (56.4) 22 (50.0) 78 
Positive 35.3 1.7 193 (82.8) 176 (75.5) 81 (46.0) 176 (75.5) 79 (44.9) 233 
LA Third 
 34.6 3.7 87 (55.1) 80 (50.6) 47 (58.8) 72 (45.6) 38 (52.8) 158 
Negative 33.9 3.8 33 (50.8) 31 (47.7) 15 (48.4) 27 (41.5) 9 (33.3) 65 
Positive 35.1 3.6 54 (58.1) 49 (52.7) 32 (65.3) 45 (48.4) 29 (64.4) 93 
LV Third 
 33.7 3.0 238 (61.5) 225 (58.1) 57 (25.3) 202 (52.2) 44 (21.8) 387 
Negative 33.1 3.1 57 (38.0) 49 (32.7) 14 (28.6) 44 (29.3) 7 (15.9) 150 
Positive 34.0 2.9 181 (76.4) 176 (74.3) 43 (24.4) 158 (66.7) 37 (23.4) 237 
NJ 
  36.8 1.7 143 (41.1) 136 (39.1) 55 (40.4) 125 (35.9) 48 (38.4) 348 
Fifth 
 36.9 1.6 90 (42.9) 88 (41.9) 34 (38.6) 78 (37.1) 29 (37.2) 210 
Negative 37.2 2.0 37 (37.0) 35 (35.0) 13 (37.1) 32 (32.0) 10 (31.3) 100 
Positive 36.7 1.3 53 (48.2) 53 (48.2) 21 (39.6) 46 (41.8) 19 (41.3) 110 
Third 
 36.6 1.7 53 (38.4) 48 (34.8) 21 (43.8) 47 (34.1) 19 (40.4) 138 
Negative 39.0 2.2 8 (23.5) 8 (23.5) 1 (12.5) 7 (20.6) 0 (0.0) 34 
Positive 35.8 1.6 45 (43.3) 40 (38.5) 20 (50.0) 40 (38.5) 19 (47.5) 104 
NY Third 
 37.5 3.3 282 (47.9) 248 (42.1) 53 (21.4) 206 (35.0) 26 (12.6) 589 
Negative 38.0 3.0 119 (39.3) 101 (33.3) 13 (12.9) 65 (21.5) 4 (6.2) 303 
Positive 37.0 3.6 163 (57.0) 147 (51.4) 40 (27.2) 141 (49.3) 22 (15.6) 286 
SAC Third 
 35.2 3.6 102 (47.7) 88 (41.1) 31 (35.2) 72 (33.6) 26 (36.1) 214 
Negative 35.1 3.7 30 (31.9) 23 (24.5) 5 (21.7) 8 (8.5) 3 (37.5) 94 
Positive 35.2 3.5 72 (60.0) 65 (54.2) 26 (40.0) 64 (53.3) 23 (35.9) 120 
Grand Total 35.8 2.7 1129 (55.3) 1026 (50.3) 347 (33.8) 924 (45.3) 283 (30.6) 2040 
† count (percentage of total) 
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TABLE 5:  MIXED EFFECTS LOGISTIC REGRESSION FOR THE OUTCOMES: CHEMICAL PREGNANCY, CLINICAL  
  IMPLANTATION, ON-GOING PREGNANCY 
 Chemical Pregnancies Clinical Implantations On-going Pregnancies 
Fixed Effects  Estimate Lower CI 
Upper 
CI 
P-value Estimate Lower CI 
Upper 
CI 
P-value Estimate Lower CI 
Upper 
CI 
P-value 
Mean Embryo -0.09 -0.44 0.26 0.6100 -0.06 -0.40 0.28 0.7160 0.13 -0.27 0.53 0.5200 
Mean Age 0.05 -0.13 0.22 0.6000 0.06 -0.12 0.25 0.4890 -0.03 -0.21 0.16 0.7760 
Day (3rd) -0.33 -0.75 0.09 0.1270 -0.43 -0.85 -0.02 0.0420 -0.47 -0.90 -0.04 0.0340 
sHLAg (Positive) 0.91 0.71 1.10 <0.0001 0.95 0.76 1.15 <0.0001 1.18 0.98 1.38 <0.0001 
Intercept -1.41 -8.06 5.23 0.6770 -2.27 -9.08 4.55 0.5150 0.10 -7.07 7.27 0.9780 
Random Effects  Estimate Lower CI 
Upper 
CI 
 Estimate Lower CI 
Upper 
CI 
 Estimate Lower CI 
Upper 
CI 
 
Site 0.36 0.00 0.81  0.29 0.00 0.69  0.32 0.00 0.78   
 
 
 
TABLE 6:  MIXED EFFECTS LOGISTIC REGRESSION FOR THE OUTCOMES: CHEMICAL PREGNANCY, CLINICAL  
  IMPLANTATION, ON-GOING PREGNANCY 
 Chemical Pregnancies Clinical Implantations On-going Pregnancies 
Fixed Effects  Odds Ratio Lower CI Upper CI Odds Ratio Lower CI Upper CI Odds Ratio Lower CI Upper CI 
Mean Embryo 0.91 0.65 1.29 0.94 0.67 1.32 1.14 0.76 1.70 
Mean Age 1.05 0.88 1.25 1.07 0.89 1.28 0.97 0.81 1.17 
Day (3rd) 0.72 0.47 1.10 0.65 0.43 0.98 0.63 0.41 0.96 
sHLAg (Positive) 2.47 2.04 3.00 2.60 2.14 3.15 3.27 2.67 3.99 
Random Effects  Median Odds Ratio Lower CI Upper CI Median Odds Ratio Lower CI Upper CI Median Odds Ratio Lower CI Upper CI 
Site 1.77 1.00 2.36 1.68 1.00 2.21 1.72 1.00 2.32 
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TABLE 7:  MIXED EFFECTS LOGISTIC REGRESSION FOR THE OUTCOMES: MULTIPLE CLINICAL IMPLANTATIONS,  
   AND MULTIPLE ON-GOING PREGNANCIES 
 Multiple Clinical Implantations Multiple On-going Pregnancies 
Fixed Effects  Estimate Lower CI Upper CI P-value Estimate Lower CI Upper CI P-value 
Mean Embryo 0.41 -0.25 1.08 0.2250 0.35 -0.50 1.19 0.4210 
Mean Age -0.12 -0.37 0.14 0.3600 -0.05 -0.34 0.24 0.7360 
Day (3rd) 0.63 0.02 1.25 0.0430 0.72 0.04 1.39 0.0370 
sHLAg (Positive) 0.40 0.07 0.72 0.0170 0.51 0.09 0.92 0.0170 
Intercept 1.66 -7.78 11.09 0.7300 -0.98 -11.60 9.64 0.8560 
Random Effects  Estimate Lower CI Upper CI  Estimate Lower CI Upper CI  
Site 0.56 0.00 1.43  0.74 0.00 1.91  
 
  
 
TABLE 8:  MIXED EFFECTS LOGISTIC REGRESSION FOR THE OUTCOMES: MULTIPLE CLINICAL IMPLANTATIONS,  
  AND MULTIPLE ON-GOING PREGNANCIES 
 Multiple Clinical Implantations Multiple On-going Pregnancies 
Fixed Effects  Odds Ratio Lower CI Upper CI Odds Ratio Lower CI Upper CI 
Mean Embryo 1.51 0.78 2.95 1.41 0.61 3.27 
Mean Age 0.89 0.69 1.15 0.95 0.71 1.27 
Day (3rd) 1.88 1.02 3.48 2.05 1.05 4.01 
sHLAg (Positive) 1.48 1.07 2.05 1.66 1.10 2.51 
Random Effects  Median Odds Ratio Lower CI Upper CI Median Odds Ratio Lower CI Upper CI 
Site 2.04 1.00 3.12 2.27 1.00 3.74 
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CHAPTER 5: 
 
A linear karyotypic association between PB-I, PB-II and blastomere 
using sequentially performed comparative genome hybridisation (CGH) 
with no association established between karyotype, morphologic, 
biochemical (sHLA-G-expression) characteristics, blastocyst formation 
and subsequent pregnancy outcome 
 
ABSTRACT 
 
Background 
The importance of oocyte/embryo ploidy to achieve implantation and a subsequent 
pregnancy.   
 
Aim 
To correlate first and second polar bodies and Day 3 blastomere ploidy, embryo 
morphology and biochemical (sHLA-G) characteristics with blastocyst development and in 
vitro pregnancy outcome. 
  
Materials and Methods 
All oocytes/zygotes and embryos were individually cultured to the blastocyst stage.  PB-I, 
PB-II and blastomeres underwent complete karyotyping and sHLA-G expression was 
measured on day 2. 
  
Results 
Fifty seven mature (MII) donor oocytes were obtained, 33/57 (57.9%) were aneuploid, 
21/57 (36.8%) were euploid and 3/57 (5%) were “inconclusive”. No correlation was found 
between CGH status of PB-I, PB-II and the GES-score.  Furthermore, no correlation was 
established between PB-I CGH results and blastocyst morphology grade.  There was a 
significant correlation between PB-I CGH and blastomere CGH results.  Euploid and 
aneuploid PB-I developed into 58% and 67% blastocysts, respectively. Kappa statistics 
(>0.7) revealed a positive correlation between the ploidy of PB-I, PB-II and the 
blastomeres. 
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INTRODUCTION 
 
Several factors are involved in achieving successful embryo implantation and a 
subsequent pregnancy. Poor embryo quality (Alikani et al., 1999) and transfer techniques 
(Schoolcraft et al., 2001), endo-uterine abnormalities and immunologic dysfunction (Sher 
et al., 2000) can lead to implantation failure.  Non-invasive methods such as embryo 
morphology/scoring and extended embryo culture to the blastocyst stage have been 
proposed to select embryos for transfer that will implant and result in a live pregnancy. 
Furthermore, a biochemical marker – soluble human leukocyte-antigen-G expression 
(sHLA-G) - major histocompatability complex - by embryos in culture has been suggested 
by several researchers to improve assisted reproductive technology (ART) outcome.   
 
However, all the above-mentioned criteria provide no information about the chromosomal 
status (ploidy) of an embryo, which is of utmost importance because certain chromosomal 
aberrations in the embryo might contribute to in vitro fertilization (IVF) failure, (Pehlivan et 
al., 2003). Early studies using preimplantation genetic screening with fluorescent in situ 
hybridization (PGS-FISH) have demonstrated that ≥50% of embryos considered for 
transfer during IVF were aneuploid (Munné et al., 1993). In the past, FISH has been the 
most common method used for analyzing polar body (PB) and blastomere chromosomal 
complements.  Initially it was suggested that the transfer of “chromosomally normal” 
embryos after PGS-FISH would lead to improved implantation and pregnancy rates. 
However, recent publications (Harton et al., 2011), ESHRE PGD Consortium Steering 
Committee-2010) have concluded otherwise. One of the shortfalls associated with FISH in 
a PGS setting is the limited number of chromosomes that can be analyzed simultaneously; 
this is due to the number of fluorochromes available. Therefore, since FISH only screens 
up to 12 chromosomes, it limits the screening of the entire human genome, consisting of 
23 chromosome pairs of which 22 chromosomes are autosomal chromosomes and the 
remaining pair is sex-determining (X, Y). Other potential problems like mosaicism is still an 
issue when performing Day 3 biopsies, (although mosaicism has been detected at later 
developmental stages), as well as the removal of more than one blastomere, leaving less 
of the remaining embryo. Studies have been reported where PGS-FISH was performed on 
polar bodies using a limited number of probes (Verlinsky et al., 1990; Kuliev et al., 2003). 
Comparative genomic hybridization (CGH) is another method for identifying 
oocyte/zygote/embryo chromosomal aberrations. The first studies using PB-CGH reported 
by Wells et al., 2002; Gutierrez-Mateo et al., 2004 and Fragouli et al., 2006 failed to 
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demonstrate any promise of practical clinical utility. It was not until Sher et al. 2007 
reported the first clinical application of CGH performed on both PB-I and PB-II. The same 
research group reported on the positive correlation between the transfer of euploid 
embryos (based on CGH performed on Day 3 blastomeres) and IVF outcome (Sher et al., 
2009).  The advantage of CGH is that the entire chromosomal complement/genome is 
analyzed. However, a downside is that polyploidy and balanced translocations cannot be 
detected reliably using mCGH as described by Kallioniemi et al., 1992, and Kirchoff et al., 
2001.  Furthermore, an initial disadvantage of CGH was that the procedure took about 72 
hours to perform.  Originally it was applied to polar bodies, leaving 5 days for analysis and 
allowing for a fresh embryo transfer, without having to cryopreserve the embryos prior to 
transfer. When blastomere biopsies were performed on Day 3 embryos (6-9 cell), the 
resulting blastocysts were individually cryopreserved/vitrified and transferred in a later 
cycle if identified as normal by Sher et al. 2009. 
 
The aim of this study is to correlate PB-I, PB-II and Day 3 blastomere ploidy, morphologic 
and biochemical (sHLA-G expression) characteristics with blastocyst development in vitro 
and pregnancy outcome. 
 
MATERIALS AND METHODS 
 
Patients 
Oocyte donors for this study were five healthy, young (≤28 years of age), consenting 
patients without reproductive problems.  Sperm from proven donors (with a record of 
successfully fathering a pregnancy) were obtained from Cryogam bank (Cryogam, CO). All 
donors were appropriately screened for infectious and sexually transmitted diseases and 
for auto-immune parameters that might adversely affect embryo implantation.  
 
Embryo Culture:  Embryology data collection: All oocytes collected were kept in 
chronological sequence and were individually cultured in 100 µl modified human tubal fluid 
(mHTF) + 10% HSA, under oil at 37 °C. All oocytes were denuded immediately after 
retrieval and graded (modification of Xia et al., 1997) (Table 1). PB-1 was micro-surgical 
removed and underwent whole genome amplification (WGA), followed by complete 
karyotyping using metaphase comparative genome hybridization (CGH). All mature 
oocytes (M II) were fertilized  by intracytoplasmic sperm injection (ICSI) and sequentially 
cultured in 50 µl droplets of Quinn’s Advantage Protein Plus Cleavage medium (In-vitro 
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fertilization, Inc., Trumbull, CT) under oil at 6% CO2, 5% O2 and 90% N2, 37°C in a 
humidified environment. On day 1 fertilization was assessed 16-18 hours post-ICSI, at 
which time alignment of the nucleoli was documented, and subsequently signs of cleavage 
at 26 hours post-ICSI. At this time PB-II was micro-surgically removed from normally 
fertilized (2PN) oocytes and underwent WGA/CGH karyotyping. On day 2 (at 46 hours 
post-ICSI the embryos were moved into 50 µl droplets of Multi Blastocyst medium (Global 
one, IVF Online) + 10% SSS (Irvine Scientific, Santa Ana, CA). The original droplets of 
culture medium surrounding each individual embryo were collected and tested for sHLA-G 
expression, using a specific enzyme linked immunosorbent assay (ELISA). Embryos with 
an optical density (O/D) range of 0.190±0.006 were considered “positive’ for the 
expression of sHLA-G.  Each individually cultured embryo was evaluated at 72 hours post-
ICSI – applying a graduated embryo Score (GES) described by Fisch et al. 2001 /2003 
(GES-score Table 2). Then, a single mono-nucleated blastomere was micro-surgically 
removed from each cleaved embryo and underwent WGA/CGH karyotyping. All embryos 
were cultured to the blastocyst stage and graded, using a modified version of Dokras et 
al.’s 1993 procedure, (Table 3), and vitrified.  
 
Blastocyst Vitrification and Warming 
 
Vitrification: was done by modifying the method previously described by Mukaida et al. 
2003. This modified technique involved the use of an ICSI needle as follows: About 10 
minutes prior to vitrification, expanded blastocysts were placed in 50 µl drops of mHTF 
with 10% SSS, vol/vol (Irvine Scientific).  Each blastocyst had its blastocoels artificially 
collapsed through assertive needle aspiration.  The inner cell mass (ICM) was positioned 
at the 6 or 12 o’clock position using a holding pipette connected to a micromanipulator. A 
30° ICSI needle was then introduced via the cellular junction of the trophectoderm into the 
blastocoel cavity and the fluid was aspirated until the blastocyst had completely collapsed 
and no blastocoel fluid remained (Mukaida et al., 2001, 2003).  Blastocysts were then 
placed in 0.5 ml of mHTF (Base solution; IVF Online) supplemented with 10% (vol/vol) 
SSS for 2) minutes at 37°C.  Thereafter, blastocysts were placed in base solution + 0.96 
mol/l DMSO (D 5879, Sigma, St. Louis, MO) + 1.2 mol/l ethylene glycol (EG; P 3265, 
Sigma) for 90 seconds. Finally, blastocysts were placed in base solution + 1.9 mol/l DMSO 
+ 2.4 mol/l EG + 1 mol/l sucrose (S 7903, Sigma) + 0.1 mol/l Ficoll (F 8636, Sigma) for 30 
seconds. Then, each blastocyst was individually placed onto a cryo-loop (Hampton 
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Research, CA) using 1-2 µl cryo-solution and plunged into liquid nitrogen. Blastocyst 
grading applied: see Table 3    (Blastocyst grading)  
 
Warming: The cryo-loop was removed from its vial and immersed into base solution + 0.34 
mol/l sucrose for 2 minutes at 37°C. The embryo was then moved to base solution + 0.17 
mol/l sucrose for 3 minutes and finally placed in base solution for 5 minutes. Intact 
embryos were cultured in 50 µl of Global One medium at 37°C in 6% CO2 for a minimum 
of 2 hours to evaluate blastocoel re-expansion (i.e. survival). 
 
Recipient Hormonal Treatment and Embryo Transfer: Following the onset of birth control 
pill-induced menstruation, oestradiol valerate IM (4-8mg) was administered every 3 days 
for a period of 8-12 days, until endometrial thickness had reached > 8 mm in sagital 
diameter and the plasma [E2] had stabilized at 1300-3000 Pmol/l. At that point, daily IM 
injections of 100 mg progesterone in oil (PIO) were initiated. On the 6th day of PIO, subject 
to patient choice and availability, two (2) thawed/warmed blastocysts were cryo-
transferred, using ultrasound guidance and an echogenic catheter (Wallace, Smith 
Medical, UK).  Serum beta human chorionic gonadotropin (β-hCG) levels were measured 
8-10 days after the transfer. The patient was considered biochemically pregnant when the 
first value was >5.0 IU and the next value 2 days later was double the first.  Clinical 
pregnancy rates were based on a 6-week ultrasound scan detecting a gestational sac 
containing a fetal heartbeat.  In the event of an ultrasound-confirmed pregnancy, an 
estrogen/progesterone supplementation regimen was continued.  Ongoing pregnancy 
rates were based on a 10–12-week ultrasound examination.  In all cases where pregnancy 
did not occur or did not survive, hormonal treatment was immediately stopped. 
 
Each blastocyst was referenced back to its oocyte, zygote and embryo of origin. All clinical 
procedures were performed by the same physician and laboratory procedures were 
performed by the same embryologist.  
 
Stimulation  
 
Patients received Lupron (TAP Pharmaceuticals, Lake Forest, IL) in a long  
protocol after pre-treatment with oral contraceptive (OC) birth control pills for 1-3 weeks 
and were treated with a human-derived gonadotropin (Bravelle; Ferring Pharmaceuticals 
Inc, Suffern, NY) in order to stimulate follicular development in the ovaries. Ovulation was 
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triggered when at least two follicles were 18 mm and half of the remaining were 15 mm. 
Oocytes were retrieved transvaginally using ultrasound guidance at 35 hours post hCG.  
 
Extraction and Amplification of Genomic DNA  
 
Genomic DNA was obtained by laser dissection and needle aspiration from three sources: 
the oocyte’s first polar body (PB-I), zygote’s second polar body (PB-II), and subsequent 
Day 3 embryo’s blastomere. The cellular material was aspirated into a 200 µl thin-walled 
PCR tube (VWR catalog, 82006-602) for lyses and amplification using the Qiagen Repli-g 
kit (catalog, 59045). Ten ng of Repli-g control genomic DNA was used as a positive control 
and 0.5 µl of nuclease-free water as a negative control (Eppendorf catalog, 955155017). 
The reactions were set up following the Repli-g protocol and incubated for 8 hours at 30°C 
for amplification, followed by 10 minutes at 70°C for enzyme inactivation. Both incubation 
steps were performed using an Applied Biosystems 2720 Thermal cycler. Amplified DNA 
was placed at either 4°C for short-term storage or at -20°C for long-term storage.  
 
Genomic DNA Confirmation and Quantification  
 
For confirmation of WGA products, 5 µl reaction aliquots were mixed with 1 µl 6X Blue-
Orange Loading Dye (Promega # G1881) and electrophoresed through a 1.0% agarose 
gel containing 0.1% ethidium bromide in TBE buffer (90mM Tris-HCl, 90 mM boric acid 
and 2 mM EDTA, pH 8.0). For quantification of the genomic DNA, 5 µl reaction aliquots 
were diluted with 95 µl of molecular biology-grade, nuclease-free water and analyzed with 
an Eppendorf BioPhotometer.  
 
Nick Translation of Genomic DNA  
 
The WGA products were fluorescently labeled using the Vysis Nick Translation Kit 
(catalog, 32-801024). One µg genomic DNA for each sample was labeled with 
SpectrumGreen™ direct-labeled dUTP by nick translation, following the Vysis protocol.  
Translation reactions were carried out using an Applied Biosystems 2720 Thermal cycler 
at 15°C for 2 hours and 70°C for 10 minutes to stop the reaction. The size of the resulting 
SpectrumGreen™ labeled probes was assessed by electrophoresis of 5 µl aliquots of 
1.0% agarose gel containing 0.1% ethidium bromide in TBE buffer (90 mM Tris-HCl, 90 
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mM boric acid and 2 mM EDTA, pH 8.0). Probes of usable quality were in the range of 300 
- 3000 bp, as per the manufacturer’s recommendation. 
  
Probe Preparation and Comparative Genomic Hybridization 
 
The SpectrumGreen™ labeled probes were purified by ethanol precipitation. Briefly, 10 
µl/200 ng nick-translated reference DNA, 1 µl/100 ng SpectrumRed reference DNA (Vysis 
# 32-80423 or 32-804024), and 10 µl/ 10 µg Cot-1 DNA (Vysis # 32-800028) used to 
suppress repetitive sequences and prevent non-specific hybridization, were added to a 1.5 
ml micro-centrifuge tube.   
 
For precipitation of the hybridization mix, 2.1 µl (0.1 volume) 3M sodium acetate, followed 
by 52.5 µl (2.5 volumes) of 100% EtOH was added to the DNA, vortexed briefly and placed 
on dry ice for 15 minutes, then centrifuged at 12 000 rpm for 30 minutes at 4°C to pellet 
the DNA. The supernatant was removed and the pellet dried for 10–15 minutes under a 
vacuum at ambient temperature. The pellet was resuspended in 3 µl molecular biology 
grade water and 7 µl CGH hybridization buffer (Vysis # 30670003) and placed in the dark 
during slide preparation.  CGH-normal metaphase slides (Vysis # 30-806010) were 
prepared following the manufacturer’s protocol. Briefly, the slides were denatured in 70% 
formamide, 10% SSC pH 5.3, and 20% molecular biology grade water for 5 minutes at 
73°C for 5 minutes followed by an ethanol dehydration series of a minute each (70%, 85%, 
and 100%).  The slides were dried by touching the bottom edge to a blotter and wiping the 
underside with a paper towel, then placed on a 45–50°C slide warmer to allow remaining 
EtOH to evaporate. The probe mix was denatured by heating for 5 minutes in a 73°C water 
bath. Ten µl of the probe mix was applied to the slides. The coverslip was placed over the 
slide and sealed with diluted rubber cement. The hybridizations were carried out with Vysis 
Hybrite chambers for a minimum of 48 hours and a maximum hybridization time of 72 
hours to clear background. Following hybridization, the cover slips were carefully removed 
along with any remaining rubber cement residue, taking care not to damage the slide 
surface. The slides were then agitated in 0.4X SSC/0.3% NP-40 wash solution at 74+1°C 
for 1-3 seconds, then let stand for 2 minutes, then agitated in 2X SSC/0.1% NP-40 at 
ambient temperature for 1-3 seconds, then let stand for 1 minute. The slides were allowed 
to dry vertically at ambient temperature in the dark. Once completely dry, 10 µl DAPI II 
counter stain (Vysis 30804931) was added to each side, followed by a cover slip, and 
immediately sealed with clear non-fluorescing fingernail polish. Keskintepe et al., 2007 
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collected and validated results from first, second PB’s and two blastomeres and reported a 
positive/negative occurrence of less that 10%. 
  
Image Capture and Analysis  
 
The following optical filters visualized the fluorochromes used in the hybridization: a filter 
set specific for DAPI, Texas Red® (Cat. No. 30-150491) and FITC (fluorescein 
isothiocyanate) (Cat. No. 30-150291) to view the counter stain, SpectrumRed or 
SpectrumGreen DNA, respectively, a triple band pass filter set designed to simultaneously 
excite and emit light specific for DAPI.  
 
Soluble HLA-G Assay 
 
A monoclonal antibody (mAb; MEM-G9 MCA 2044; Serotec, Raleigh, NC against sHLA-G 
was used to coat a 96-well Nunc-Immunoplate (Fisher Scientific, Chino CA) using a 
concentration of 2 µg/ml in 0.1 mol/l carbonate buffer at pH 9.5 for 1 hour at 37ºC. The 
plate was then refrigerated overnight at 4ºC. On the following day, the plate was 
thoroughly washed using 100 µl of phosphate-buffered saline (PBS) and 0.05% Tween 20. 
The wash was repeated twice using 100 µl PBS and 5% bovine serum albumin (BSA) for 
15 minutes each. A 50 µl aliquot of PBS and 5% BSA was added to each well before 
adding the sample of 50 µl of embryo supernatant. Amniotic fluid (AF) was used as a 
positive control. AF (50 µl) and 50 µl of pure blastocyst culture media (Irvine Scientific) in 
which no embryos had been cultured (the negative control) were incubated for a period of 
1 hour at 37ºC. After incubation, the plates were washed three times with PBS, followed by 
incubation with a specific biotin conjugated mAB (w6/32 MCA81B; Serotec) at a 1:1000 
dilution in PBS and 1% BSA for 45 minutes at 37ºC and then washed five times with PBS. 
Streptavidin alkaline phosphatase conjugated (BD Bioscience Pharmigen, San Diego, CA) 
at a concentration of 1:1000 in carbonate buffer was incubated for 30 minutes at 37ºC and 
washed five times with PBS, after which phosphatase substrate was added at a 
concentration of 1 mg/ml in 10% diethanolamine at pH 9.8 for 30 minutes. The colorimetric 
reaction was then stopped by the addition of 50 µl of 3 mol/l NaOH. The sHLA-G 
concentration was determined by absorbance at 405 nm on the EL800 Universal 
Microplate Reader (Bio-Tek Instruments Inc., Winooski, VT). 
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Statistical analysis 
 
Fisher’s exact test was used to test for association between two categorical studied 
variables. The small marginal totals for some levels of the categories variables necessitate 
the use of this test. The agreement between the PB-I and PB-II and blastocyst was 
evaluated through the kappa statistic. The median levels of expression of sHLA-G for the 
categories of oocyte grade, PB-I, PB-II and blastocyst grade were calculated together with 
the interquartile range (IQR). To compare the median levels of sHLA-G between the levels 
of these variables two statistical methods were used. Since oocyte grade has a strict 
ordinal structure the estimation and testing of the Spearman correlation coefficient 
between sHLA-G and oocyte grade is an optimal test for the hypothesis of no difference in 
median sHLA-G levels across the categories of oocyte grade. For the remaining variables 
a Kruskal-Wallis test (non-parametric analysis of variance) was performed for the 
comparison of the median levels of soluble sHLA-G. 
 
RESULTS  
 
Fifty-seven (57) oocytes from donors (≤28 years of age) were studied. The indication was 
that the majority of oocytes were aneuploid - CGH results for meiosis I of PB-I tested 
revealed that 21/57 (36.8%) were euploid, 33/57 (57.9%) aneuploid and 3/57 (5.2%) 
inconclusive (INC).  Furthermore, CGH results for meiosis II of the PB-II tested revealed 
that 25/57 (44.0%) were euploid, 27/57 (47.4%) were aneuploid and 5/57 (9.0%) were 
inconclusive (INC).   All Day 3 embryos underwent biopsy – removing a mono-nucleated 
blastomere.  Forty-five of 57 embryos had ≥ 7 blastomeres and were categorized grade 1 
or 2 (78.9%).  CGH results for mitosis (Day 3 mono-nucleated blastomeres) revealed that 
23/57 (40.4%) were normal, 31/57 (54.4%) were abnormal and 3/57 (5.3%) were 
inconclusive (INC):  The results were reported as inconclusive as a result of no cell, no 
amplification or no clear fluorescent staining/ no interpretation. 
     
Metaphase II oocytes were also graded, using light microscopy, the best quality was grade 
1 and poorest quality was grade 3 (Table 1).  There were 33 aneuploid oocytes – 18/54 
(54.5%) originated from grade 1 (best quality) oocytes, the remaining 15 (45.5%) 
originated from grade 2/3 (poorer quality) oocytes. Furthermore, there were 21 euploid 
oocytes – 8/21 originated from grade 1 (best quality) oocytes (38.1%) and the remaining 
13 (61.9%) originated from grade 2/3 (poorer quality) oocytes.  No association was found 
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between the best oocytes - grade 1 (highest quality) - and euploid chromosomal 
compliment of PB-I (Fisher’s exact: p=0.758). Furthermore, there was no association 
between oocyte grade and euploid chromosomal compliment of PB-II (the same as for PB-
I). The majority of embryos were abnormal across all initial grades (Fisher’s exact: p= 
0.548). 
 
There was no association between an oocyte’s grade/quality and subsequent blastomere 
biopsy’s CGH results.  The majority of blastomeres were aneuploid. Sixty one percent 
(61%) of the embryos that originated from the so called “best” quality oocytes were 
aneuploid and 58% of the embryos that originated from average/poor (grade 2/3) oocytes 
were euploid as revealed by the CGH results from the blastomere biopsies (Fisher’s exact: 
p = 0.233). However, our data showed there was a significant agreement between the 
CGH results of PB-I and PB-II, respectively, Kappa=0.72 (se=0.11, p<0.0001), indicating 
that PB-I and PB-II provided nearly the same information regarding their ploidy status. 
Furthermore, there was a significant agreement between PB-I and the blastomere biopsy 
CGH results. These two parameters also provide nearly the same information regarding 
their ploidy status, with Kappa=0.84 (se=0.12, p<.0001).  Interestingly, no association was 
observed between the CGH results of PB-I and subsequent blastocyst grade. The 
agreement between PB-II and the blastomere biopsy was similar to that of BP-I with 
Kappa=0.75 (se=0.11, p<.0001). There was no association between PB-II and subsequent 
blastocyst development. In both PB-II categories, euploid or aneuploid oocytes developed 
into about the same ratio of blastocysts. Interestingly, in cases where PB-I was euploid, 
58% reached the blastocyst stage, and where PB-I was aneuploid, 67% reached the 
blastocyst stage. Furthermore, in cases where blastomeres were euploid, 62% reached 
the blastocyst stage, and where blastomeres were aneuploid, 58% reached the blastocyst 
stage, indicating a lack of association (Fisher’s exact p=0.923). The findings were similar 
when the blastomere CGH results were correlated with blastocyst formation (Fisher’s 
exact p= 0.770).  
 
There was no difference in the mean expression of sHLA-G between the categorical levels 
of PB-I, PB-II and blastocyst grade. However, oocyte grade and sHLA-G expression was 
negatively correlated, with Spearman’s correlation coefficient = -0.27 (p=0.0432). This is a 
weak correlation but reflects that the poorest oocyte grade had the highest expression 
(mean sHLA-G OD = 0.170 ± 0.04) compared to best oocyte grade with lower expression 
(mean sHLA-G OD=0.150 ± 0.03).  The data for all 57 oocytes and their chromsomal 
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status of PB-I, PB-II, Day 3 blastomere’s and sHLA-G respectively are presented in Table 
4. Implantation/pregnancy outcome of vitrified/warmed blastocyst were 50% implantation, 
80% pregancy, three set of singletons and one set of twins  
(Table 5).   
 
DISCUSSION 
 
Identifying euploid embryos prior to transfer in order to reduce the number of embryos for 
transfer, without sacrificing pregnancy rate and at the same time reducing high order 
multiple gestations have been of great interest to researchers. In our study we attempted 
to correlate the chromosomal status for PBl, PBll and blastomere, oocyte grading, embryo 
morphology score (GES) and sHLA-G (a biochemical embryo marker) in order to find any 
characteristic that could be used to assist in identifying/estimating of an embryo's viability 
and potential to develop into a live baby  We used 57 Mature (MII) oocytes obtained from 
oocyte donors and fertilized with proven sperm donors to study their chromosomal status 
by CGH, and resulting “normal” blastocysts were followed to determine if a live birth was 
obtained. The sequential chromosomal status of PBI, PBII and blastomere, respectively, 
was screened for by metaphase CGH. The rate of aneuploidy in PB I and II was 53% in all 
oocytes and 54% in subsequent Day 3 embryos. A further breakdown indicated that the 
aneuploidy rates for PB I (meiosis I) and PB II (meiosis II) were 58% and 47%, 
respectively. Any difference in ploidy between an oocyte’s PB I and PB II could possibly be 
due to a rescue/correction mechanism, mosaicism, and malsegregation or cross-over 
errors during prophase I as described by Schmerler et al. 2011, or non-disjunction and 
premature separation as illustratrated by Vialard et al., (2006) (Figure 1, p.170).  Kuliev et 
al. 2011 also speculated that missing signals might be due to the hybridization failure that 
can lead to misinterpretation.  
 
Fragouli et al., 2009 reported overall aneuploidy of 65% in oocytes after CGH testing was 
performed. A further breakdown indicated that the aneuploidy rates for PB I (meiosis I) and 
for PB II (meiosis II) were 36 and 46%, respectively.  These results support the findings in 
our study regarding the genetic status of PB I and PB II. However, in another study by 
Fragouli et al., 2009b they reported only 3% aneuploidy when young oocyte donors 
underwent PB I CGH testing – these results contradict the findings in our study: we 
reported 58% of oocytes obtained from young egg donors were abnormal. Statistical 
analysis in the present study revealed that the correlation found between PB I, PB II and 
Stellenbosch University  http://scholar.sun.ac.za
163 
  
blastomere chromosomal results is good (Kappa >0.7 for all three pair-wise comparisons). 
Therefore they could be used as a proxy for one another. However, we did find a negative 
association between embryo morphologic quality and corresponding genetic status of 
embryos on day 3. Baltaci et al., 2006 reported that when embryo quality at the cleavage 
stage was correlated with chromosomal abnormalities, the morphological assessment 
might not reflect the chromosomal status of the embryo, because among the aneuploid 
embryos considerably high proportions were morphologically good quality, confirming our 
findings. We, therefore, suggest that an embryo’s morphology can not be correlated with 
its ploidy prior to transfer. This supports data by Munné et al., 2007 suggesting that the 
best way to select euploid embryos for transfer is to use a combination of both 
morphologic and genetic testing.  We reported that 31/50 (62%) of abnormal Day 3 
embryos developed into blastocysts.  Our data indicated that there was no association 
between the expression of sHLA-G and embryo ploidy.  In our study we reported a 
significant positive association between PB I and blastomere ploidy which furthermore 
confirms that sperm derived from young healthy donors likely contributes very little to any 
additional aneuploidy after fertilisation.  Magli et al. 2004 concluded that the major 
application of PB biopsy is the detection of maternally derived chromosomal aneuploidies 
and translocations in oocytes, and could be applied as a viable alternative to blastomere 
biopsy.  In a large study by Li et al. 2005, 42% embryos were screened for 16, 18, 21 and 
XY and underwent extended culture to the blastocyst stage and 20% progressed to the 
blastocyst stage. After re-testing of the blastocyst’s chromosomal complement, 61% were 
confirmed abnormal.  This study confirms the similar high percentage of blastocyst 
aneuploidy as reported in our study. 
 
Interestingly, Hassold and Jacobs 1984 reported that at least 50% of first trimester 
spontaneous miscarriages were chromosomally abnormal. Veiga et al., 1987 reported that 
26% of oocyte and zygote were aneuploid by FISH.  Munné et al. 1993 reported 
aneuploidy to be the most prominent chromosome anomaly found in normally developing 
monospermic embryos.  Several other researchers (using FISH) have reported oocyte 
aneuploidy rates in excess of 50% in women older than 40 years of age (Sandalinas et al., 
2002, Kuliev et al., 2003, Gutierrez-Mateo et al., 2004, Fraguoli et al., 2006 and Hassold et 
al. 2007). Gutierrez-Mateo et al. 2004 reported 48% aneuploidy after CGH was performed 
on PB I. Montag et al. 2009 concluded that the detection of the paternal influence on the 
genetic constitution of the embryo is not possible with PB diagnosis. However, PB 
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diagnosis can be applied in cases of monogenetic diseases, as well as cases of maternal 
structural and numerical chromosome aberrations. 
 
In all the above cases – only a limited number of chromosomes were evaluated, (about 
one-quarter of the genome) – leaving three-quarters untested. This leads to the 
assumption that several “normal” embryos could have been aneuploid if the whole genome 
was screened.  The conclusions drawn from these studies were based on incomplete 
genetic screening of embryos.  The most recent study reported was a poster presentation 
at 2011 ESHRE, Magli et al. 2011 reported that 5 chromosomes (13, 16, 18, 21, and XY) 
were analyzed and 50% were aneuploid. Furthermore, they reported that PB I and PB II do 
not reveal identical chromosomal information - which supports the findings in our study 
(Table 4). Geraedts et al. 2010 suggested that the polar body (PB) approach be thoroughly 
investigated by a panel of researchers and reported annually at ESHRE PGD Consortium 
2011.  Array CGH screening of the first and second polar bodies added valuable 
information to the criteria needed in order to select an viable embryo for transfer as 
reported by Geraedts et al., 2011 and Magli et al., 2011. In spite of the fact that more than 
half of mature (M II) oocytes obtained from young donors were aneuploid; the majority 
were fertilizable and subsequently developed into blastocysts. We hypothesize that the 
ability to fertilize eggs and subsequent extended embryo culture to blastocysts in no way 
affirms the chromosomal integrity of those blastocysts.  The outcome of our small study 
and the transfer of vitrified/warmed blastocysts that originated from normal 
oocytes/zygotes and Day 3 blastomeres as determined by sequential PGS of PB-I, PB-II 
and blastomere, respectively, resulted in encouraging implantation and pregnancy results 
and limiting high order multiples (Ta 5). We conclude that future studies regarding that 
sequential chromosomal screening of the whole genome to determine the chromosomal 
status of an embryo will shed more light on this controversial topic.   
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TABLE 1. Oocyte Grading used for CGH –study  
 
Grade 1: Homogeneous cytoplasm, intact PB, normal oocyte shape, no cytoplasmic 
defect, no PV and zonae defect, normal oolemma. 
 
Grade 2: Homogeneous cytoplasm, and at least 2 of following 
: 
Fragmented PB 
Abnormal oocyte shape 
Cytoplasmic droplets 
Vacuoles 
Grainy spots 
Increased PV space 
Darken zonae or defect 
Double oolemma 
 
Grade 3: No homogenous cytoplasm, and at least 3≥ above. 
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TABLE 2. Graduated embryo scoring (GES) of cleavage stage embryos. 
 
Evaluation  
Hours after 
insemination  Developmental milestone  Score   
    
1  16–18  Nucleoli aligned along pronuclear axis  20  
    
    
2  25–27  Cleavage regular and symmetrical     Fragmentationa  30  
    
    
      Absent  30  
    
    
      <20%  25  
    
    
      >20%  0  
    
3  64–67  Cell number and grade
b 7CI, 8CI, 8CII,   
   9CI  20  
    
    
      7CII, 9CII, 10CI, 11CI, Compacting I  10  
    
Total score        100  
 
 
Fisch 2001. Graduated embryo score (GES).  
[a] If the embryo was not cleaved at 25–27 hours, grading of fragmentation should occur at 
the 64–67 hour evaluation if the embryo reached the seven-cell stage and had <20% 
fragmentation. 
[b] Grade I = symmetrical blastomeres and absent fragmentation. Grade II = slightly uneven 
blastomeres and <20% fragmentation. Grade III = uneven blastomeres and >20% 
fragmentation. Grade A embryos are seven or more cells with <20% fragmentation. 
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TABLE 3. Blastocyst grading:  
 
Blastocyst grading according to Dokras et al., 1993 was performed as follows:  
 
Grade 1 blastocysts were characterized by early cavitation resulting in the formation of an 
eccentric and then expanded cavity lined by a distinct inner cell mass region and 
trophectoderm layer. 
 
Grade 2 blastocyst exhibited a transitional phase where single or multiple vacuoles were 
seen which over subsequent days developed into the typical blastocyst appearance of a 
grade 1 blastocysts. 
 
Grade 3 blastocysts were defined as blastocysts with several degenerative foci in the 
inner cell mass with cells appearing dark and necrotic. 
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TABLE 4  Data for all 57 oocytes 
 
Oocyte # Oocyte Grade 1st PB 2nd PB Blastomere sHLA-G Blast Grade 
1 1 18L N 18G 0.139 BII 
2 1 N N N 0.119 BII 
3 1 17L,22L INC INC 0.139 BII 
4 1 INC INC INC 0.149 NO Blast 
5 2 INC N N 0.178 BIII 
6 2 4L,5L,17L,21G 22L,7G 22L 0.18 BI 
7 1 INC INC INC 0.109 BI 
8 1 1L,13L,16L 12G,15G,16G,20G 16L,1G,13G 0.146 BI 
9 2 N N N 0.125 BIII 
10 1 N N N 0.173 NO Blast 
11 2 18L,21L,22L 21L,17G,22G 18L,21L 0.148 NO Blast 
12 2 N N N 0.201 BII 
13 2 22G 11L N 0.149 BII 
14 1 21L,22L,5G 4G,5G,13G,19G 3G,4G,5G,16G,22G 0.158 NO Blast 
15 1 22L,5G 17L,4G,5G 5G,6G,22G 0.209 BII 
16 1 20L,22L 12G,15G,22G 5L,22L 0.117 BII 
17 2 N N N 0.138 BII 
18 3 16L,20L,4G 4G,13G,17G 16L,9G 0.191 BI  
19 1 N N N 0.135 BII 
20 2 N N N 0.163 BII 
21 1 N N N 0.136 EBIII 
22 2 20L,22L,4G 22L,7G 20G 0.149 BII 
23 3 1L,9L,15L 22L 1G,9G,15G,22G 0.145 BII 
24 3 N N N 0.189 BI 
25 3 16L,7G 15L,6G,13G 4G,7G,19G 0.141 BI 
26 1 3L,16G,21G 5G 22L,3G,21G 0.127 EBIII 
27 2 5L 5G N 0.189 EBIII 
28 1 7L 10G,14G 10L,19G 0.137 BII 
29 1 N N N 0.161 BII 
30 1 N N N 0.202 BII 
31 2 21L,11G,12G,15G 9G 11L,12L,22G 0.155 NO Blast 
32 2 N N N 0.131 NO Blast 
33 3 N 12L 22L,5G,6G 0.122 BIII 
34 3 N N N 0.167 BI 
35 2 N N N 0.195 BIII 
36 1 4G,10G,22L N 24L,22G 0.153 NO Blast 
37 2 19L,21L,1G 7L 1L,21G 0.197 NO Blast 
38 1 N N N 0.149 BII 
39 1 4L,16G,18G 3G 10L,22G 0.176 NO Blast 
40 2 14G,15G 22L 11G,14G 0.164 BII 
41 1 21L 14G,17G 13G 0.129 BII 
42 1 7G,13G,17G,20G 4L 7L,17L,20L 0.205 BII 
43 1 1L,21L N 1G,4G,5G 0.201 NO Blast 
44 2 N N N 0.284 NO Blast 
45 1 1G,16G,17G 4L,5L 20G 0.107 EBIII 
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TABLE 4 continue 
 
 
46 1 6G,9G N 9L,1G,8G 0.114 NO Blast 
47 1 N N N 0.107 NO Blast 
48 3 N N N 0.153 EBIII 
49 2 18L,1G,17G,19G 6L 17L,19L 0.149 BII 
50 3 N N N 0.176 BIII 
51 3 1L,2L,21L FRAG 12G,21G 0.226 NO Blast 
52 3 5G,6G,17G,19G 5G,14G 5L,17L,19L 0.226 NO Blast 
53 1 16L,5G,6G 7L 10G,21G 0.164 CIII 
54 2 5L 7L,13L,17L 4G,5G 0.16 BIII 
55 2 N N N 0.123 NO Blast 
56 1 21L,22L,5G 4G,5G,19G 3G,5G 0.165 BII 
57 1 1L,16L,20L FRAG 16L,20L 0.191 BII 
L=Loss 
G=Gain 
N= NORMAL set of chromosomes  
FRAG = Polar body was fragmented and DNA amplification was not possible  
PB1 = Polar body 1 
PB2 = Polar body 2 
INC = DNA amplification was possible but imaging and analysis was not possible   
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TABLE 5   CGH –study pregnancy outcome  
 
# Embryo recipients  5 
Age years (ave) 37±1.5 
# Euploid blastocyst vitrified 11 
# Euploid blastocyst warmed  11 
# Euploid blastocyst that survived warming (%) 10/11 (97.9) 
# Euploid blastocysts transferred (total)           10 
# Euploid blastocysts transferred (ave) 2.0 
Implantation/euploid blastocyst transferred (%) 5/10 (50) 
Live babies/euploid blastocyst transferred (%) 5/10 (50) 
Birht rate per warmed euploid blastocyst (%) 5/11 (45.5) 
Full term pregnancies (%) 4/5 (80) 
Singletons  3 
Twins (two babies) 1 
Triplets 0 
Miscarriages 0 
 
 
 
Figure 1: Diagram of non-disjunction and premature separation as illustratrated by  
      Vialard et al., (2006) 
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CHAPTER 6 
 
THE MORPHOLOGICAL, BIOCHEMICAL AND GENETIC FEATURES OF 
EMBRYOS THAT HAVE BEEN SHOWN TO BE PREDICTIVE OF 
IMPLANTATION AND PREGNANCY OUTCOME IN ART 
 
ABSTRACT 
Introduction 
Identifying a developmentally competent embryo to transfer that has the highest probability 
to develop into a live baby has been an issue of debate and continues research. 
 
Aim 
The aim of this chapter is to discuss the morphological, biochemical and genetic features 
of an embryo that has been shown to be predictive of implantation and pregnancy 
outcome in ART using most current evidence. 
 
Methods 
A literature search was performed looking at the correlation between pronuclear 
morphology, early cleavage, cleavage stage embryos, blastocyst development, the 
presence of sHLA-G, CGH, PGS, embryo development and implantation/pregnancy rates 
in ART. 
 
Results 
Based on the available literature, a combination of observations could assist the scientist 
with embryo selection. The pronuclear stage morphology, the early embryo division, 
cleavage embryo stage and quality of the day 3 embryos provides limited guidance.  
However, choosing a blastocyst with a positive sHLA-G result on Day 5 is the optimal 
combination to make the final selection before embryo transfer or freezing 
 
DISCUSSION 
This non-invasive approach should improve pregnancy outcome and reduce multiple 
pregnancy rates. As far as the use of the more invasive technology such as aCGH is 
concerned, more research on pregnancy outcome is needed. 
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 INTRODUCTION 
 
Since the inception of assisted reproductive technology (ART) two decades ago, it has 
been constantly evolving as far as ovulation induction, embryo culture conditions, culture 
medium and embryo transfer techniques are concerned. However, identifying a 
developmentally competent embryo to transfer that has the highest probability to develop 
into a live baby have been an issue of debate and continuous research. Currently embryo 
selection is predominantly based on morphological appearance. Several developmental 
characteristics have been suggested as selection criteria in order to identify a viable 
embryo. In several earlier reported studies it was evident that morphological evaluations 
furnish clues that enhanced the ability in choosing the best embryos for transfer (Cummins 
et al., 1986; Puissant et al., 1987; Staessen et al., 1992; Visser et al., 1993; Roseboom 
1995; Ziebe et al., 1997; Shoukir et al., 1997; Van Blerkom 1997). However, these 
methods were severely limited to provide reliable evidence for predicting normal embryo 
implantation and live birth outcome. Furthermore, it has been suggested that 
morphological evaluation does not fully reflect the developmental potential of a 
preimplantation embryo (Munne & Cohen, 1998). Scoring for Day 3 embryos were first 
reported by Desai et al. 2000, whereas all prior scoring systems were based on the 
second day of culture (Day 2). In 2001, Fisch et al., introduced a graduated embryo 
scoring (GES) system in which embryos were individually cultured, allowing for sequential 
microscopic assessment of developmental stages starting on Day 1 through Day 3 of 
embryo culture. More recent, extended embryo culture to the blastocyst stage has been 
promoted by studies of Gardner et al., 1999a; Gardner et al., 2000a and Gardner et al., 
2000b.  Jurisicova et al. 1996a/b reported that soluble Human Leukocyte Antigen-G 
(sHLA-G) expression was present during preimplantation human embryo development and 
was detected in culture; medium surrounding grouped embryos (Fuzzi et al., 2002). This 
biochemical marker could be used as a non-invasive tool to identify embryos with high 
implantation potential. The first successful clinical application of PGD was reported by 
Handyside 1990. A few years later, Kallioniemi et al., 1992 developed comparative 
genome hybridization (CGH) to screen the whole genome’s DNA in tumors. This technique 
was adopted to study the DNA of single cells (like blastomeres) by Wells et al., 1999 and 
Voullaire et al., 2000.  There have been reports on the successful use of array-CGH by Hu 
et al., 2004 and Wells et al., 2004 and more recent the use of SNP-array to detect any 
chromosome imbalances and genome wide linkage analysis by Handyside et al., 2010. 
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The aim of this chapter is to discuss the best available evidence of morphological, 
biochemical and genetic features of an embryo that have been shown to be predictive of 
implantation and pregnancy outcome in ART. These features will be discussed under the 
headings non-invasive and invasive methods. 
 
NON-INVASIVE METHODS 
 
Pronuclear Morphology 
 
The presence of two pronuclei has been the standard for assessing “normal” fertilization 
and has been associated with normal embryo development (Tesarik et al., 1989) and early 
stages of RNA-synthesis (Tesarik et al., 1986). Additional evaluation of pronuclei such as 
positioning within the ooplasm, their size, nucleoli distribution, orientation with respect to 
the polar bodies and the presence of a cytoplasmic halo have been suggested to be of 
value. 
 
Several studies reported on the positive correlation between pronuclear morphology and 
embryo morphology/development, namely Salumets et al., 2001, Van Blerkom et al., 2002; 
Ebner et al., 2003; Scott 2003; Balaban et al., 2004; Shen et al., 2006; Sjöblom et al., 
2006; Depa-Martynow et al., 2007; Alvarez et al., 2008, Liao et al., 2006, Nicoli et al., 2007 
and Zamora et al., 2011.  However, some studies by Wittemer et al., 2000; Payne et al., 
2005, James et al., 2006 and Nicoli et al., 1010 reported no correlation between 
pronuclear morphology and embryo morphology/development. 
 
The most important point of interest is without doubt the correlation of pronuclear 
morphology and pregnancy rates. The following studies reported a positive correlation 
between pronulear morphology and implantation/pregnancy outcome in ART: Lundqvist et 
al., 2001; De Placido et al., 2002; Lukaszak et al., 2003; Kattera & Chen, 2004; Shen et 
al., 2006; Gianaroli et al., 2007; Li et al., 2007; Scott et al., 2007; Alvarez et al., 2008; Liu 
et al., 2008 and a prospective study by Montag & Van der Ven 2001. However, there were 
some studies that reported no correlation between pronulear morphology and 
implantation/pregnancy outcome in ART: Salumets et al., 2001; Payne et al., 2005; Chen 
& Kattera, 2006; James et al., 2006; Liao et al., 2006; Nicoli et al., 2007; Brezinova et al., 
2009, Arroyo et al., 2007; and Arroyo et al., 2010. 
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A few studies have been addressing the positive correlation between pronulear 
morphology and embryo ploidy: Sadowy et al., 1998; Chen et al., 2003; Coskun et al., 
2003; Gamiz et al., 2003; Gianaroli et al., 2003; Balaban et al., 2004; Borges et al., 2005 
and Gianaroli et al., 2007. However, there was a study by Arroyo et al., 2010 which 
reported no association between pronuclear morphology and genetic status of an embryo. 
 
Early zygote cleavage evaluation 
 
Shoukir et al., 1997 defined “early cleavage” as the timing at which the first mitotic division 
post fertilization takes place - this phenomenon has been extensively studied to be used 
as additional criteria for embryo selection prior to transfer and as a predictor of embryo 
development potential and improved implantation/pregnancy rates.  As early as 1984, 
Edwards et al., postulated that early cleavage resulted into a higher degree of 
developmental competence compared to those embryos that did not undergo early 
cleavage. 
 
Several studies have also been published on the topic of “early cleaving/fast dividing” 
embryos and its subsequent effect on embryo morphology and implantation/pregnancy 
outcome in vitro. The effect of early cleaving zygotes on subsequent embryo development 
has been reported.  Fenwick et al., 2002 associated early cleavage with increased 
developmental potential, Van Montfoort et al., 2004, associated early cleavage with 
improved blastocyst development and Fu et al., 2009 associated early cleavage with 
improved embryo quality. Retrospective studies that reported a positive correlation 
between these “fast cleavers” and implantation and pregnancy outcome were published by 
Shoukir et al., 1997, Ziebe et al., 1997, Sakkas et al., 1998, Bos-Mikich et al., 2001, 
Petersen et al., 2001, Tsai et al., 2002, Salumets et al., 2003, Van Montfoort et al., 2004, 
Windt et al., 2004, Ciray et al., 2005, Giorgetti et al., 2007, Rehman et al., 2007 and Fu et 
al., 2009. Prospective studies confirming the above is also of importance (Isiklar et al., 
2002; Brezinová et al., 2003). 
 
On the other hand prospective studies by Brezinová et al., 2004 and Chen and Kattera 
2006 reported that the transfer of early cleaved embryos did not benefit 
implantation/pregnancy rates. Furthermore, in 2008, Sundström & Saldeen confirmed the 
above findings. As with pronuclear stage embryo morphology there is no consensus in the 
international literature on potential advantages/disadvantages of early embryo cleavage. 
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Developmental stage: Blastocyst vs cleavage stage transfer  
 
Since the inception of IVF, the majority of IVF clinics transferred embryos at the cleavage 
stage. However, extended culture of embryos to the blastocyst stage have since been 
reported by Gardner and Lane 1997; Menezo et al., 1998 Gardner et al., 2000a/b and Pool 
2002.  The main purpose of the trend towards blastocyst transfer is an attempt to reduce 
the number of embryos being transferred, resulting in a reduction of multiple implantations 
after IVF/ICSI-ET therapy. 
 
Extended embryo culture has its benefits and shortfalls: 
 a reduction in the number of available embryos, however, it has been speculated that 
extended culture distinguish between embryos with a poor or a high developmental 
potential (Tesarik 1994; Van Blerkom 1994).  
 Improved implantation rates with a reduced number of embryos transferred resulted 
in a reduction of multiple pregnancies. 
 Blastocyst stage transfers might eliminate some chromosomally abnormal embryos 
for transfer (Alfarawati et al., 2011a/b) since Magli et al., 2000 reported that many 
Day 3 embryos with a ”normal” morphology on Day 3 are actually chromosomally 
abnormal due to mosiacism. That said, extended embryo culture does provide 
information about an embryo’s viablity in vitro, however it should not be directly 
associated with pregnancy outcome. In Chapter 4 of this thesis it was reported that 
58% of aneuploid day 3 embryos did reach the blastocyst stage of development, 
therefore refuting the belief that blastocyst stage transfers might eliminate some 
chromosomally abnormal embryos for transfer. 
 
Blastocyst grading systems have been developed by Cohen et al., 1985, Dokras et al.,  
1993, Gardner and Schoolcraft  1999b, Richter et al., 2001 and Kovacic et al., 2004.  
These morphological grading systems take into account expansion of the blastocoel 
cavity, characteristics of the inner cell mass (ICM) and the trophectoderm (TE). In 2000, 
Balaban et al., reported that the transfer of good quality blastocysts were associated with 
improved implantation rates compared to poor quality blastocysts. Racowsky et al., 2000 
suggested that extended culture of at least two, but preferably three more high quality 
eight-cell embryos on day 3, should develop into sufficient blastocysts for transfer and/or 
cryopreservation.  Papanikolaou et al., 2005 similarly suggested that four good quality Day 
3 embryos should undergo extended culture and be transferred at the blastocyst stage, 
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providing patients with a better chance of achieving a live birth compared to cleavage 
stage embryo transfer.  
 
Several studies have reported improved implantation/pregnancy rates when transferring 
blastocyst embryos compared to cleavages stage embryos: Blake et al 1004; Schwarzler 
et al., 2004; Levitas et al, 2004; Pantos et al., 2004a/b; Papanikolaou et al., 2005; Blake et 
al., 2005; Blake et al., 2007 and Mangalraj et al., 2009. Papanikolaou et al., 2008 
performed a meta-analysis to compare studies where equal number of embryos in both the 
cleavage-stage and the blastocyst-stage were transferred and compared clinical 
pregnancy rate, multiple pregnancy rate and live birth rate outcomes. They found that 
clinical pregnancy rates were significantly higher in patients who received a blastocyst-
stage embryo for transfer compared to patients that received a cleavage-stage embryo for 
transfer. Live birth rates were also significantly higher in the blastocyst-stage compared to 
cleavage-stage embryo category. 
 
Some studies reported no difference in ART outcome when blastocyst and cleavage stage 
transfers were compared (Bungum et al., 2003; Hreinsson et al., 2004; Utsunomiya et al., 
2004. Controversially, Levron et al., 2002) reported a significant decrease in implantation 
rates associated with blastocyst transfer concluding blastocyst transfer had a negative 
effect on clinical pregnancy rates. Finally a few studies by Criniti et al., 2005; Henman et 
al., 2005 and Zech et al., 2007, suggested that transferring of a single blastocyst could 
effectively reduce multiple pregnancies without compromising the live birth rates as 
reported by American Society for Reproductive Medicine 62nd Annual Meeting, 2006. 
 
BIOCHEMICAL EVALUATION 
 
Soluble HLA-G 
 
The implantation mechanism is a very poorly understood aspect of reproduction. It is a 
highly complex dialog (cross-talk) between the embryo and the endometrium (Simón et al., 
1995; Hill 2001; Viganò et al., 2003; Shimomura et al., 2006. Implantation requires the 
successful suppression of the maternal immune system. The human body will identify and 
discriminate against foreign tissue by major histocompatability complex (MHC), human 
leukocyte antigen (HLA) originated from a group of genes located on the short arm of 
chromosome six (6).  The MHC evokes T-cell intervention to non-self antigens expressed 
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by an individual of the same species.  The human fetus is considered a non-self tissue to 
the maternal uterus due to paternal MHC antigens. However, during pregnancy the 
immune system develops fetal tolerance (Saito et al., 2007). HLA-G produced by the 
extra-villous cytotrophoblast (the only fetal contact with maternal uterine cells), confers 
immuno-tolerance through interaction with maternal uterine membrane lymphocytes.  This 
scenario would suggest that HLA-G protects the fetus from maternal immune response 
attack.  HLA-G is expressed by the placenta throughout gestation and is also present in 
amniotic fluid.  Soluble HLA-G (a spliced iso-form of membrane bound HLA-G) is in 
suspension and can be detected in culture medium. sHLA-G, a non-classic type I human 
leukocyte antigen, was first identified in the media surrounding groups of embryos and 
blastocysts in culture by Jurisicova et al.,  1996a/b.  Menicucci et al 1999, first identified, 
sHLA-G (a non-classic type I human leukocyte antigen), in the culture media surrounding a 
group of Day 3 embryos. Fuzzi et al., 2002 has shown that the presence of sHLA-G in the 
culture media harboring groups of three day old cleaved embryos, correlated both with 
their cleavage rate and with their overall subsequent implantation potential.  Hviid et al., 
2004 postulated that the presence of sHLA-G protected the conceptus from destruction by 
the maternal immune response.   
 
However, there has been some criticism of using the optical density (OD) value as our 
sHLA-G unit value; no previous reported studies performing sHLA-G analysis have 
reached consensus on the appropriate way to report these results (Fournel et al., 2000; 
Rebmann et al., 2004; Criscuoli et al., 2005; Noci et al., 2005; Yie et al., 2005; Desai et al., 
2006; Rebmann et al., 2007; Sargent et al., 2007; Vercammen et al., 2008). 
 
The detection of soluble HLA-G in culture medium surrounding embryos has been 
reported by Jurisicova et al., 1996a; Menicucci et al., 1999 and Fuzzi et al., 2002. Several 
studies regarding sHLA-G and its effect on pregnancy outcome have been reported since 
(Sher et al., 2004; Sher et al., 2005a; Sher et al., 2005b; Criscuoli et al., 2005; Noci et al., 
2005; Yie et al., 2005; Desai et al., 2006; Fisch et al., 2007 Rebmann et al., 2007; Kotze et 
al., 2010). The prospective randomized trial by Kotze et al., 2010 on more than 200 
patients showed a significant benefit when selecting embryos on the basis of sHLA-G. In 
Chapter 3 the multicentre study also confirmed the value of sHLA-G to predict pregnancy 
outcome. It was also emphasized in Chapter 3 that this biochemical tool can also be used 
to reduce multiple pregnancies. In review studies by Sargent et al., 2007 and Vercammen 
et al., 2008 they thoroughly evaluated and discussed previous studies regarding sHLA-G 
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and ART outcome. In a meta-analysis by Vercammen et al. they reported that sHLA-G is 
moderately helpful in predicting pregnancy, however if the embryos are of good quality 
sHLA-G has much better diagnostic performance. Furthermore, Rebmann et al., 2004 
addressed specific issues dealing with sHLA-G ELISA protocols. 
 
It is important that the threshold values should be standardised and one should consider 
this as a valuable non-invasive embryo marker to assist with embryo selection and the 
theoretical potential to improve pregnancy outcome and simultaneously reduce multiple 
pregnancies.  A combination of sHLA-G expression and extended embryo culture to the 
blastocyst stage might provide future tools by which to select single embryos for transfer. 
 
INVASIVE METHODS 
 
Embryo Pre-implantation Genetic Screening (PGS) 
 
Pre-implantation genetic screening of embryos is applied to patients at risk such as: 
advanced maternal age (AMA), recurrent pregnancy loss, repeat IVF failure or severe 
male factor infertility (Baruch et al., 2008). 
 
In the past the most common technique used for PGS was fluorescence in situ-
hybridization (FISH) – a fast and relatively easy procedure to perform. However, recently 
the validity of FISH PGS was scrutinized by Staessen et al., 2008 since this procedure did 
not improve implantation and delivery rates in women <36. In contrast, Hardarson et al., 
2008 reported that PGS caused a decrease in women with advanced maternal age (AMA). 
Possibly due to cleavage stage embyos affected by mosaicism that could have affected 
the accuracy of PGS (Munne et al., 1994; Bielanska et al., 2002; Li et al., 2005). Finally 
another possible explanation why FISH PGS does not improve pregnancy/implantation 
rates is the fact that the complete genome (22 pairs of outosomal and the two sex 
chromosomes) is not screened – leaving the potential to transfer aneuploid embryos, 
(untested) which could potentially influence embryo development and implantation. 
Kallioniemi et al., 1992 developed comparative genome hybridization (CGH) to screen the 
whole genome’s DNA in tumors. This technique was modified to study the DNA of single 
cells (like blastomeres) by Voullaire et al., 1999 and Wells et al., 1999.  The CGH 
technique is superior to FISH since it screens the whole genome for anomalies such as 
chromosome imbalances due to aberrant segregation and structural imbalances 
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(gains/losses) larger than 10-20 Mb as reported by Griffin et al., 1998 and Malmgren et al., 
2002. A disadvantage of CGH is that it is very time/labor intensive – it takes up to four 
days to obtain results after hybridization and amplification of the DNA and comparing the 
test DNA to that of a normal template of chromosomes. First (PB-I) and second polar body 
(PB-II) screening (evaluating the oocyte and zygote’s genome), allowing fresh embryos 
transfers, have been reported by Wells et al., 2002; Sher et al., 2007; Obradors et al., 
2008; Obradors et al., 2009 and Fragouli et al., 2009.  Day 3 blastomere was evaluated to 
detect the influence of paternal contribution as reported by Wilton et al., 2001; Voullaire et 
al., 2002; Sher et al., 2007; Sher et al., 2009 and Kotze et al., 2012. 
 
Kotze et al., 2012 reported no association between the chromosomal status of PB-I, PB-II, 
Day 3 blastomeres and subsequent blastocyst formation. However, they reported 
respectable live birth outcome when sequential screening was applied and normal 
embryos developed into blastocysts and were transferred. 
 
Lately, the removal of several trophectoderm cells at the blastocyst stage has been 
reported by Fragouli et al., 2009 and Schoolcraft et al., 2010.  Blastocyst biopsy required 
embryo cryopreservation, allowing time to complete CGH analysis.  Euploid embryos can 
be thawed and transferred in a future FET cycle. However, potential detrimental effects of 
cryopreservation post PGD has been reported by Joris et al., 1999, Edgar et al., 2000 and 
Zheng et al., 2005, resulting in a 30-40% reduction in implantation potential. 
 
Recently the introduction of vitrification of blastocysts by Mukaida et al., 2003 and Zhang 
et al., 2009 has significantly improved the survival of warmed embryos.  Sher et al., 2007 
and Kotze et al., 2012 reported 50% live birth rates after the transfer of PGS 
vitrified/warmed blastocysts.  
 
Lately, a faster technology has been developed, allowing a more rapid and more detailed 
analysis of PB-I, PB-II, Day 3 blastomeres and trophectoderm cells, namely array-CGH 
(Hu et al., 2004; Wells et al., 2004; Le Caignec et al., 2006; Treff et al., 2010; Treff et al., 
2011).  Different approaches (by modifying earlier procedures) to screen the whole 
genome compliment within 16 hours and to potentially avoid embryo cryopreservation of 
PGS embryos have been suggested by Gutierrez-Mateo et al., 2004 and Landwehr et al., 
2008. 
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Screening the whole genome has indicated that anomalies could be present in any of an 
embryo’s chromosomes. In the study by Kotze et al., 2012 and Traversa et al., 2011, it has 
been shown that aneuploid embryos have the potential to develop to a blastocyst. These 
findings contradict the belief that aneuploidy of the larger chromosomes (1-12) are less 
likely to develop into a blastocyst. FISH indentifies a single point on a chromosome while 
CGH-probes cover the entire length of a chromosome, therefore structural anomalies can 
be detected such as partial duplications and deletions. Translocation errors can be 
detected by the ability of CGH to determine a loss/gain of parts of chromosomes. Traversa 
et al., 2010 has shown that FISH suffers from high false positive abnormality rates. 
Improved PCR technologies (array-CGH) have been reported by Traversa et al., 2010 to 
improve translocation screening.  Furthermore, CGH can detect translocation in cases 
where the fragments are large enough – balanced translocation can thus be determined as 
well as the ploidy status of all other chromosomes. FISH analyzes each cell individually for 
the specific probe(s) that are applied. 
 
Traversa et al., 2010 demonstrated the reliability and feasibility of CGH to detect 
aneuploidy in blastocysts.  Kotze et al., 2012 used sequential CGH screening of PB-I, PB-
II and Day 3 blastomeres to identify aneuploid embryos, subsequent blastocysts were 
vitrified.  Blastocysts that were classified as euploid were warmed and transferred, 
resulting in excellent implantation and pregnancy outcomes. 
 
Most recently a more rapid method to perform cyto-genetic screening has been 
introduced, namely array CGH. Currently there are two approaches that are being applied: 
single nucleotide polymorphism array (SNP–array) and CGH-array. 
 SNP-array: Common polymorphic DNA sequences found throughout the genome is 
used to detect any chromosome imbalances and genome wide linkage analysis 
(Handyside et al., 2010; Vanneste et al., 2009; Treff et al., 2010; Treff et al., 2011). 
 CGH-array: test and reference DNA is hybridized to DNA probes fixed to a slide. 
Several reports on the successful use of array-CGH: Hu et al., 2004; Wells et al., 
2004 and Le Caignec et al., 2006. Furthermore, some clinical applications have been 
reported by Hellani et al., 2008, Fishel et al., 2010 and Rius et al., 2010. 
 
The latest studies to improve the efficiency/accuracy of PGS are the use of BAC 
microarrays in order to detect aneuploidy in all chromosomes as reported by Fragouli et 
al., 2011 and Guiterrez-Mateo et al., 2011. Furthermore, this technique could also be used 
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to determine specific segmental errors during chromosomal rearrangement as reported by 
Alfarawati et al., 2011a and Fiorentino et al., 2011.  
 
Based on the previous experience with FISH-PGS it is too early to comment on the true 
value/benefit of aCGH. More data regarding pregnancy outcome is needed before a final 
conclusion can be rendered, however, this technology (despite being invasive and costly) 
looks very promising in assisting clinicians and scientists with this embryo selection 
method for selective patients. 
 
CONCLUSION 
 
To conclude, based on the available literature it is logical to use all available tools for 
embryo selection. A combination of observations for embryo selection, starting with the 
pronuclear stage morphology, early zygote cleaving, cleavage-stage embryo 
morphology/quality on Day-3, but ultimately choosing a blastocyst on Day 5 with sHLA-G 
values available, will assist the scientist in making the final decision before selecting an 
embryo for transfer or cryopreservation. This non-invasive approach should improve 
pregnancy outcome and reduce multiple pregnancy rates. As far as the use of the more 
invasive approach technology such as aCGH is concerned, more research on pregnancy 
outcome is needed. 
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Chapter 7 
 
CONCLUSIONS AND FUTURE PERSPECTIVE  
 
ABSTRACT 
 
A combination of observations for embryo selection, starting with oocyte grading, 
pronuclear stage morphology, early zygote cleaving and cleavage-stage embryo 
morphology/quality on Day-3, however, ultimately using extended embryo culture and 
choosing a blastocyst on Day 5 with positive sHLA-G values available, will assist the 
scientist in making the final decision before selecting an embryo for transfer or 
cryopreservation. The use of aCGH (for chromosomal analysis) is invasive and is still 
considered experimental. 
 
DISCUSSION 
 
Since the inception of IVF there has been great progress in the ART arena.  However, 
there are some areas that still lack understanding and are in need of continuous research.  
The reduction of multiple gestations might be resolved if the mechanism of implantation, 
the identification of embryos to transfer with the highest probability to implantation are 
systematically investigated. In this thesis two approaches were ultimately investigated: 
non-invasive and invasive.  
 
A literature review was thus performed to research the impact of the oocyte/zygote and the 
embryo on implantation/pregnancy rates.  The morphologic characteristics of the oocyte;- 
cumulus –oocyte-complex (COC), zona pellucida, perivitelline space, cytoplasm, meiotic 
spindle and the polar body and its appearance was studied. The morphologic 
characteristics of the zygote;- pronuclei orientation, the embryo and its effect on embryo 
development, ploidy and blastocyst formation and its effect on implantation and pregnancy 
outcome was also reviewed. The pronuclear morphology, early cleavage and a 
biochemical marker that is expressed by developing embryos (soluble Human Leucocyte-
Antigen-G) and its role in predicting pregnancy outcome was discussed as non-invasive 
markers. “Omics” is another non-invasive approach in order to identify the most competent 
embryos for transfer. “Omics” covers genomics, transcriptomics, proteomics, and 
metabolomics but provides limited information and more research and is required in this 
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field. The value of blastocyst transfer and the improved ongoing pregnancy rate compared 
to cleavage stage embryos was also highlighted based on a recent meta-analysis.  
Genetics testing using FISH, CGH and array-CGH and the future of genomics was 
discussed as invasive markers. 
 
In the future the ultimate goal is to have a non-invasive set of criteria and parameters to 
apply to developing embryos in vitro by which to identify the most competent embryo/s for 
transfer that each will lead to pregnancy and a single live baby. In the first prospective 
randomized study in the international literature comparing the traditional way of embryo 
evaluation versus sHLA-G expression plus a cumulative GES-score on day 3 as selection 
criteria was reported. It was concluded that by combining a positive sHLA-G expression 
with the highest GES-score on Day 3 resulted into significantly improved pregnancy 
outcome. Furthermore a multicentre study evaluating the impact of sHLAG on pregnancy 
outcome was undertaken. This multi centre study indicates the benefit in the use of sHLA-
G but the threshold values must be standardised. Clinics should consider this assay as a 
valuable non-invasive embryo marker to assist in improving pregnancy outcome with the 
theoretical potential to reduce multiple pregnancies.  A combination of sHLA-G expression 
and extended embryo culture to the blastocyst stage might provide future tools by which to 
select single embryos for transfer and reduce the risk of multiple pregnancies, without 
compromising the pregnancy rates. 
 
Another important fact is the ploidy status of the embryo. This invasive approach includes 
embryo biopsy for either polar bodies, day 3 blastomeres or day5/6 trophectoderm.  FISH 
has been used extensively, using a single day 3 blastomere, to identify single gene 
anomalies and aneuploidy in a limited number of chromosomes.  FISH was also 
successfully used for gender selection.  The introduction of WGA/CGH was an 
improvement to FISH since all 23 pairs of chromosomes were analyzed.  CGH however, 
only revealed gains/losses in chromosomes and the process was very time consuming.  
Since then, arrayCGH was introduced, it analyzes the whole genome in fine detail (small 
base-pairs).  A real-time “same day” assay was recently introduced.  Quantitative real time 
polymerase chain reaction is a rapid analysis of the whole genome and results are 
available within four (4) hours. 
 
 A study on the ploidy status of oocytes and embryos were conducted in chapter 5. In spite 
of the fact that more than half of mature (M II) oocytes obtained from young donors were 
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aneuploid; the majority were fertilizable and subsequently developed into blastocysts. We 
hypothesize that the ability to fertilize eggs and subsequent extended embryo culture to 
blastocysts in no way affirms the chromosomal integrity of those blastocysts. (Figure 1 – 
Pictures of Deceptive Blastocyst Development)  The outcome of our small study and the 
transfer of vitrified/warmed blastocysts that originated from normal oocytes/zygotes and 
Day 3 blastomeres as determined by sequential PGS of PB-I, PB-II and blastomere, 
respectively, resulted in encouraging implantation and pregnancy results and limiting high 
order multiples. Based on the previous experience with FISH-PGS it is too early to 
comment on the true value/benefit of aCGH. More data regarding pregnancy outcome is 
needed before a final conclusion can be rendered, however, this technology (despite being 
invasive and costly) looks very promising in assisting clinicians and scientists with this 
embryo selection method for selective patients. 
 
CONCLUSION 
 
To conclude, based on the available literature it is logical to use all available tools for 
embryo selection. A combination of observations for embryo selection, starting with the 
pronuclear stage morphology, early zygote cleaving, cleavage-stage embryo 
morphology/quality on Day-3, but ultimately choosing a blastocyst on Day 5 with sHLA-G 
values available, will assist the scientist in making the final decision before selecting an 
embryo for transfer or cryopreservation. This non-invasive approach should improve 
pregnancy outcome and reduce multiple pregnancy rates. As far as the use of the more 
invasive approach technology such as aCGH is concerned, more research on pregnancy 
outcome is needed. 
 
We conclude that despite all the above mentioned parameters to select an embryo for 
transfer that will develop into a live baby, extensive research and international 
corroboration is needed in order to improve and standardize such criteria. 
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Figure 1:  Pictures of Deceptive Blastocyst Development  -  
  (Four) 4 CGH abnormal blastocyst – (Five) 5 CGH normal blastocyst 
 
 
 
Oocyte 
# 
Oocyte 
grade 
1st PB 2nd PB Blastomere sHLA-G Blast Picture 
 
8 1 1L,13L,16L 12G,15G,16G,20G 16L,1G,13G 0.146 BII 
 
10 1 N N N 0,173 NO BLAST  
15 1 22L,5G 17L,4G,5G 5G,6G,22G 0.209 BII 
 
18 3 16L,20L,4G 4G,13G,17G 16L,9G 0.191 BI 
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19 1 N N N 0.135 BII 
 
21 1 N N N 0.136 EBIII 
 
30 1 N N N 0.202 BII 
 
49 2 18L,1G,17G,19G 6L 17L,19L 0.149 BII 
 
55 2 N N N 0.123 NO BLAST  
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